The spatial regulation of astrocyte mitochondria by Miro1 by Stephen, T-L
 
 
 
The spatial regulation of astrocyte mitochondria 
by Miro1 
 
Terri-Leigh Stephen 
 
A thesis submitted to University College London  
for the degree of Doctor of Philosophy 
 
September 2015 
Department of Neuroscience, Physiology and Pharmacology 
 
 
I, Terri-Leigh Stephen, confirm that the work presented in this thesis is my own. Where 
information has been derived from other sources, I confirm that this has been indicated in the 
thesis. 
	 2	
Abstract 
Mitochondria are energy generating organelles important for regulating the levels of Ca2+ 
inside cells. In terms of astrocytes, intracellular Ca2+ is crucial for many aspects of their 
signalling and for regulating their release of molecules that can profoundly modulate neuronal 
signalling. In addition, astrocytes take up potentially harmful molecules to prevent neuronal 
damage, a process that is energetically demanding. Therefore, it is expected that effective 
spatiotemporal provision of energy and Ca2+ buffering, by mitochondria, is important in 
astrocytes.  
In this thesis, a mechanism is proposed for the spatial regulation of mitochondria within the 
processes of astrocytes involving the EF-hand Ca2+-sensing motifs of the Mitochondrial Rho-
GTPase protein, Miro1. Live-cell confocal microscopy of rat organotypic hippocampal slices, 
revealed that enhancing neuronal activity induces transient mitochondrial remodelling in 
astrocytes alongside a reduction in mitochondrial trafficking, mediated by elevations in 
intracellular Ca2+. Stimulating neuronal activity also induces mitochondrial confinement 
within astrocytic processes close to synapses. Furthermore, the Ca2+-sensing EF-hands of 
Miro1 are important for regulating mitochondrial trafficking in astrocytes and required for 
their confinement near synapses. Additionally, activity-dependent mitochondrial positioning, 
by Miro1, reciprocally regulates intracellular Ca2+ signalling within astrocytes. Disrupting the 
regulation of astrocyte intracellular Ca2+, by Miro1, reduces the number of excitatory 
synapses, potentially though elevated gliotransmission. These results suggest that the spatial 
regulation of mitochondria in astrocytes is not only important for astrocyte communication 
and gliotransmission, but also for maintaining the function of surrounding neurons.  
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Chapter 1 
 
Introduction 
1.1 Neuronal Synaptic Transmission 
Neurons are electrically excitable cells within the brain, first described over 100 years ago by 
Santiago Ramon Cajal, that transmit and process information (Finger, 2004). The point of 
information transfer between neurons is called the synapse (Figure 1.1), of which there are 
two types: chemical and electrical. Electrical synapses allow bidirectional transfer of 
information, where rapid passage of ions from the cytoplasm of one neuron to another occurs 
via small gap junctions of around 3.5 nm (Kandel et al., 2000). This transfer, however, does 
not allow signal gain, as the signal received by the postsynaptic neuron is the same or weaker 
than that of the source neuron. These synapses facilitate the fastest type of response, required 
for defensive responses, but they do not allow for signal modulation. Chemical synapses, 
however, are specialized for directional information transfer and are the main type of synapse 
in the central nervous system (CNS) (Eccles, 1964) *.  
*All future reference to ‘the synapse’ in this thesis will allude to the chemical synapse.   
	 22	
1.2 Cytoarchitectural Organization of the Brain - Two classes of cells 
A typical neuron is composed of a cell body (soma), dendrites and a single axon (Alberts, 
2008). The axon emanates from the soma at the axon initial segment (AIS) or hillock) and can 
reach up to 1 meter in humans. The axon sends out signals to other neurons or muscles, thus 
forming the output end of the neuron. In most long neurons, signal propagation through the 
axon is enhanced by a myelin sheath (formed mainly of cholesterol), which prevents 
dissipation of the signal through insulation. Myelin is white in appearance and thus pertains to 
the white matter of the brain. Dendrites collectively referred to as the dendritic tree, form the 
input end of the neuron. The dendritic tree serves to maximize connections with neighbouring 
neurons (Figure 1.1).  
The synapse is the point at which communication between neurons occurs. Typically, a 
synapse consists of a small protrusion from the axon (axonal bouton or terminal) and a 
projection of a dendrite (dendritic spine). Axons can also form synapses with the dendritic 
shaft, the soma of other neurons or other axons (axo-axonal synapses). The gap between the 
axonal bouton (presynaptic terminal) and the dendritic spine (postsynaptic terminal) is called 
the synaptic cleft. The distance separating the pre- and postsynaptic membranes is usually 
around 20-40 nm and it is here that small molecules called neurotransmitters traverse 
(Hormuzdi et al., 2004) (Figure 1.1).  
However, this simple description makes light of the sheer complexity of the brain. Each 
neuron forms hundreds of connections with a multitude of other neurons, forming highly 
complex neuronal networks that coordinate signalling underlying every thought process, 
including our emotions. 
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Figure 1.1 Neuronal morphology. A typical neuron composed of a cell body (soma), dendrites 
and a single axon. Axons contact dendritic protrusions called spines forming the synapse. 
Synapses are specialised subdomains that enable the communication between two neurons. These 
signals of communication propagate through the axon, insulated by myelin. Gaps in the myelin 
sheath are called nodes of Ranvier. 
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At the synapse, a third component influences the connections made by neurons. These cells 
are a type of glia known as astrocytes. Glial research first began when Virchow described a 
connective substance that formed a sort of ‘glue’, in which the neural cells appeared to be 
embedded (Virchow, 1858). They were later termed astrocytes by von Lenhossek in 1893, as 
they appeared to be star-shaped (von Lenhossék, 1893).  
Astrocytes, also known as astroglia, are the most abundant cell-type in the brain (Azevedo et 
al., 2009) and they project out two types of processes; very fine perisynaptic processes that 
wrap themselves around most synapses, and vascular processes (end feet) that are much larger 
and closely appose blood vessels. Astrocytes can be classed into two groups: fibrous and 
protoplasmic. Fibrous astrocytes are found in white matter and have long thin, unbranched 
processes, whose end-feet ensheath gaps in the myelin sheath, surrounding axons, known as 
nodes of Ranvier (Sofroniew and Vinters, 2010). At nodes of Ranvier the axonal membrane is 
not insulated and it is here that signalling can occur. Protoplasmic astrocytes are instead found 
in grey matter and have branched processes that ensheath synapses, forming the tripartite 
synapse (Sofroniew and Vinters 2010) (Figure 1.2). This thesis will focus on the latter, 
protoplasmic type of astrocyte.  
Protoplasmic astrocytes are the most numerous cell population in the rodent, primate and 
human cortex. However, human protoplasmic astrocytes are larger and more complex than 
their primate and rodent counterparts (Oberheim et al., 2009). The longest human 
protoplasmic processes were roughly 2.6 fold longer than the longest protoplasmic rodent 
processes (97 µm vs 37 µm, respectively). Human astrocytes also extend 10 times more 
processes than rodent astrocytes (37.5 vs 3.75 processes extending from the cell body) 
(Oberheim et al., 2009).  
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Other types of glia that exist include microglia, oligodendrocytes, Bergmann glia and radial 
glial cells.  
 
1.2.1 Microglia 
Microglia are the macrophages of the brain and their role is to remove debris and foreign 
material in the CNS. They contribute to the immune response by secreting cytokines and 
other signalling molecules in addition to the presence of antigens on their surface (Hanisch 
and Kettenmann, 2007, Facci et al., 2014).  
 
1.2.2 Oligodendrocytes 
Oligodendrocytes are a type of glia cell that produce myelin, which wraps around the axon, 
insulating it, to reduce signal leakage and increase the speed of propagation (Fields, 2008). 
Astrocytes can interact with oligodendrocytes to stimulate the production myelin (Ishibashi et 
al., 2006). 
 
1.2.3 Bergmann Glia 
Bergmann glia are a type of astrocyte in the cerebellum that play an important role during 
development (Lordkipanidze and Dunaevsky, 2005) and also influence the activity of neurons 
in the cerebellum (Purkinje cells) (Wang et al., 2012).  
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1.2.4 Radial Glia 
Radial glial cells are bipolar-shaped cells that span the width of the cortex during 
development of the CNS. They form the primary progenitor cell pool and are capable of 
differentiating into neurons, astrocytes and oligodendrocytes (Kriegstein and Alvarez-Buylla, 
2009). During development, neurons use radial glial cells as scaffolds, traveling along their 
fibres in order to reach their final destinations (Noctor et al., 2001).  
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Figure 1.2 Astrocyte morphology. A typical protoplasmic astrocyte composed of a cell body (soma), 
many branched process and end feet. Their cell bodies are small and irregular from which numerous 
ramified extensions/processes protrude. Some processes terminate with bulbous end feet, which can 
contact synapses or blood vessels.  
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1.3 The electrical basis of signalling in the brain 
Ion channels are found in all electrically excitable cells and are central to neuronal activity. 
They are membrane spanning, pore-forming protein complexes that exhibit selective 
permeability for specific ions (molecules that carry electrical charge). They allow certain ions 
to cross the cell membrane (lipid bilayer). These ions are specific to the composition of the 
channel. The most important ions that underlie neuronal signal conduction are sodium (Na+), 
potassium (K+), calcium (Ca2+) and chloride (Cl−) (Kew and Davies, 2010). An ion channel is 
only capable of conducting charge when it is in the open state. However, the ion channel may 
also exist in an inactivated or closed state. The difference between these two states is the 
propensity to return to the open state i.e. inactivated channels are more likely to return to the 
open conducting state. 
Transmitter-gated ion channels are ligand activated ion channel. Upon binding of selective 
ligands, to their respective ion channels, their structure becomes altered to allow the flow of 
ions across the membrane. In contrast, voltage gated ion channels enter the open state when 
the transmembrane voltage potential surpasses a specific threshold. Ion channels can be 
further classified by their ion selectivity and membrane structure. 
 
1.3.1 Excitatory neurotransmission and plasticity  
In neurons, ion channels establish the resting membrane potential (the state at which neurons 
are quiescent) and also determine the propagation of signals in the brain through the firing of 
action potentials (APs). In its resting state a neuron is fairly negative (around -70 mV) in 
comparison to the extracellular environment (Eccles, 1964).  Because the membrane is 
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polarised, an increase in the resting membrane potential is called hyperploarisation (e.g. from 
-70 mV to -75 mV), which decreases the ability of the cell to fire an AP (inhibitory). In 
contrast, a reduction in the resting membrane potential is called depolarisation (e.g. from -70 
mV to -45 mV), which increases the ability of the cell to fire an AP (excitatory). At rest, 
Na+/K+-ATPases actively transport 2 K+ molecules into the cell and 3 molecules of Na+ out of 
the cell, at the energetic cost of 1 molecule of adenosine tri-phosphate (ATP). A neuron 
becomes depolarised when a presynaptic neuron releases a chemical transmitter that perturbs 
the resting membrane potential. This activates voltage-gated channels on the depolarised 
neuron that permit Na+ influx. Consequently, an AP fires if depolarisation occurs above a 
specific threshold (-55 mV) and a cascade of positive ion entry ensues. Eventually K+ flows 
out of the cell in order to restore the equilibrium gradient for K+ and this restores the cell to its 
resting state. Depolarisation, therefore, is defined as the rapid increase in voltage across the 
membrane with a return to the resting state. APs are forward propagating depolarisation 
waves that spread from their point of origin at the AIS, along the axon, mediated by the flow 
of charged ions through voltage sensitive ion channels. They can also propagate backwards 
through the proximal dendritic tree (Eccles, 1964). Directionality of the AP is mediated by 
Na+ channel inactivation. The speed of AP propagation along the axon is enhanced by myelin. 
The myelin sheath increases the speed of AP propagation by mediating saltatory conduction, 
where the signal hops/leaps from one node of Ranvier to the next (Figure 1.1).  
Presynaptic terminals contain neurotransmitter-filled vesicles, which release their contents 
into the synaptic cleft upon arrival of an AP. The AP induces an influx of calcium (Ca2+) ions 
through voltage-dependent, Ca2+-sensitive ion channels (VDCCs) at the presynaptic terminal. 
These Ca2+ ions bind synaptotagmin and SNARE (soluble N-ethylmaleimide-sensitive factor 
attachment protein receptor) proteins located within the membranes of synaptic vesicles (SVs) 
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and this allows vesicle fusion with the plasma membrane and consequently, release of their 
contents into the synaptic cleft. These transmitters then diffuse across the synaptic cleft and 
bind to specialized receptors embedded in the postsynaptic membrane (Figure 1.3). 
Depending on the neurotransmitter, postsynaptic receptors determine the response triggered 
by the AP. To allow for further signal transduction, vesicular transporters (VGLUTs in the 
case of glutamatergic signalling) located on SVs replace the neurotransmitters released by 
exocytosis during signal propagation. Immediately apposed to these postsynaptic receptors is 
an elaborate interconnected network of proteins called the postsynaptic density (PSD). These 
proteins are important for anchoring, trafficking and modulating the activity of postsynaptic 
receptors.     
The main excitatory neurotransmitter in the brain is glutamate (mono-sodium glutamate), 
which binds to postsynaptic glutamate-gated ionotroptic receptors: N-methyl-D-aspartate 
(NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and Kinate 
receptors (NMDAR, AMPAR and KAR). Binding of glutamate to AMPARs induces the 
influx of cations (Na+, Ca2+ or K+), dependent on the subunit organisation of the receptor (for 
example GluR2-containing AMPARs are Ca2+ impermeable). AMPAR opening induces 
depolarisation of the postsynaptic membrane and this promotes the opening of NMDARs, 
which are found together at the excitatory PSD (Scannevin and Huganir, 2000). NMDARs are 
ligand-gated, requiring the binding of glutamate and a co-agonist (glycine or D-serine) and 
voltage-gated, due to having a magnesium (Mg2+) ion that blocks their opening until 
depolarisation removes it. In this way NMDARs are thought to be molecular coincidence 
detectors, reducing spontaneous activity and form association between neural events. 
NMDARs are highly permeable to Ca2+ (as well as being permeable to K+ and Na+) and are 
the primary site of postsynaptic Ca2+ influx (Bliss and Collingridge, 1993). Excess influx of 
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Ca2+ through NMDARs is thought to underlie neuronal excitotoxicity (cell death induced by 
excessive excitatory transmission). Glutamate can also bind metabotropic glutamate receptors 
(mGluRs), which instead induces a G-protein coupled intracellular signalling cascade that can 
affect ion channel conductance indirectly (Figure 1.3).  
Modifications of AMPAR properties underlie the synaptic plasticity process of long-term 
potentiation and depression (LTP and LTD). LTD is the state of weakening of synaptic 
activity. LTP, on the other hand, is the process of persistent strengthening of synaptic activity 
and underlies learning and memory formation (Bliss and Collingridge, 1993, Matsuo et al., 
2008). Initially a synapse is stimulated repeatedly and this results in an upregulatation of 
dendritic receptors followed by an upregulation of presynaptic neurotransmitter-containing 
vesicles. The initial connection is strengthened and maintained in this way.  
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Figure 1.3 Structure of the excitatory synapse. A. Synapses are typically the point where the axon 
terminal of a neuron transmits signals to the spine of another neuron through the gap between them. 
This gap is called the synaptic cleft. Here, processes/end feet projected from nearby astrocytes can 
influence signal transmission. This is known as the tri-partite synapse. B. Inset shows the movement of 
important molecules at the synapse. Here, astrocyte processes/end feet can influence the concentration 
of these molecules. They can buffer glutamate and convert it to non-toxic glutamine. They can also 
buffer K+, Na+ and Ca2+. This can influence the ability of neurons to fire action potentials. Glutamine 
can also be released from astrocytes and following being taken up by neurons it is broken down to 
produce substrates for energy production. The levels of astrocyte intracellular Ca2+ can also influence 
the release probability of gliotransmitters, which include glutamate, D-serine and ATP. 
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1.3.2 Excitatory/ Inhibitory balance 
Whether a synapse is inhibitory or excitatory depends on which ion channels conduct the 
postsynaptic response as well as the postsynaptic receptor expression profile. Their receptor 
expression profile is determined by activity of the surrounding neuronal circuitry. Inhibitory 
signalling is a process that makes neurons less likely to generate an AP and arises from a 
more negative postsynaptic potential (inhibitory synaptic postsynaptic potentials (IPSPs)). 
The opposite are excitatory postsynaptic potentials (EPSPs) where a more positive current is 
generated. While glutamate acting on glutamate receptors is the main form of excitatory 
neurotransmission the primary transmitters involved in inhibitory signal transduction are 
GABA (γ-Aminobutyric acid) and glycine. GABA acts on GABA receptors (GABARs): 
GABAA and GABAB. GABAARs are permeable to Cl- upon GABA binding, while GABABRs 
are coupled to potassium channels via G-proteins (G-protein couple receptors (GPCRs)). 
Glycine acts on glycine receptors (GlyRs), which are also ionotropic and permeable to Cl-. 
Tight control must exist over the maintenance of excitatory-inhibitory (E/I) balance. 
Uncontrolled excitatory neurotransmission, for example, chronic NMDAR activation, can 
lead to excitotoxicity. Excitotoxicity eventually results in significant damage and ultimately 
cell death. Uncontrolled Ca2+ elevations in neurons have been implicated in ischaemic cell 
death during stroke (MacDonald et al., 2006). Excessive excitatory neurotransmission as well 
as defective inhibitory neurotransmission have been associated with epilepsy (McNamara et 
al., 2006). On the other hand, excessive inhibition or insufficient excitation may eventually 
lead to decreased brain function. 
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Interestingly, reactive astrocytes have been shown to release GABA in a mouse model of 
Alzheimer’s disease (AD), reducing the spiking activity of granule cells in the dentate gyrus 
(Jo et al., 2014). Conversely, astrocytes can release glutamate, ATP and D-serine under 
certain conditions of neuronal stimulation. This suggests a direct role for astrocytes in 
maintaining the E/I balance that may go awry during pathology.  
 
1.3.3 Role of astrocytes at the excitatory synapse  
Astrocytes have a multitude of functions that include maintenance of the blood brain barrier 
(Abbott et al., 2006), nutrient support of neurons (Dienel and Cruz, 2004), promotion of 
oligodendrocyte myelinating activity (Ishibashi et al., 2006), modulation of vascular blood 
flow (Parri and Crunelli, 2003, Attwell et al., 2010), promoting repair of the brain in response 
to damage (Sofroniew, 2005) and transmitter uptake and release (Kimelberg and Nedergaard, 
2010). This thesis will focus on the latter of these specialities.    
 
1.3.3.1 Astrocyte excitability 
A type of astrocyte excitability exists, based on changes in intracellular Ca2+ (Duffy and 
MacVicar, 1995). Astrocytes are connected by gap junctions and thus create an electrically 
coupled syncytium (Bennett et al., 2003).  Consequently, changes in local astrocyte Ca2+ can 
propagate through their network, via these gap junctions and alter the function of distant 
astrocytes. This type of signalling is thought to occur on a slower timescale compared to 
neuronal signal transmission (19 µm/s for Ca2+ wave propagation versus 10-100 m/s for AP 
propapagtion) (Fiacco and McCarthy, 2006) but nevertheless exists as an important form of 
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long-range signal propagation. Astrocyte Ca2+ signalling or excitability can be evoked by 
neuronal synaptic activity (Schummers et al., 2008), which also increase the motility of their 
synapse-associated processes (Perez-Alvarez et al., 2014). Astrocyte Ca2+ signalling is termed 
a type of excitability because it can evoke the release of chemical modulators called 
gliotransmitters (glutamate, ATP, D-serine, GABA). In addition, because these transmitters 
play a crucial role in modulating synaptic transmission (Araque et al., 1998, Di Castro et al., 
2011), plasticity (Haydon and Carmignoto, 2006) and LTP (Navarrete and Araque, 2011) the 
communicative link between neurons and astrocytes is said to be bidirectional.  
 
1.3.3.2 Gliotransmission 
Gliotransmission is the process by which astrocytes release vesicles packed with 
gliotransmitters via exocytosis. Astrocytes express proteins known to be involved in vesicle 
fusion including proteins of the SNARE complex (synaptobrevin-2, syntaxin), synaptotagmin, 
Munc18a and complexin-2, which are critical for gliotransmitter release (Parpura and Zorec, 
2010). The transporters necessary for vesicle packaging of glutamate (VGLUT1 and 
VLGUT2) were expressed by isolated astrocytes (Zhang et al., 2004). Additionally, altering 
the SNARE complex, for example, resulted in the failure of astrocytes to release glutamate 
(Zhang et al., 2004). ATP released from astrocytes interacts directly with neurons, serving to 
regulate their own glutamatergic transmission and enhancing the levels of AMPARs 
(Theodosis et al., 2008). In addition, astrocyte released ATP can be converted to adenosine, 
which can act on G-protein-coupled adenosine receptors (A1, A2A, A2B and A3) to suppress 
synaptic transmission (Elmenhorst et al., 2007). A1 receptors decrease cAMP levels and have 
been reported to decrease Ca2+ conductance. A2B and A3 receptors instead increase 
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phospholipase activity. Adenosine receptors have been shown to regulate the blood brain 
barrier and modulate blood flow through vasodilation (Newman, 2003). Reducing adenosine 
receptor activation has been linked to an increase in excitatory transmission (Pascual et al., 
2005). 
Moreover, astrocytes are actively involved in excitatory neurotransmission, as they remove 
excess glutamate from the synaptic cleft via glutamate transporters (glutamate transporter 1 
(GLT1) and glutamate aspartate transporter (GLAST)), also known as excitatory amino acid 
transporters (EAATs 2 and 1, respectively). These transporters are important for maintaining 
physiological levels of extracellular glutamate (Figure 1.3B).  Astrocytes also maintain 
homeostasis of various ions such as Na+ K+ Cl- and H+ (Simard and Nedergaard, 2004). For 
example, when the extracellular K+ concentrations become high, astrocytes uptake K+ and 
transfer it to adjacent astrocytes via gap junctions by a process called spatial buffering (Kofuji 
and Newman, 2004). Due to spatial buffering, astrocytes prevent toxic accumulation of 
extracellular K+.  
Therefore, via regulation of their intracellular Ca2+ levels, it is clear that astrocytes play an 
essential role in regulating information processing in the CNS. It is not clear, however, 
whether this bidirectional signalling, and the release of gliotransmitters, occurs exclusively 
under physiological conditions or reciprocally plays a role during pathophysiological 
conditions.   
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1.3.4 Astrocytes influence the formation and function of synapses  
Astrocytes secrete many factors that have the potential to profoundly alter the structure and 
function of nearby neurons. Several important, studies elegantly revealed that culturing 
neurons in astrocyte-conditioned media (ACM) affected the number and function of synapses 
(Pfrieger and Barres, 1997, Nagler et al., 2001, Ullian et al., 2001) indicating that factors 
released specifically by astrocytes are responsible for these neuronal alterations. These 
molecules include Thrombospondins (TSPs1-4), the glycoprotein tenascin C, SPARC 
(secreted protein, acidic and rich in cysteine) and SPARC-like-1 (Hevin) (Kucukdereli et al., 
2011). 	
Further studies investigated the influence of astrocyte-released factors on rat retinal ganglion 
cells (RGCs) in culture. Astrocyte-released cholesterol increased the number of RGC 
glutamatergic synapses (Mauch et al., 2001). Mauch and colleagues found that cholesterol 
applied to RGC cultures increases the frequency of spontaneous synaptic events by increasing 
the quantal content and release of SVs (Mauch et al., 2001). Cholesterol does this by binding 
to synaptophysin, an important molecule involved in the formation of SVs (Thiele et al., 
2000). Similarly, a study by Christopherson and colleagues revealed that astrocyte-released 
TSPs (TSP-1 and TSP-2) increased the number of RGC synapses nearly 3-fold 
(Christopherson et al., 2005). Immunodepletion of TSPs from ACM decreased RGC 
synaptogenesis. The TSP-induced synaptogenesis was primarily observed in the developing 
brain (post-natal week 1) and downregulated in the mature adult brain (post-natal week 3) 
(Adams and Lawler, 2004). TSPs 3 and 4 were also expressed by astrocytes, where TSP-4 
was primarily present in mature astrocytes (post-natal day 17) (Cahoy et al., 2008). This 
suggests a role for astrocyte-released TSPs in the adult CNS. More recently, the gabapentin 
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receptor alpha-2-delta-1 has been identified as the receptor responsible for the TSP-mediated 
excitatory synaptogenesis (Eroglu and Barres, 2010).  
 
1.3.4.1 Glypicans 
A study by Allen and colleagues identified Glypican 4 (Gpc4) and Glypican 6 (Gpc6), 
heparan sulphate proteoglycans, as astrocyte-secreted factors that increase synaptic AMPAR 
expression and strengthen their activity (Allen et al., 2012). Addition of purified Gpc4 to 
RGCs induced a 2.5-fold increase in surface GluR1-containg AMPARs. Gpc4 was sufficient 
to strengthen individual synapses, reflected in an increase in mEPSC frequency and 
amplitude, although very large amplitude events induced by astrocytes were absent. Gpc6 
also increased surface GluR1 AMPARs. Reducing the levels of Gpc4 and Gpc6 in ACM, 
which was subsequently added to RGC cultures, was unable to increase the amplitude of RGC 
mEPSCs. In addition the clustering of surface GluR1 was reduced. However, it is important to 
note that synapse formation did occur, presumably due to the release of other astrocyte-
specific synaptogenic molecules. Reducing the levels of Gpc4 or Gpc6, on their own, was not 
sufficient to reduce synaptic activity. From these results, they conclude that both Gpc4 and 
Gpc6 are necessary for enhancing postsynaptic activity in RGCs (Allen et al., 2012).  
 
1.3.4.2 SPARC 
SPARC on the other hand, negatively regulates synaptogenesis, which is important for 
preventing over-excitation in the CNS (Jones and Bouvier, 2014). Astrocyte-released SPARC 
influences the level of synaptic AMPARs. Neurons grown with SPARC KO astrocytes had 
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significantly more surface containing GluR1 and GluR2 synapses than neurons co-cultured 
with SPARC WT astrocytes. Jones and colleagues also found enhanced synaptic signalling 
and impaired LTP in hippocampal slices from SPARC KO mice (Jones et al., 2011). They 
show that SPARC regulates surface AMPARs through β3-integrin receptors, which have been 
shown to stabilise GluR2 subunits at synapses (Cingolani et al., 2008).  
 
1.3.4.3 Semaphorin 3a 
Molofsky and colleagues, identified semaphorin 3a (Sema3a) as an astrocyte-released 
molecule that has important consequences for synapse regulation, motor neuron (MN) AIS 
orientation, MN survival and normal patterning of a subtype of sensory neuron (TrkA) 
(Molofsky et al., 2014). The receptor for semaphorin, Nrp1, was more highly expressed by 
MNs and dorsal root ganglion (DRG) TrkA+ sensory neurons, suggesting a specific neuronal 
subtype response induced by Sema3a. Additionally, Sema3a was shown to negatively regulate 
axon growth where it repelled axons (Molofsky et al., 2014). This research demonstrates that 
stable positional cues from developing astrocytes influences aspects of sensorimotor circuit 
formation and postnatal refinement of the neural network. 
 
1.3.4.4 SPARC-like-1/Hevin 
Kucukdereli and colleagues showed that SPARC-like-1 or Hevin increases synapses in RGCs 
in vitro and in vivo and is required for their maturation (Kucukdereli et al., 2011). Hevin is 
expressed primarily by astrocytes in the cortex of the developing CNS (peaking at post-natal 
day 15-25) (Risher et al., 2014). It is required for the connectivity of synapses in the thalamus 
	 40	
and cortex (Risher et al., 2014). In addition, Hevin interacts with Neuroligin-1 and Neurexin-
1-alpha. Neuroligin-1 is important for regulating synaptic content and thus important for 
excitatory synaptic responses (Varoqueaux et al., 2006). 
 
1.3.4.5 Tenascins 
 
Tenascins are a family of extracellular matrix glycoproteins. Tenascin-C (TN-C) is expressed 
by astrocytes in the developing nervous system and has been shown to be important for their 
proliferation and differentiation (Wiese et al., 2012). Evers and colleagues observed impaired 
plasticity in the hippocampus of 1-month-old TN-C KO mice. Indeed, LTP induction was 
shown to be significantly reduced and LTD abolished at CA1-Schaffer collateral synapses, 
whereas, LTP in the dentate gyrus (DG) and CA3 were described as normal in TN-C KO 
mice (Evers et al., 2002). The study also draws a link between TN-C deficiency and impaired 
L-type Ca2+ channel-dependent synaptic plasticity in the CA1, mediated by 
proteoglycans/integrins.  
 
1.3.4.6 Other mediators 
 
Tumour necrosis factor alpha is also linked to both glutamate release and the insertion of 
AMPARs into nearby neurons (Beattie et al., 2002, Santello et al., 2011). In addition, 
chemokines released from astrocytes have a strong regulatory effect on the activity of 
NMDARs (Gao and Ji, 2010). Astrocytes also express ephrin-A3, which interacts with EphA4 
(expressed by dendritic spines) to decrease levels of GLT-1 and GLAST (Carmona et al., 
2009). EphB receptors and ephrin-B ligands are also expressed by astrocytes, ephrin-B3 being 
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the most active during LTP (Zhuang et al., 2010). Ephrin-B3 enhances D-serine release by 
regulating serine racemase (SR), the enzyme responsible for the conversion of L-serine to D-
serine and an SR-interacting protein, protein kinase C-alpha (PKCα). Specifically, ephrin-B3 
downregulates PKCα, increasing the interaction between SR and Protein Interacting with C-
kinase (PICK1), resulting in D-serine release (Zhuang et al., 2010). Zhuang and colleagues 
identified that both EphB3 and EphA4 receptors were necessary for astrocyte D-serine 
release, by measuring D-serine levels in Eph-B3 and EphA4 KO cultured astrocytes. 
Therefore, while ephrin-A signalling regulates levels of GLT-1 and GLAST, ephrin-B 
signalling regulates D-serine release for activation of postsynaptic NMDA receptors and thus 
is important for LTP.  
 
Taking into account the above studies, it is abundantly clear that astrocytes release molecules 
that can profoundly influence many aspects of synapse formation and function. The question, 
however, remains as to what exactly controls the release of these synaptogenic molecules 
from astrocytes.  
 
1.4 Metabolic Specialization of Neurons and Glia 
Most energy in the brain comes from the metabolism of blood glucose either by glycolysis, 
through the Krebs/tricarboxylic acid (TCA) cycle or oxidative phosphorylation. Glycolysis is 
the first stage of energy production where glucose is oxidised, in the cytosol, to pyruvate via a 
series of enzymatic reactions, with a net gain of two molecules of ATP. This process does not 
involve oxygen and so is termed anaerobic. When oxygen is available pyruvate is 
decarboxylated to acetyl coenzyme A (Acetyl CoA) and transported inside the matrix of 
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mitochondria. There, Acetyl CoA enters the Krebs/TCA cycle were it is completely oxidised 
into two molecules of CO2, one molecule of guanosine triphosphate (GTP) is produced and 
three NAD+ (oxidised nicotinamide adenine dinucleotide) and one FADH (flavin adenine 
dinucleotide) are reduced to three molecules of NADH and one FADH2. These molecules are 
energy-rich in that they carry electrons that are necessary for the electron transport chain 
(ETC) of oxidative phosphorylation- the major source of ATP in aerobic organisms (Alberts, 
2008). The process of oxidative phosphorylation means that, through mitochondria, cells can 
produce a significant amount of energy in the form of ATP in the presence of oxygen, which 
is supplied by the circulatory system.  
Neurons are thought to rely more on oxidative phosphorylation and astrocytes are thought to 
be more glycolytic, however the latter is still debated in the field where significant oxidative 
metabolism has been observed in astrocytes (Wyss et al., 2009). Certainly, tight metabolic 
coupling must exist, at glutamatergic synapses, between neurons and nearby perisynaptic 
astrocyte processes (Chatton et al., 2003).  
The large ion movements that underlie synaptic signalling upon AP induction (mainly Ca2+, 
Na+ and K+) impose a large localised energetic demand on neuronal function. In fact, 50 % of 
brain energy is used to restore these ionic gradients. Other processes relying on an abundant 
ATP supply include filling SVs and LTP.          
In terms of astrocytes, glutamate represents a significant metabolic cost. Following GLT-1 or 
GLAST-dependent uptake, glutamate is converted to non-toxic glutamine and this process 
requires energy in the form of ATP. Glutamine can be released from astrocytes to supply 
neurons with a source of glutamate, which they cannot synthesise themselves. Along with the 
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uptake of glutamate GLT-1 and GLAST couple the inward movement of one molecule of 
glutamate to three Na+ ions and one hydrogen (H+) ion and the outward movement of one K+ 
ion. This gives rise to a significant accumulation of Na+ in the processes of astrocytes (Rose 
and Ransom, 1996, Bergles and Jahr, 1997). This rise in Na+ activates the astrocytic Na+/K+-
ATPase (Magistretti and Pellerin, 1999) (Figure 1.3B). This represents a further energy 
demanding process that generates a diffusion gradient for glucose within the astrocyte 
network, directly coupled to synaptic activity. However, evidence suggests that oxidative 
activity exists in astrocytes (Hertz et al., 2007, Lovatt et al., 2007). Using nuclear magnetic 
resonance spectroscopy, it was estimated that astrocytes account for ~ 25 % of total brain 
oxidative metabolism (Serres et al., 2008). Indeed ultrastrucutal analysis revealed that fine 
astrocytic processes ensheathing synapses contain a substantial quantity of mitochondria 
(Grosche et al., 1999, Lovatt et al., 2007, Oberheim et al., 2009). Alongside this, astrocyte 
glutamate transporters were shown to physically interact with mitochondria (Rose et al., 2009, 
Genda et al., 2011, Bauer et al., 2012). Therefore, if mitochondria are able to position 
themselves in the vicinity of glutamate transporters in order to provide energy for glutamate 
uptake and metabolism what are the mechanisms involved in mitochondrial spatial 
regulation?  
 
1.4.1 The mechanisms of energy supply by mitochondria 
The brain consumes a disproportionate percentage of the body’s energy supply (making up 
only 2% of the body’s weight, it consumes 20% of the body’s resting energy i.e. 10 times 
more relative to its weight) in order to maintain proper signal propagation (Mink et al., 1981). 
Because energy cannot freely diffuse throughout the extensive neural network, tight 
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regulatory mechanisms must exist to ensure adequate energy delivery on a rapid timescale. At 
the synapse, where communication between neurons occurs, energy supply is particularly 
important.  
In neurons, energy supply is tightly coupled to demand by mitochondria. Mitochondria are 
membrane bound organelles (Figure 1.4A) that came to be found in most eukaryotic cells 
through an ancient bacterial symbiotic relationship (Henze and Martin, 2003). In addition to 
supplying cellular energy in the form of ATP, mitochondria are involved in cellular 
differentiation, growth and cell death (McBride et al., 2006). Mitochondrial dysfunction has 
been implicated in several neurological disorders such as Autism (Oliveira et al., 2005) and 
Schizophrenia (Kolomeets and Uranova, 2010) as well as neurodegenerative diseases such as 
AD (Pereira et al., 1998; Wang et al., 2008), Huntington’s disease (HD) (Mangiarini et al., 
1996, Lin et al., 2001) and Parkinson’s disease (PD) (Exner et al., 2012). The number and 
morphology of mitochondria can vary extensively between cells, tissue and organisms. For 
example, red blood cells have no mitochondria, while liver cells can contain more than 2000 
(Alberts et al., 2002). Structurally, mitochondria are composed of an outer and inner 
membrane, juxtaposing the intermembrane space, cristae and matrix (Figure 1.4A). 
The molecular machinery for energy production, the ETC, is located within the cristae of 
mitochondria and is comprised of five protein complexes (Figure 1.4). The process of ATP 
generation begins with the transfer of electrons from electron donors: NADH (complex I) or 
FADH2 (complex II) to electron acceptors: NADH-ubiquinone reductase or succinate-
ubiquinone reductase, respectively. Electrons are then passed along a chain of carriers 
(ubiquinone, cytochrome C oxidoreductase (complex III), cytochrome C and cytochrome C 
oxidase (complex IV)) before being donated to oxygen (O2) to make water. The energy of the 
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movement of electrons through complex I, III and IV is used to move H+ ions out of the 
matrix into the intermembrane space. This movement of H+ ions creates an electrochemical 
gradient across the mitochondrial membrane termed proton motive force. The movement of 
ions back into the matrix is used to power ATP synthase, which creates ATP from the 
phosphorylation of ADP (adenosine di-phosphate), termed oxidative phosphorylation or 
chemiosmosis (Alberts, 2008) (Figure 1.4B). The outcome of this is that mitochondria 
generally have a negative membrane potential relative to the cytoplasm (between -150 and -
180 mV) termed delta psi (ΔΨ). Although vital for metabolism, oxidative phosphorylation 
produces reactive oxygen species (ROS) that lead to the production of free radicals. These 
damage cells, contributing to aging and disease. Therefore, the maintenance of mitochondria 
is of particular importance to overall cell health and survival. 
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Figure 1.4 Structure of the mitochondrion and the mitochondrial respiratory chain. A. Mitochondria 
are composed of an outer mitochondrial membrane (OMM) and an inner membrane (IMM). Between 
these two membranes is the inter membrane space. Within the inner membrane is the mitochondrial 
matrix. Mitochondria can also buffer calcium (Ca2+) and sodium (Na+) via the mitochondrial Ca2+ 
uniporter (MCU) and the mitochondrial Na+/Ca2+ exchanger (mNCX) and the Na+/H+ antiporter, 
respectively. ATP is released from mitochondria via the ATP/ADP antiporter. B. ATP is produced in 
the mitochondrial matrix by the electron transport chain, which enables oxidative phosphorylation.  
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1.4.2 Mitochondria in neurons and astrocytes 
Mitochondria are non-uniformly distributed in neurons and localise at sites of elevated 
demand for energy production or Ca2+ buffering, such as synapses (Chang et al., 2006), active 
growth cones (Morris and Hollenbeck, 1993) and nodes of Ranvier (Fabricius et al., 1993). 
Synaptic activity itself acts as a cue for mitochondria to position themselves at post-synaptic 
sites where they can provide ATP and buffer Ca2+ directly (Macaskill et al., 2009). 
Mitochondria are required to be mobilized in order to transport damaged mitochondria back 
to the soma for degradation and to replenish the useable pool of mitochondria throughout the 
axons and dendrites (Miller and Sheetz, 2006, Frederick and Shaw, 2007).  
In addition, there is evidence to suggest that mitochondria, in particular their positioning, is 
important for the regulation of neuronal morphology and synapse formation in E18-19 rat 
cultures (Li et al., 2004). Li and colleagues find that dendritic mitochondria localise to spines 
upon stimulation of neuronal activity (Li et al., 2004). They subsequently depleted dendritic 
mitochondria by overexpressing the dominant negative form of the dynamin-related protein 1 
(Drp1) or the optic atrophy 1 protein (OPA1) in E18-19 hippocampal neuron cultures (Li et 
al., 2004). Decreasing mitochondrial density in cultured neurons (at 13 DIV) decreased the 
density of spines and synapses, while the reverse was true for increasing the density of 
mitochondria in the dendrites (overexpressing the WT form of Drp1) (Li et al., 2004). 
Although it is well established that Drp1 plays an important role in controlling mitochondrial 
fission, it also maintains normal ER morphology and distribution as well as vesicle 
endocytosis (Pitts K.R, 1999, Li et al., 2013). These results indicate that mitochondrial 
density and positioning within dendrites is directly correlated with the formation and 
functionality of excitatory synapses.  
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Mitochondria are present in the processes of astrocytes that ensheath synapses (Grosche et al., 
1999, Lovatt et al., 2007, Oberheim et al., 2009) and are reportedly mobile within their 
processes (~ 600 nm in diameter) (Ito et al., 2009, Lavialle et al., 2011, Jackson et al., 2014). 
Jackson and colleagues reported that astrocyte mitochondrial trafficking was bidirectional in 
organotypic hippocampal slices, with 44 % and 56 % moving in the retrograde (towards the 
soma) and anterograde (away from the soma) direction, respectively (Jackson et al., 2014). 
Instead, in neurons 61 % and 39 % where moving in the retrograde and anterograde direction, 
respectively. Interestingly, they found that astrocyte mitochondria moved significantly slower 
and covered shorter distances than in dendrites. This suggests that different mechanisms 
regulate mitochondrial trafficking in neurons and astrocytes.  
Jackson and colleagues report that mitochondrial trafficking within astrocyte processes, in 
organotypic hippocampal slices, seems to be regulated by both microtubule and actin 
cytoskeletons (Jackson et al. 2014). They show that pharmacological disruption of 
microtubule (with vinblastine) or actin (with cytochalasin D) assembly significantly 
decreased the fraction of moving mitochondria. However, Kremneva and colleagues, report 
that microtubules are the main regulators of mitochondrial trafficking in cultured astrocytes 
(Kremneva et al., 2013). They report that mitochondria align more with microtubules than 
actin filaments under basal conditions. They show that pharmacological disruption of 
microtubules (with nacodazole) disrupts basal mitochondrial motility while depolymerisation 
of actin filaments (with Latrunculin B) does not disrupt basal mobility. However, disrupting 
actin filaments did block Ca2+-dependent mitochondrial stopping. From this they conclude 
that mitochondria couple to microtubules when intracellular Ca2+ is low and are highly motile. 
When elevations in intracellular Ca2+ occur, mitochondrial motility is reduced and they 
become anchored to actin filaments due to Ca2+-dependent interactions. In addition, they 
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suggest that the motility of astrocytic mitochondria is inversely related to intracellular Ca2+ 
and mitochondrial mobility requires intact microtubules. An inability of mitochondria to 
translocate to high Ca2+ microdomains, wherein they become immobilized and take up 
excessive Ca2+, is likely to result in cell death through excitotoxicity and give rise to 
neurological disorders (MacAskill and Kittler, 2010, Rintoul and Reynolds, 2010, Larsen et 
al., 2011). It is not currently known whether this is the case in astrocytes.  
Astrocyte mitochondria have been shown to localise at sites of glutamate uptake in astrocytes 
(Chaudhry et al., 1995, Bezzi et al., 2004). Genda and colleagues reported, using mass 
spectrometry, that immunoaffinity purified GLT-1 from rat cortices interacts with 
mitochondrial proteins (Genda et al., 2011). They also show that mitochondria co-localise 
with GLT-1 in astrocytes in slices and in vivo. Furthermore, mitochondria were less likely to 
appose GLT-1 when neuronal activity was blocked with the Na+ channel blocker tetrodotoxin 
(TTX) in astrocyte processes in slices (Jackson et al., 2014). Alongside this, TTX and TFB-
TBOA (astrocyte specific glutamate transporter blocker) increased mitochondrial mobility in 
astrocytes. They infer from this that neuronal activity regulates mitochondrial trafficking via 
glutamate transporter activation in astrocyte processes. This suggests that astrocyte 
mitochondria may be able to respond to the demands of astrocyte signalling and position 
themselves at sites of energy consumption or Ca2+ buffering.  
Apart from the above, very little is known about the specific mechanisms that control the 
spatial regulation of mitochondria in astrocytes. Their positioning could be important for 
regulating intracellular Ca2+, which underlies Ca2+-dependent processes such as 
gliotransmission. Downstream, Ca2+-dependent gliotransmission can have important 
consequences for neuronal function. Thus, elucidating the mechanisms that control 
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mitochondrial trafficking and positioning within astrocyte processes appears to be necessary 
to further our understanding of astrocyte biology.  
 
1.4.3 The Mitochondrial Rho-GTPase protein (Miro)        
In neurons, an important regulator of mitochondrial trafficking and positioning is the outer-
mitochondrial membrane Rho-GTPase protein, Miro. Miro consists of two cytoplasmic 
GTPase domains and two EF (embryonic fibroblast)-hand Ca2+-binding motifs (Figure 1.5A). 
There are two mammalian isoforms of Miro, Miro1 and Miro2, which share 60 % homology 
(Fransson et al., 2006). The first evidence that Miro played a role in mitochondrial trafficking 
came from a study in Drosophila where knocking out the protein disrupted the transport of 
mitochondria into neuronal axons (Guo et al., 2005). Further experimentation has revealed 
that Miro couples mitochondria to microtubules via Kinesin or Dynein motors in neurons 
(Macaskill et al., 2009b, Wang and Schwarz, 2009). Binding of Miro to Kinesin or Dynein 
motors is mediated by trafficking kinesin proteins (Trak1 or Trak2) (Figure 1.5B). Trak1 
mediates Kinesin binding and, therefore, anterograde mitochondrial transport, while Trak2 
mediates Dynein binding and, therefore, retrograde mitochondrial transport (Schwarz, 2013). 
Long-range mitochondrial transport is mediated by the microtubule cytoskeleton (Morris and 
Hollenbeck, 1995, Schwarz, 2013), while short-range trafficking is regulated by actin 
filaments (Ligon and Steward, 2000, Hollenbeck and Saxton, 2005). 
Mechanistically, when Ca2+ binds the EF-hand domains of Miro1, a conformational change 
(of either Miro1 itself or the motors) results in uncoupling of mitochondria from the 
microtubule network. This results in mitochondrial docking at sites of high Ca2+, such as the 
synapse, in order to maintain ionic homeostasis (Macaskill et al., 2009b) (Figure 1.5B). Wang 
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and Schwarz proposed that Ca2+ elevations in neurons lead to a change in the conformation of 
the kinesin motor KIF5 (also known as kinesin-1), which results in it binding directly Miro1 
thus preventing the binding of Miro1 to the microtubule network (Wang and Schwarz, 2009) 
(Figure 1.5B2). They show this using co-immunoprecipitation experiments where elevating 
free Ca2+ does not disrupt Miro-kinesin heavy chain binding. Functionally, they show that 
disrupting the EF-hand-dependent regulation of mitochondrial trafficking diminishes neuronal 
resistance to excitotoxicity. Another study by MacAskill and colleagues showed, using a 
GST-pulldown assay, that binding of KIF5C to Miro1 is inhibited when Ca2+ concentrations 
are elevated in an EF-hand dependent manner (Figure 1.5B1). They also show that indirect 
binding of KIF5 to mitochondria is inhibited when intracellular Ca2+ concentrations are 
elevated with glutamate (100 µM for 10 minutes with 1 µM glycine) (Macaskill et al., 
2009b).  
The GTPase domains of Miro1 may also be involved in transducing cellular signalling 
cascades into alterations in mitochondrial transport (MacAskill et al., 2009a). For example the 
recruitment of Trak2 to neuronal mitochondria is dependent on the activity of the first 
GTPase domain of Miro1 (GDP-bound Miro1 recruits Trak2, allowing mitochondrial 
coupling to the microtubule network) (MacAskill et al., 2009a). However, far less has been 
established regarding the GTPase domains of Miro1.   
 
In addition to being implicated in mitochondrial trafficking, Miro proteins have other 
important functions, for example the profusion proteins mitofusins (Mfn1/Mfn2) were shown 
to interact with both Miro1 and Miro2 (Misko et al., 2010) and this suggests that Miro 
proteins play a role in regulating mitochondrial morphology. Indeed, Miro1 increases 
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mitochondrial fusion at resting levels of intracellular Ca2+, whilst it increases fragmentation 
when intracellular Ca2+ levels increase in a Drp1-dependent manner (Saotome et al., 2008). In 
Drosophila, overexpression (OE) of phospho-resistant dMiro in the brain was found to be 
toxic and caused age-dependent loss of dopaminergic neurons, the cell type selectively 
affected in PD (Liu et al., 2012, Tsai et al., 2014). As well as this, knockdown of Miro in 
Drosophila neurons results in a reduction in mitochondria and induces tau-mediated 
neurodegeneration by increasing tau phosphorylation at Ser262 (Iijima-Ando et al., 2012). 
This implicates defects in Miro-mediated mitochondrial regulation in the pathogenesis of AD. 
In addition, knocking out Miro1 is lethal prior to birth (prenatally) and specific neuronal 
knock out (KO) of Miro1 reduces the number of mitochondria from cortico-spinal tract axons 
(Nguyen et al., 2014). Furthermore, mice with neuronal loss of Miro1 exhibit symptoms of 
motor neuron disease (MND). Nguyen and colleagues conclude that defects in neuronal 
mitochondrial motility and distribution are sufficient to cause neurological disease (Nguyen et 
al., 2014). 
 
In conclusion, whilst Miro1 is an important regulator of mitochondrial trafficking in neurons, 
next to nothing is known regarding Miro proteins in astrocytes. At the RNA level, Miro1 
(Rhot1) is present in astrocytes at higher levels than in neurons (fragments per kilobase of 
exon per million fragments mapped) (Cahoy et al., 2008). Whether it is expressed at the 
protein level and how it functions to regulate astrocyte mitochondria is not known.  
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Figure 1.5 The structure of the mitochondrial Rho-GTPase protein Miro1. A. Miro1 contains two Ca2+-
binding domains flanked by two GTPase domains and a mitochondrial-binding domain. B. Miro1 
enables mitochondria binding to the microtubule network via adaptor proteins Trak1/2 and KIF5 for 
anterograde transport (away from the some) and dyein, via dynactin for retrograde transport (towards 
the soma). When Ca2+ binds Miro1 via its EF-hand domains, it causes mitochondria to detach from the 
microtubule transport network. Three models have been proposed for how this uncoupling occurs. 1- 
Upon Ca2+ binding Miro1, Trak1/2 remains bound to Miro1 and this complex uncouples from the 
KIF5-microtubule complex. 2- Upon Ca2+ binding Miro1, KIF5 remains bound to Miro1 and Trak1/2 in 
a complex that uncouples from the microtubule network. 3- Upon Ca2+ binding Miro1, KIF5 and the 
mitochondrial-Trak1/2 complex binds syntaphilin, which acts like an anchor. 
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1.5 Astrocyte Ca2+ signalling  
 
Ca2+ signalling in astrocytes is essential for their function as well as for the function of 
neurons. Astrocyte Ca2+ fluctuations underlie the release of gliotransmitters, which 
profoundly affect aspects of neuronal synaptic transmission (Panatier et al., 2011, Navarrete 
et al., 2013), including LTP and LTD (Pascual et al., 2005, Chen et al., 2013a), thus 
impacting on the mechanisms of learning and memory. Astrocyte Ca2+ signalling also has 
important consequences for the regulation of blood flow in the CNS (termed functional 
hyperemia) (Filosa et al., 2004, Mulligan and MacVicar, 2004, He et al., 2012, Otsu et al., 
2015). In addition, astrocyte Ca2+ signalling can impact on the regulation of sleep, where 
impairing SNARE-dependent gliotransmission impairs aspects of sleep induction (Halassa et 
al., 2009). This mechanism was proposed to involve ATP release from astrocytes, which 
regulates the levels of adenosine (Halassa et al., 2009). Adenosine levels are elevated during 
periods of wakefulness and are reduced during sleep (Huang et al., 2011). Elevations in 
astrocyte Ca2+ have also been implicated in the regulation of breathing. They have been 
shown to respond to physiological decreases in pH with elevations in intracellular Ca2+ and 
subsequently release ATP. ATP induced increases in breathing through the activation of 
neurons of the retrotrapezoid nucleus (region of the brainstem responsible for regulating 
breathing) (Gourine et al., 2010). 
 
Astrocyte Ca2+ signalling can take many forms. Srinivasan and colleagues separated astrocyte 
Ca2+ fluctuations into somatic responses and process responses that consisted of waves 
(propagating fluctuations within an area of 14.8 ± 1.4 μm2) and microdomain responses 
(spatially confined fluctuations within an area of 0.7 ± 0.01 μm2) (Srinivasan et al., 2015). 
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They revealed that significantly more Ca2+ fluctuations occur in the processes of astrocytes 
rather than the soma, in hippocampal slices and in the cortex, in vivo. Process microdomain 
responses were defined as non-propagating fluctuations that occurred within an area of ~ 0.7 
µm2. Their somatic responses occurred within a region of ~ 80 µm2 and Ca2+ waves (confined 
to the processes) were defined as expanding and contracting fluctuations that spread within an 
area of ~ 15 µm2  (Srinivasan et al., 2015). The speed of the Ca2+ wave propagation in human 
acute slice cortical astrocytes was 43.4 µm/sec and was unaffected by TTX (Oberheim et al., 
2009). On the other hand, in mouse acute slice astrocyte cortices these Ca2+ waves propagated 
at a slower speed of 8.6 µm/s (Oberheim et al., 2009). These Ca2+ waves are considered a 
form of intercellular astrocyte communication (Dani et al., 1992) and have been observed to 
efficiently modulate synaptic activity (Pasti et al., 1997, Araque et al., 1999). 
 
1.5.1 Mitochondrial Ca2+ buffering in astrocytes  
 
Mitochondria actively uptake Ca2+ via the mitochondrial Ca2+ uniporter (MCU), powered by a 
negative membrane potential and release Ca2+ to the cytosol via the mitochondrial 
Na+/Ca2+ exchanger (mNCX) (Grosche et al., 1999, Kintner et al., 2007, Palty et al., 2010, 
Drago et al., 2011, Parnis et al., 2013). Release of Ca2+ from the ER internal stores, via 
activation of both inositol 1,4,5-trisphosphate receptors (IP3Rs) and ryanodine receptors 
(RyRs) (Hua et al., 2004), contributes to an increase in cytosolic Ca2+ in astrocytes. Synaptic 
activity can also evoke feedback cytosolic Ca2+ transients in astrocytes, which have the 
potential to alter the release probability of gliotransmitters (Perea and Araque, 2005, Serrano 
et al., 2006, Di Castro et al., 2011, Navarrete et al., 2013). These Ca2+ transients can 
propagate in a wave like manner, expanding from its point of origin through the astrocyte 
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network, via gap junctions. Mitochondria have been implicated in the propagation of these 
Ca2+ waves in cultured astrocytes (Simpson and Russell, 1998) and the up-regulation of 
mitochondrial function in Xenopus oocytes increased the velocity of these Ca2+ waves 
(Jouaville et al., 1995). Increases in intracellular Ca2+ precedes an increase in mitochondrial 
Ca2+ that can persist for ~ 30 minutes in cultured astrocytes. This suggests that mitochondrial 
Ca2+ uptake plays an essential role in the clearance of physiological intracellular Ca2+ loads 
(Boitier et al., 1999).  
 
Interestingly, altering mitochondrial Ca2+ buffering alters the release probability of glutamate 
from cultured astrocytes. Reyes and Parpura decreased mitochondrial Ca2+ handling with the 
mitochondrial un-coupler carbonyl cyanide p-trifluoromethoxy-phenyl-hydrazone (FCCP, 1 
µM), which depolarises the mitochondria by disrupting the H+ gradient of the inner membrane 
and found that this increased glutamate release from astrocytes. Increasing mitochondrial Ca2+ 
accumulation with CGP37157 (an mNCX blocker, which blocks mitochondrial Ca2+ efflux) 
resulted in increased glutamate release by astrocytes (Reyes and Parpura, 2008). These data 
suggest that intracellular Ca2+ levels are directly correlated with glutamate release and more 
importantly altering the Ca2+ buffering capacity of mitochondria can affect this phenomenon 
(Reyes and Parpura, 2008). Taken together, this reveals that the ability of mitochondria to 
buffer Ca2+ in astrocytes is important in terms of both astrocyte functionality and neuronal 
signalling. Ca2+-dependent gliotransmission has been shown to have important consequences 
for synaptic transmission and plasticity (Navarrete et al., 2013, Perez-Alvarez et al., 2014, 
Volterra et al., 2014). Moreover, in a model of AD, astrocytes show elevated resting Ca2+, 
increased Ca2+ transients and enhanced intracellular Ca2+ waves (Kuchibhotla et al., 2009), all 
of which, may contribute to elevated gliotransmitter release. 
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In addition, Simpson and Russel showed that mitochondria in cultured astrocytes are found in 
close association with sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA)-
expressing ER sites (Simpson and Russel, 1998). This close association infers that 
mitochondria are important for the propagation of Ca2+ released from nearby ER IP3Rs/RyRs. 
Csordas and colleagues showed, using drug-inducible fluorescent inter-organelle (Pericam-
tagged) linkers (FKBP-FRB heterodimerization system) in a basophilic leukaemia RBL-2H3 
cell line, that increasing the distance between the outer-mitochondrial membrane (OMM) and 
the ER to ~ 15 nm enhanced the efficiency of Ca2+ transfer from the ER to the mitochondria. 
In contrast, reducing the mitochondria–ER gap to 5 nm blocked the accommodation of IP3Rs 
(shown to protrude ~ 10 nm from the ER membrane) and thus prevents efficient ER-
mitochondria Ca2+ transfer (Csordas et al., 2010). Moreover, structural and functional analysis 
has revealed zones of close contact between mitochondria and the ER called mitochondria-
associated ER membranes (MAMs) (Giorgi et al., 2009). MAMs enable highly efficient lipid 
exchange and transmission of Ca2+ from ER to mitochondria (Hayashi-Nishino et al., 2009, 
Scharwey et al., 2013). In addition, the close association of mitochondria and the ER occurs 
during apoptosis, where MAPL induces an interorganellar platform between the ER and 
mitochondria by SUMO (Small Ubiquitin-like Modifier 1)-ylating Drp1, stabilizing its 
oligomeric form (Prudent et al., 2015). This is required to drive the disassembly of OPA1 
oligomers, which leads to remodelling of the mitochondrial cristae and cytochrome c release 
(Prudent et al., 2015). However, discerning the components of ER–mitochondria contact sites 
and the regulation of Ca2+ and lipid exchange at the MAMs within astrocytes remains to be 
resolved. 
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1.5.2 Potential routes for elevating astrocyte Ca2+  
 
Many potential routes exist for elevating astrocyte intracellular Ca2+ and factors that 
determine which route is involved include age or stage of development and brain region 
(Verkhratsky et al., 2012, Rusakov et al., 2014). The most established route is via synaptic 
glutamate activation of group I mGluRs, in particular mGluR5, which trigger G-protein-
coupled receptor cascades via Ca2+ release from internal stores (Cai et al., 2000, Carmignoto, 
2000, D'Ascenzo et al., 2007, Fellin et al., 2007, Rusakov et al., 2014). Activation of these 
mGluRs induces the release of gliotransmitters (D'Ascenzo et al., 2007, Fellin, 2009). 
 
1.5.2.1 Release from internal stores 
 
Release of Ca2+ from the ER internal stores, via activation of both RyR and IP3Rs, contributes 
to an increase in intracellular Ca2+ in astrocytes (Hua et al., 2004). Interestingly, Boitier and 
colleagues showed using cultured astrocytes, that ER-induced intracellular Ca2+ was followed 
by an increase in mitochondrial Ca2+ (Boitier et al., 1999).  Genetically removing IP3R2 
(knock out (KO) mouse) seemed to abolish Ca2+ transients in astrocytes. In these mice no 
neuronal deficits were observed and this lead to the premature conclusion that astrocyte Ca2+ 
signalling was not involved in maintaining neuronal function (Agulhon et al., 2010). 
However, Srinivasan and colleagues found that IP3R2 KO mice do exhibit Ca2+ transients both 
in the soma (although these were dramatically reduced) and processes (Srinivasan et al., 
2015). They determined that somatic Ca2+ responses mainly result from internal store release, 
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while Ca2+ responses in the processes occur as a result of entry from the extracellular 
environment and are not dependent on internal store release of Ca2+ (in vitro and in vivo). 
IP3R2 KO mice also exhibited frequent in vivo cortical astrocyte Ca2+ fluctuations (in the 
soma and processes) in response to a 3 second air puff to the space (startle response). They 
reveal an early and late stage of Ca2+ fluctuations. The early stage appeared to be dependent 
on alpha1-adrenergic receptors, while the late stage was neither dependent on alpha1-
adrenergic receptors or IP3R2 receptors (Srinivasan et al., 2015). 
 
1.5.2.2 Store-operated Ca2+ channels (SOCs) 
 
Ca2+ entry from the extracellular space can occur via store-operated Ca2+ channels (SOCs) 
(these include TrpC1 channels) when the internal ER Ca2+ stores are depleted in astrocytes. 
This also triggers significant mitochondrial Ca2+ transients (Lo et al., 2002, Golovina, 2005, 
Singaravelu et al., 2006, Malarkey et al., 2008), which implies that mitochondria may be in 
close association with the astrocytic plasma membrane. In addition, compromising 
mitochondrial Ca2+ buffering, through mNCX silencing, reduced SOC entry. These results 
reveal the importance of mitochondrial Ca2+ handling, and in particular mNCX activity, for 
proper regulation of intracellular Ca2+ through SOC-dependent Ca2+ entry in astrocytes (Parnis 
et al., 2013).  
 
1.5.2.3 Ionotropic glutamate receptors (iGluRs) 
 
Ionotropic glutamate receptors (iGluRs- NMDA and AMPA receptors) represent another 
route for astrocyte Ca2+ entry. However, it is important to note that separating the 
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contributions of neuronal and astrocyte NMDARs is difficult. Initially, immunocytochemical 
analysis of adult rat cortical astrocytes showed that some distal processes, and only rarely cell 
bodies, express the NMDAR subunits NR1 and NR2A/B (Conti et al., 1996). NR1, NR2B and 
NRC subunits were also detected in mouse cortices by polymerase chain reaction (PCR), 
which amplifies DNA from specifically targeted genes, if they are present (Schipke et al., 
2001). Glutamate and NMDA induced Ca2+ transients in cultured cortical rat astrocytes 
(Zhang, 2003, Palygin et al., 2010) and NMDA evoked Ca2+ transients in cortical slice 
astrocytes (astrocyte responses were measured by whole-cell patch clamp) (Schipke et al., 
2001, Lalo et al., 2006). It has also been confirmed that human astrocytes (foetal and adult) 
express all known NMDAR subunits (NR1, NR2A-D, NR3A-B) and that these receptors are 
functional, inducing Ca2+ influx upon stimulation (Lee et al., 2010). More recently, a 
transcriptome screen (RNAseq) revealed that NR2C was the most highly expressed NMDAR 
subunit in astrocytes (Zhang et al., 2014). In addition, astrocytic NMDARs are not blocked by 
magnesium (Mg2+) as greatly as neuronal NMDARs (Lalo et al., 2006). Interestingly, 
transient global forebrain ischemia was shown to result in the expression of functional (NR2B 
containing) NMDARs in the CA1 and subicular regions of the hippocampus (Krebs et al., 
2003). Moreover, glutamate was shown to illicit Ca2+ entry via these astrocyte NMDARs. 
However, while the presence of functional astrocytic NMDARs in rodents and humans is 
apparent in the cortex, the existence of NMDARs in hippocampal astrocytes, under 
physiological conditions, is still debated. TTX-resistant NMDA-induced Ca2+ responses were 
reported in astrocytes in hippocampal slices of young rats (< 12 days) (Porter and McCarthy, 
1995) but not in mature rats (Shelton and McCarthy, 1999). These results suggest that age and 
preparation could influence whether or not hippocampal astrocytic NMDARs are concluded 
to be present and functional. AMAPA receptors have also been shown to play a role in 
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mediating Ca2+ entry (Araque et al 2001). This suggests that astrocytes may utilise ionotropic 
glutamate receptors, thus providing a greater arsenal for glutamate buffering at the synapse by 
astrocytes. 
 
1.5.2.4 Endothelin receptors (ERTs) 
 
Ca2+ influx has also been proposed to occur via Gq protein-coupled endothelin receptors 
(ETRs) (Srinivasan et al., 2015). Edothelin binds to ETRs and induces astrocyte Ca2+ influx. 
Purinergic receptors are also capable of eliciting astrocyte Ca2+ influx. Studies of astrocytes in 
culture (Neary et al., 2003) and in brain slices (Porter and McCarthy, 1996) revealed robust 
Ca2+ responses to ATP and to more selective agonists of specific purinergic receptors. 
Astrocytes were found to express P2Y1, P2Y2, P2X1-4, P2X6 and P2X7 purinergic receptors 
(Fields and Burnstock, 2006; Hashioka et al., 2014) and ATP signalling was shown to 
regulate Ca2+-dependent glutamate release via astrocyte P2Y metabotropic G-protein-coupled 
receptors (Guthrie et al., 1999). Additionally, P2X7 ionotropic receptor activation is capable 
of mediating the release of glutamate from astrocytes, which is dependent on increases in 
intracellular Ca2+ (Duan et al., 2003). Interestingly, P2Y receptor antagonists have been 
proposed as potential neuroprotective agents in the hippocampus, cortex and cerebellum 
following neuronal death associated with neurodegenerative diseases such as Alzherimer’s, 
Parkinson’s, Huntington’s disease as well as Amyotrophic lateral sclerosis (Volonte et al., 
2003). In addition, activation of purinergic signalling in astrocytes via P2Y4 receptors, which 
can be induced by instances of trauma, stimulates the release of thrombospondin-1, an 
extracellular matrix molecule that induces synapse formation during development and might 
have a role in CNS repair and remodelling after injury (Tran and Neary, 2006). 
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1.5.2.5 Alpha1-adrenergic receptors 
 
Alpha1-adrenergic receptors have also been shown to play a role in regulating intracellular 
Ca2+ signals in astrocytes. Locus coeruleus released norepinephrine (induced by whisker 
stimulation or air-puff startle response) gave rise to long-range Ca2+ signals through activation 
of astrocytic alpha1-adrenergic receptors in vivo (Ding et al., 2013). Locomotion also induced 
astrocyte Ca2+ signals that were blocked by Terazosin (a selective alpha1-adrenergic receptors 
antagonist) (Paukert et al., 2014). Norepinephrine acting on alpha1-adrenergic receptors 
induces Gq-protein coupled increases in intracellular astrocyte Ca2+.  
 
1.5.2.6 Transient receptor potential A1 (TrpA1) channels 
 
Shigetomi and colleagues showed that transient receptor potential A1 (TrpA1) channels 
induce Ca2+ responses in membrane microdomains in astrocytes (using the membrane tethered 
genetically encoded Ca2+ indicator (GECI) Lck-GCaMP3) (Shigetomi et al., 2013). They used 
the specific TrpA1 antagonist HC030031 to block these microdomain Ca2+ responses in 
astrocyte in slices. These TrpA1-mediated transients appear important for maintaining 
signalling at the inhibitory synapse (where HC030031 reduced CA1 pyramidal neuron mini 
inhibitory postsynaptic currents (mIPSCs)). Ca2+ signalling in astrocytes was also shown to 
affect the levels of extracellular GABA and therefore inhibitory signalling. The study finds 
that TrpA1-mediated Ca2+ transients regulate GAT-3-dependent astrocyte GABA influx, 
which impacts on interneuron mIPSCs. 
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1.5.2.7 Nicotinic acetylcholine receptors (nAChRs) 
 
Nicotine influences memory by inducing synaptic transmission at acetylcholinergic synapses 
(Kenney and Gould, 2008). Astrocytes express nicotinic acetylcholine receptors (nAChRs) 
(Gahring et al., 2004, Hernandez-Morales and Garcia-Colunga, 2009) and nicotine binding to 
astrocyte nAChRs increases intracellular Ca2+ concentrations (Sharma and Vijayaraghavan, 
2001) and stimulates the release of D-serine (Lopez-Hidalgo et al., 2012). D-serine binding 
postsynaptic NMDARs allows the ion flux necessary for inducing LTP (Lopez-Hidalgo et al., 
2012). Interestingly, in AD, patients treated with nicotine exhibited improved cognitive 
function (Rangani et al., 2012). Similarly, activation of muscarinic acetylcholine receptors 
(mAChR) also increases intracellular Ca2+ concentrations (Shelton and McCarthy, 1999). 
 
1.5.2.8 Glutamate transporter-mediated entry 
 
Glutamate, released during synaptic activity, can be taken up by the astrocyte glutamate 
transporters (GLT-1) along with Na+. The plasma membrane Na+/Ca2+ exchanger (NCX) 
extrudes Na+ and brings Ca2+ into the cell (Goldman et al., 1994, Rojas et al., 2008, Reyes et 
al., 2012, Jackson et al., 2014). During low levels of activity the NCX extrudes Ca2+ in 
exchange for Na+ (Goldman et al 1994). Jackson and colleagues report that blocking the 
reverse mode of the NCX (blocking Ca2+ entry) increases mitochondrial trafficking in 
astrocytes. From this, they hypothesise that neuronal activity regulates glutamate transporter 
induced Ca2+ entry (via the NCX), which arrests mitochondria at sites of glutamate uptake.  
 
	 64	
Due to the many potential routes that have been implicated in mediating the influx of 
astrocyte Ca2+, it can be concluded that astrocytes are highly variable in the channels and 
receptors they express (Verkhratsky et al., 2012, Rusakov et al., 2014). It may be that 
astrocytes are plastic in the components they exhibit, altering which receptors or channels are 
present on their membrane in response to their surrounding environment. It may be that this is 
regulated by neuronal-secreted factors. Thus, narrowing down the mechanisms involved in 
elevating astrocyte Ca2+ and the downstream impact on mitochondrial trafficking requires 
further clarification. The interplay between mitochondrial trafficking and intracellular Ca2+, in 
response to astrocyte activation, may be important for regulating their proximity to glutamate 
release sites i.e. synapses.  
 
1.6 Mitochondrial quality control - Fission, Fusion and Mitophagy 
 
Mitochondria are dynamic organelles that constantly undergo fission and fusion events, which 
profoundly alter their morphology. These events ensure sufficient exchange of genetic 
material and proteins amongst the mitochondrial network, which is essential for proper 
mitochondrial function (Chang et al., 2006). Fission is the process of elongated mitochondria 
breaking into smaller more rounded mitochondria involving Drp1 and the fission 1 protein 
(Fis1). Fusion is instead the formation of elongated mitochondria from smaller mitochondria 
and involves the mitofusins (Mfn1 and Mfn2) as well as OPA1 (Chang and Reynold 2006; 
Leisa et al 2009). 
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1.6.1 Fission and fusion  
Under basal conditions, astrocyte mitochondria undergo fission and fusion events (50 % of 
events were fusion and 50 % fission) in acute cortical slices (Motori et al., 2013). 
Pharmacologically elevating intracellular Ca2+ in astrocytes resulted in remodelling or 
rounding of mitochondrial (Tan et al., 2011). Although the functional relevance of altering 
mitochondrial morphology is not clear, it may affect their ability to buffer Ca2+ and release 
ATP. Longer mitochondria, perhaps, might allow a greater area for ATP production and Ca2+ 
buffering, while it may be easier for shorter, more rounded mitochondria to position 
themselves in spatially restricted regions of the cell (i.e. very fine astrocyte processes or near 
synapses in neurons) (Chang and Reynolds, 2006). 
Interestingly, cellular injury alters the balance between mitochondrial fission and fusion 
events in astrocytes. Cortical injury and treatment with pro-inflammatory stimuli in acute 
slices induced rapid mitochondrial fission, along with an increase in Drp1 activity (Mortori et 
al., 2013). The induced inflammatory insult induces the production of nitric oxide (NO), 
which activates Drp1 and induces mitochondrial fission in astrocytes. ATP production was 
compromised in fragmented astrocyte mitochondria and the generation of ROS was elevated, 
affecting cell survival (Mortori et al., 2013). NO, itself, can alter gene transcription, 
mitochondrial respiration and induce cell death by apoptosis, directly. Interestingly, inducible 
nitric oxide synthase (iNOS), which catalyses the production of NO from L-arginine, was 
elevated in astrocytes (significantly more than in neurons) from AD patient tissue (Heneka et 
al., 2001) and mouse models of AD (Heneka et al., 2005). These results reveal the importance 
of identifying the mechanisms that regulate mitochondrial morphology in astrocytes as well 
as how it is dysregulated during disease.    
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1.6.2 Mitophagy 
Mitophagy is the process by which damaged mitochondria are degraded. Upon mitochondrial 
damage or stress, various proteins are recruited to their surface, which targets them for 
lysosomal degradation. Lysosomes are vesicles that contain hydrolytic enzymes that are 
capable of degrading virtually every type of biomolecule, thus it acts as the cell’s waste 
disposal system. The main pathway for mitochondrial degradation involves activation of 
phosphatase and tensin homologue deleted on chromosome 10-induced putative kinase 1 
(PINK1) and the E3 ubiquitin ligase, parkin. Upon mitochondrial damage, PINK1 
accumulates on the OMM, recruits parkin from the cytosol and activates it by 
phosphorylation. Activated parkin then ubiquitinates various substrates on the OMM. These 
include VDAC1 (voltage-dependent anion channel 1), Drp1, Mfns, TOM (translocase of 
OMM)-20 and Tom-40 (Cai et al., 2012). Ubiquitination is the process of accumulation of the 
protein ubiquitin (a small regulatory protein). This physically alters the structure of the 
protein being ubiquitinated and signals for it to be degraded by the lysosome.  
Once ubiquitinated by active parkin, mitochondria are subsequently recognized by ubiquitin-
binding autophagic components, e.g. LC3 (microtubule-associated protein light chain 3), 
HDAC6 (histone deacetylase 6) and p62 sequestosome, that promote the formation of 
autophagosomes and induce mitochondrial clearance by fusion with lysosomes. Loss-of-
function PINK1/parkin mutations have been associated with forms of early-onset PD (Exner 
et al., 2012).  
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1.6.3 The role of Miro in mitophagy 
 
Miro has also recently been shown to be involved in the cascade that regulates mitophagy 
(Wang et al., 2011, Tsai et al., 2014). It has been identified as a substrate for Parkin mediated-
ubiquitination (Birsa et al., 2014) and PINK1-mediated phosphorylation (Wang et al., 2013 
leading to its degradation thus preventing trafficking of damaged mitochondria and allowing 
for their clearance (Wang et al., 2011, Liu et al., 2012, Birsa et al., 2013). These findings 
suggest a possible link between Miro-mediated transport pathways and PD-associated 
disruption of mitochondrial turnover. 
 
1.6.4 Mitophagy in astrocytes 
Interestingly, parkin dysfunction has been shown to impair mitochondrial function in 
astrocytes and contribute to the pathogenesis of PD (Ledesma et al., 2002). Glial cells 
cultured from parkin-null mice exhibited increased expression of pro-apoptotic proteins and 
reduction in heat-shock protein 70, which is protective. Together this contributes to decreased 
neuroprotection by astrocytes (Solano et al., 2008). Moreover, Ledesma et al. 2002 have 
shown that astrocytes express lower levels of parkin, which has been suggested to exhibit 
differences in subcellular distribution compared to neurons. These data warrant further 
investigation into the importance of astrocyte specific differences in parkin expression and 
localisation, the cellular response to a lack of parkin, and the subsequent effect on PD 
pathogenesis. 
Regulation of the autophagy (programmed cell death) machinery is crucial for mitochondrial 
clearance and affects mitochondria function in astrocytes (Motori et al. 2013). For example, 
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knocking out the gene encoding Atg7 (essential for autophagosome production and lipidation 
of LC3-B), in astrocytes, resulted in highly hyperfused mitochondria, ROS production and 
ultimately cell death (Motori et al. 2013). Importantly, Motori and colleagues highlight that a 
failure to maintain the functional architecture of mitochondria affects astrocyte survival 
(Motori et al. 2013). With amyloid-β peptide treatment (a model of AD) astrocyte Ca2+ 
overload occurred along with excessive ROS production. This was observed to induce 
mitochondrial depolarisation through activation of the DNA repairing enzyme poly ADP-
ribose polymerase-1 (PARP-1) and opening mitochondrial permeability transition pore 
(mPTP) (Angelova and Abramov, 2014).  
A recent discovery by Davis and colleagues revealed that RGC axons shed mitochondria at 
the optic nerve head (ONH) that are internalized and degraded by adjacent astrocytes. They 
show that axonal mitochondria accumulate in large protrusions that are subsequently pinched 
off to form membrane-enclosed evulsions that are engulfed by astrocytes. Axonal 
mitochondria were confirmed within adjacent astrocytes, exhibiting phagocytic activity (high 
expression of the phagocytic marker Mac2) (Davis et al., 2014). This process was termed 
transcellular mitophagy and is predicted to be a widespread phenomenon, occurring 
elsewhere in the CNS (Davis et al. 2014).  
Taken together these data suggest that the pathway of mitophagy exists in astrocytes, but it 
remains to be determined how similar or dissimilar this mechanism is to neurons. Many 
questions exist regarding the components involved in the putative astrocyte mitophagy 
pathway and also how it may be regulated.  
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1.7 Implicating astrocyte mitochondria in disease  
It has been mentioned previously in this thesis that astrocytes provide both structural and 
energetic support for neurons. However, relatively little attention has been given to 
establishing the link between maintaining mitochondrial function in astrocytes and neuronal 
dysfunction. Some evidence does exist that directly implicates astrocyte mitochondrial 
dysfunction in neurological disorders (Table 1.1).  
1.7.1 Alzheimer’s disease (AD)  
Alzheimer’s disease (AD) is a chronic, progressive neurodegenerative disease where amyloid 
plaques, neurofibrillary tangles and tauopathies result in synapse and neuron loss (Abramov et 
al., 2004). Interestingly, a model of AD (beta-amyloid peptide treatment) causes loss of the 
mitochondrial resting membrane potential, inducing free radical production and oxidative 
stress specifically in astrocytes and not in neurons (Abramov et al., 2004). This impaired the 
ability of the astrocytes to maintain neuronal integrity and ultimately resulted in neuronal 
damage. It is particularly important to note that any mitochondrial phenotype in this model of 
AD precedes any neuronal phenotype. Interestingly, the astrocyte mitochondrial response to 
β-Amyloid was supressed by antioxidants (TEMPO).  
Another interesting study conducted by Angelova and Abramov 2014, revealed that in a 
model of AD (amyloid-β peptide, Aβ), Ca2+ signalling was elevated in astrocytes but not in 
neurons. This was due to the high levels of membrane cholesterol expression in astrocytes. 
Aβ significantly reduced the levels of glutathione (GSH) in neurons and astrocytes, an effect 
that was dependent on Ca2+ entry from external sources. Altering membrane cholesterol 
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regulation modified the astrocyte response to Aβ (elevated Ca2+ signalling, ROS production 
and mitochondrial depolarisation), which lead to improved neuroprotection (Angelova and 
Abramov, 2014, Narayan et al., 2014). This indicates that astrocyte intracellular Ca2+ regulates 
mitochondrial function and that both are disrupted in disease. 
 
1.7.2 Huntington’s disease (HD)  
Huntington’s disease (HD) manifests in preferential striatal neurodegeneration associated 
with mitochondrial dysfunction (Shin et al., 2005). In a model of HD (expression of mutant 
Huntington, mHtt), astrocyte mitochondrial dynamics were severely disrupted. mHtt impaired 
mitochondrial Ca2+ buffering and altered their membrane permeability, which can be 
particularly damaging (Oliveira, 2010). Mice expressing mHtt specifically in astrocytes show 
weight loss, have motor function deficits, and premature mortality compared to WT or control 
transgenic mice (Bradford et al., 2009). Brains from HD patients and from mouse models of 
HD show accumulation of mHtt in striatal astrocytes (Bradford et al., 2009). mHtt also 
decreased GLT-1 and GLAST expression, which are critical for the uptake and subsequent 
detoxification of glutamate (Oliveira, 2010). The compromised ability of astrocytes to buffer 
glutamate, at the synapse, decreased the threshold for excitotoxic neurodegeneration 
(Oliveira, 2010). These results indicate a potential new therapeutic target for HD. 
1.7.3 Parkinson’s disease (PD)  
Parkinson’s disease (PD) is a progressive neurodegenerative disorder, caused by the death of 
dopaminergic neurons in the Subtantia nigra. It manifests in resting tremors with impairments 
in movement. Similarly, expression of proteins containing PD-related gene mutations (for 
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example, human protein deglycase DJ-1 mutations) in cultured astrocytes impairs 
mitochondrial dynamics. This compromises their neuroprotective ability and thus renders 
neurons more sensitive to toxic insults (Larsen et al., 2011, Schmidt et al., 2011, Lev et al., 
2013). 
1.7.4 Amyotrophic lateral sxlerosis (ALS)  
Amyotrophic lateral sclerosis (ALS) or motor neuron disease (MND) is characterised by 
degeneration of motor neurons in the spinal cord, brain stem and motor cortex. It results in 
progressive muscle weakness, atrophy and spasticity (Wong et al., 1995). In mutant SOD-1 
astrocytes, a model of ALS/MND, mitochondria displayed severely impaired oxygen 
consumption and respiratory control, increased ROS production and disrupted membrane 
potential. This deceased the ability of the astrocytes to sustain motor neuron survival. 
However, mitochondrial-targeted antioxidants prevented this neuronal death (Wong et al., 
1995, Cassina et al., 2008). 
1.7.5 Epilepsy  
In addition, specific disruption of astrocyte mitochondrial function has dramatic consequences 
for aspects of neuronal function and in some cases survival. Treatment with flurocitrate (FC) 
induced specific disruptions in astrocyte mitochondrial function and resulted in focal, 
followed by global epileptiform activity (epilepsy) with some animals exhibiting convulsive 
seizures (Voloboueva et al., 2007). This resulted in neuronal damage and eventual death. In 
addition to this, abnormal synapse development, function and elimination were observed 
along with an imbalance in the E/I balance. 
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1.7.6 Other diseases and disorders 
 
Other diseases such as Down’s syndrome, Fragile X, and Rett Syndrome all exhibit astrocyte 
defects, impacting on neuronal development and/or function, but their impact on astrocyte 
mitochondrial function remains unclear. Fragile X syndrome (FXS) is the most common form 
of inherited mental impairment, and typically results from the transcriptional silencing of the 
FMR1 (fragile X mental retardation 1) gene and loss of the protein, FMRP (fragile X mental 
retardation protein) (Bhakar et al., 2012). FXS symptoms include neurodevelopmental delay, 
anxiety, hyperactivity, motor abnormalities, autistic-like behaviour and epilepsy. FMRP was 
thought to be expressed only in neurons, however, it was more recently shown to have 
specific roles in astrocytes (Pacey and Doering, 2007), where it is expressed at might higher 
levels (Cahoy et al., 2008). In FXS, astrocytes contribute to abnormal dendrite and synapse 
development in Fmr1 (loss of which induces Fragile X) deficient mice (Jacobs and Doering, 
2010).  
 
These data highlight the need to elucidate the mechanisms that regulate mitochondrial 
function in astrocytes. Mitochondrial trafficking may be actin or microtubule dependent 
(Jackson et al., 2014) but the exact motor proteins are unknown. The regulation of mitophagy 
in astrocytes is another important mechanism that remains to be addressed.  
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Table 1.1 Astrocyte dysfunction implicated in the pathogenesis of neurological disorders and diseases 
along with the resulting impact on neural function.  
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1.8 Thesis aims 
 
1. Extensively characterise the nature of basal mitochondrial trafficking in astrocyte processes 
compared to neurons and establish a link, if any, between neuronal signal transmission and 
mitochondrial trafficking dynamics in astrocytes. 
2. Define the role of Miro1 in astrocytes through the functional relevance of mutating the EF-
Ca2+-sensing hands of Miro1 on mitochondrial trafficking and positioning as well as the 
impact on cytosolic Ca2+ regulation and synapse formation. 
3. Define the role of knocking-out astrocyte Miro1 on mitochondrial trafficking and 
positioning in astrocytes, as well as the functional consequences for neuronal synapse 
formation i.e. does this link to a potential disease phenotype? 
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Chapter 2 
 
Materials and Methods  
 
2.1 Cell culture  
 
2.1.1 Primary neuronal cultures 
Primary hippocampal neuronal cultures were isolated from E18 Sprague-Dawley rats of either 
sex as described previously (Banker and Goslin, 1998) with some modifications. Isolated 
hippocampi were incubated in 0.25 % trypsin (diluted in dissection media) for 15 minutes at 
37’C. Pelleting the cells and resuspending in attachment media (Minimal Essential Media 
(MEM) (Gibco), 10 % heat-inactivated horse serum (HRS) (Gibco), 1 mM sodium pyruvate, 
0.6 % glucose) removed the trypsin solution. Following trituration, which involved passing 
the tissue through a narrow fire polishes glass Pasteur multiple times until a cloudy 
suspension forms, cells were counted using a Neubauer Haemocytometer and cell viability 
was assessed by erythrosin B exclusion. 350, 000 cells were plated in 6 cm dishes containing 
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13 mm coverslips pre-coated with poly-L-lysine (500 mg/ml) and attachment media. 
Attachment media was changed the following day to maintenance media (Neurobasal 
Medium (NB) (Gibco), B27 supplement (Gibco), 2 mM L-Glutamine, 10 U/mL penicillin and 
100 µg/mL streptomycin (Pen-Strep), 0.6 % glucose). These cultured neurons were used as 
mixed cultures due to the presence of astrocytes. The number of astrocytes present could be 
amplified or minimised by adjusting the length of time the culture initially spent in serum-
containing-attachment media. Cultures were maintained at 37°C with 5 % CO2 in a 
humidified incubator. 
 
2.2.2 Preparation of primary astrocytes 
Primary cultures of astrocytes were prepared from E18 Sprague-Dawley rats or transgenic 
Rhot1 mouse lines (E16) as previously described (Banker and Goslin, 1998, Al Awabdh et 
al., 2012) with some modifications. Cells were treated with 0.25 % trypsin and titurated by 
passing through a narrow glass Pasteur and, following pelleting, resuspended and maintained 
in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) with 20 % heat-inactivated foetal 
bovine serum (FBS) (Gibco) and 1 % Pen-Strep (10 U/ml, 100 µg/ml) at 37°C with 5 % CO2 
in a humidified incubator. Media was changed initially the day after plating and subsequently 
every 5 days until confluency was reached (7-10 days after plating). Cells were passaged after 
reaching 80-90 % confluency. Purity of these cultures has been previously described as being 
> 98 % by electron microscopy morphological studies, cell marker expression and 
pharmacological responsiveness (containing < 2 % OPCs and microglia) (Schildge et al., 
2013). 
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2.2.3 Transgenic cultures 
The ras homolog family member T1 (Rhot1) transgenic mouse line 
(MBTN;EFD0066_2_F01;Allele:Rhot1tm1a(EUCOMM)Wtsti) was obtained from the Wellcome Trust 
Sanger Institute as part of the International Knockout Mouse Consortium (IKMC) and were 
produced using the Knockout-First strategy to target Rhot1 in JM8.F6 embryonic stem cells 
(C57BL/6N background) backcrossed to C57BL/6J-Tyrc-Brd. Animals were set up for 
breeding and were maintained by Guillermo Lopez-Domenech and Josef Kittler under 
controlled conditions (temperature 20 ± 2°C; 12 hour light- dark cycle). Food and water were 
provided ad libitum. 
 
2.1.4 Preparation of transgenic cultures 
For Rhot1 transgenic mouse cultures, coverslips were prepared as described in the section 
above. To gain Rhot1-/- cortical astrocytes or hippocampal neurons, heterozygous pairs were 
crossed and animals were taken from the pregnant female when embryos are at embryonic 
day 16 (E16). All pups were kept separate during the dissection stages and a tissue sample 
from the tail of each embryo was taken in order to allow genotyping (Table 2.1.1). 
After dissecting the cortices or hippocampi in ice-cold HBSS, each embryonic cortical or 
hippocampal pair was incubated in 0.2 % trypsin and 5000 units/mL DNAse for 12 minutes at 
37oC. The tissue was then washed twice in HBSS before trituration in 1 mL attachment 
medium as described previously. Neurons were then plated at the same concentration as 
above (350, 000 cells plated in 6 cm dishes containing 13 mm coverslips pre-coated with 
poly-L-lysine (500 mg/mL)). Astrocytes were plated at roughly double the density of neurons 
and plated in dishes without coverslips.  
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2.1.5 Genotyping Rhot1 transgenic lines 
To extract deoxynucleic acid (DNA) for genotyping, 65 μl of alkaline buffer (0.2 mM 
disodium ethylenediaminetetraacetic acid (EDTA) and 25 mM NaOH) was added to 1 mm 
long tissue samples (tail tips) placed in thermo cycler tubes from each pup in order to dissolve 
the tissue. To further aid this process, the samples were incubated in a polymerase chain 
reaction (PCR) machine at 94°C for 45 minutes, and then chilled to 4oC. To neutralize the 
alkaline buffer, a tris(hydroxymethyl)aminomethane (Tris)-HCl based solution (65 μl, 40 mM 
Tris-HCl) was added to each sample. 
The genotyping PCRs were then run using the components listed in table 2.1.1. Two different 
PCRs were run using the sample, one to detect the wildtype or mutant Rhot1 allele using 
forward primer 5’-TTAGGATTTGTACTTTGCCCCTG-3’, reverse primer 5’-
AAAACCCTTCCTGCATCACC-3’ and Cassette primer 5’-TCGTGGTATCGTTATGC-
GCC-3’. The first two primers anneal to the wildtype allele and give a longer PCR product of 
an expected band size of 546 bp, whereas the cassette primer together with the reverse primer 
anneal to the Rhot1 mutant allele and give a shorter expected band of 277 bp and a separate 
PCR was run to detect the lacZ using forward primer 5’-ATCACGACGCGCTGTATC -3’ 
and reverse primer 5’-ACATCGGGCAAATAATATCG-3’. The primer sequences were taken 
from the protocol supplied with the animals by Sanger. The PCR was performed in 30 cycles 
at an annealing temperature of 58°C and using an extension time of 45 s. 
On occasion the genotyping was performed externally by Stuart Martin (UCL) using the same 
protocol. 
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Table 2.1.1 Genotyping Polymerase Chain Reaction 
 
 
2.1.6 Passaging/splitting cells 
Once grown to confluency (around 90 %) trypsin solution was added (137 mM NaCl, 2.7 mM 
KCL, 8 mM Na2HPO4, 1.5 mM KH2PO4, 2.5 g/L trypsin (from porcine pancreas, Sigma), 0.2 
g/L EDTA, 0.0015 g/L phenol red) at 37°C with 5 % CO2 for 5 minutes to detach cells from 
the dish surface. Fresh culture medium, preheated to 37°C, was applied to quench the trypsin 
and the cells were then pelleted by centrifugation and resuspended in the appropriate medium 
before being re-plated on 6 cm dishes. 
 
2.1.7 Co-culture system 
Primary cultures of cortical astrocytes were prepared from E18 transgenic mice as above and 
cultured on 6 cm dishes. Once grown to confluency the cells were passaged as above with 
additional scraping to remove any stuck cells and to yield a maximal number of cells. 
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Astrocyte culture medium, preheated to 37°C, was applied to quench the trypsin and 
following pelleting, the cells were resuspended in conditioned neuronal medium before being 
added to mouse neurons (prepared in the same way as the E18 Sprague-Dawley rats described 
above but plated at a slightly lower density to accommodate the astrocyte monolayer) at DIV 
6 (unless otherwise stated) (days in vitro (DIV) refers to the age of the neurons). Astrocytes 
were added at a concentration of around 0.5 million cells per 6 cm dish. Prior to co-culturing, 
the astrocytes could be transfected (either virally transduced (see section 2.6.1) or 
nucleofected (see section 2.6.3)) to effectively separate the astrocyte signal from the neuronal 
signal. 
 
 
 
 
 
 
 
  
  
Table 2.1.1 Cell culture media and reagents 
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2.2 Organotypic slice culturing 
Slices of CNS tissue were prepared from rodent brains and maintained for a maximum of 21 
days. Slices were incubated at 37°C, supplied with oxygen and frequently supplementated 
with culture medium (minimum of every 5 days). Under these conditions, neurons continue to 
differentiate and develop in a similar manner to that which is observed in an intact brain 
(Gahwiler et al., 1997). The Stoppini interface method allows for maintenance of the intact 
three-dimensional structures within the tissue. It involves culturing slices on porous 
membrane inserts (confetti) where tissue thinning occurs to around 5-8 layers of cells, instead 
of a monolayer, in the case of the roller tube technique (Stoppini et al., 1991, De Simoni and 
Yu, 2006). Sagittal brain slices (300 µm) were obtained from Sprague-Dawley rats or from 
transgenic mouse lines (in the case of mito-dendra2 experiments), at postnatal day 7-10, using 
a vibratome (Leica VT1200 S) in ice-cold dissection medium (HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) buffered EBSS (Earle's Balanced Salt Solution)). Slices were 
cultured on sterile 0.45 µm Omnipore membrane filters (Millipore) (Koyama et al., 2007) in a 
humidified incubator at 37°C with 5 % CO2. Slices were maintained for at least 7 days in 
culture medium (72 % MEM + glutamax (Gibco), 25 % HRS, supplemented with 20 mM 
HEPES, 36 mM glucose and 1.06 % Pen-Strep (10 U ml-1, 100 µg ml-1) with 16 % Nystatin 
(10, 000 U ml-1) prior to transfection or transduction and imaged 3 days later. For mouse 
slices the culture medium was supplemented with 5 mM Tris solution. Media was changed 
the day after slicing and every five days after that. All steps were carried out in a laminar flow 
cabinet under aseptic techniques.  
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Table 2.2.1 Organotypic slicing media 
 
 
 
 
 
 
 
 
Figure 2.2.1 Organotypic hippocampal slice culturing. Once dissected the brain is sliced in the sagittal 
orientation as shown (300 µm thick). The hippocampus is then dissected from the rest of the tissue. 
These slices are kept for at least a week on culture inserts and subsequently infected before imaging.  
 
	 83	
 
 
2.3 Materials 
 
2.3.1 Antibodies and drugs 
A rabbit Miro1 antibody (Atlas, HPA010687) was used to label Miro1 and Miro2 (1:500) in 
organotypic slices and in western blots (1:1000). The vesicular glutamate transporter 1 
(VGLUT1) guinea pig antibody (Synaptic Systems, 135-304) was used to label synapses 
(1:500 for slices and 1:1000 for cultures). A NeuN mouse antibody (Chemicon International 
(Millipore), MAB377) was used to label neuronal cell bodies (1:500). The GFAP rabbit 
antibody (DAKO, Z0334) was used to label astrocytes (1:500). In some cases a mouse GFAP 
antibody was used (DAKO, MO761) (1:500). A MAP2 mouse antibody (Sigma Aldrich, 
M9942) was used to label dendrites (1:500). A Homer-1 rabbit antibody (Synaptic Systems, 
160-003) was used to label post-synaptic terminal (1:300). A mouse GluR2 antibody 
(Millipore, MAB397) was used to label AMPA receptors (1:400). A rabbit Actin (Sigma 
Aldrich, A2066) antibody was used at 1:1000 for western blotting experiments. Secondary 
antibodies Alexa-405 mouse and Alexa-633 rabbit were purchased from Invitrogen and used 
at 1:500. The HRP-conjugated secondary rabbit antibody was purchased from Rockland (611-
1102) and used at 1:1000. 
 
TTX (Tetrodotoxin) (used at 1 µM), D-APV ((2R)-amino-5-phosphonopentanoate) (used at 
50 µM), MK-801 (Dizoclipine) (used at 100 µM) and MCPG (α-methyl-4-
carboxyphenylglycine) (used at 1 mM) were purchased from Tocris Bioscience. 4-AP (4-
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Aminopyridine) (used at 100 µM), glycine (used at 1 µM), glutamate (L-glutamatic acid) 
(used at 100 µM), NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione) 
(used at 50 µM) and EGTA (ethylene glycol tetraacetic acid) (used at 100 µM) were 
purchased from Sigma Aldrich. 
 
2.3.2 Other materials 
All cell culture dishes were from Techno Plastic Products (TPP) Switzerland. All chemicals 
were from Melford or Sigma Aldrich unless otherwise stated. 
 
2.3.3 Plasmid constructs 
mtdsRed2, encoding mitochondrially targeted dsRed2 utilises the cytochrome c subunit VIII 
mitochondrial targeting sequence (N-terminally attached) was obtained from Clontech 
(PT3633-5). Miro1WT-ires-mtdsRed2 and Miro1ΔEF-ires-mtdsRed2 constructs were made in 
the lab by cloning Miro1 constucts into a bicistronic ires vector containing mtdsRed2 
(Macaskill et al., 2009b). pGFAP-MyrGFP (GFAP-driven GFP) was purchased from 
Addgene (#22672) (Nam and Benezra, 2009). pCMV-GCaMP6s was also purchased from 
Addgene (#40753) (Chen et al., 2013b). Pre-synaptically targeted GCaMP5 (Sy-GCaMP5) 
was cloned by Victoria Vaccaro using SyGCaMP2 (#26124) (Dreosti et al., 2009) from 
Addgene as a target vector and inserting GCaMP5G from Addgene (#31788) (Akerboom et 
al., 2012) via the restriction sites SalI and NotI.  
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2.4 Molecular Biology 
 
2.4.1 Polymerase Chain Reaction (PCR) 
Except in the case of genotyping (see Table 2.1.1) PCR was carried out using High-fidelity 
Phusion DNA polymerase (Finnzymes) following the manufacturer’s instructions. The PCR 
reaction was assembled as described in Table 2.4.1, and then subjected to a PCR programme 
with appropriate primer annealing temperature (calculated used Finnzymes Tm calculator) 
and extension time, depending on the experiment (annealing time is 30 s/kb for normal PCR 
and 1 min/kb for reverse PCR) (Figure 2.4.1). 
Per PCR, 1 μl of DNA template (DNA concentration of ~ 50 ng/μl) was added to 49 μl of the 
PCR mix and temperature cycling was achieved using a GeneAmp® PCR System 2700 
(Applied Biosystems) PCR machine. The PCR product was either purified directly after 
validating correct product length using an agarose gel or purified from the agarose gel using 
QIAquick purification kit (Qiagen). 
 
 
 
 
 
Table 2.4.1 Standard Polymerase Chain Reaction 
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Figure 2.4.1 Standard Polymerase Chain Reaction programme. An initial melting step occurs at 95°C, 
where DNA is denatured. Subsequently, 25-30 cycles of a melting step (95°C, 30 s), annealing step 
(variable annealing temperature, 30 s) and extension step (72°C, variable time of 30 s - 1 min/ kb) take 
place. During the annealing step, the temperature is lowered to allow binding of the primers to the 
template, while the extension step allows for DNA polymerization due to the high temperature 
tolerance of Phusion (MyTaq). After temperature cycling, the temperature is kept at 72°C for 5 min 
before the samples are held at 4°C. 
 
2.4.2 Agarose gel 
Agarose gels were made melting 1 % agarose in 1x TBE buffer (10x solution purchased from 
National Diagnostics diluted in ddH2O). 1 μl of ethidium bromide or 5 μl of StarSafe (Lonza) 
was added to visualise the DNA with UV light. Gels were let to set, and then loaded with 
DNA samples diluted in 6x loading buffer (0.25 % bromophenol blue and 40 % sucrose) 
alongside a DNA ladder (Hyperladder I, Bioline) and run at 90-100 V for the required time 
(approximately 1 hour). 
2.4.3 Digestion and purification 
5 μl of the purified insert and 1 μg of the vector were digested with the selected restriction 
enzymes (NEB) in the appropriate digestion buffer (NEB), supplemented with BSA for 1.5 
hours at 37°C. Digests were run on an agarose gel and bands were excised and purified using 
Gel extraction kit (Qiagen) following the manufacturer’s instructions. 
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2.4.4 Ligation 
Purified insert and vector were combined at a 3:1 ratio and incubated with 2 μl of T4 ligase 
buffer and 1 μl of T4 ligase (total reaction volume 20 μl) at RT for 30 minutes and at 4°C 
overnight. 
2.4.5 Chemically competent cells 
Competent cells were prepared with Inoue method (Inoue et al., 1990) by Nathalie Higgs. 
2.4.6 Transformation of competent cells 
Competent cells were thawed on ice. 50 μL of cells were transferred to a 14 mL round bottom 
falcon tube. Following incubation for 30 minutes on ice with the appropriate amount of DNA 
(3 μL of ligations or 10 pg of plasmid DNA), bacteria were heat shocked at 42°C for 45 
seconds. Cells were then incubated on ice for 2 minutes, 200 μL of RT LB media 
supplemented with 0.4 % glucose were added, and cells incubated in a bacterial shaker (230 
rpm) at 37°C for 1 hour before plating onto agar plates with the appropriate resistance. Plates 
were then incubated overnight at 37°C. 
The next day colonies were picked and grown overnight in 10 mL of LB media with the 
appropriate resistance. DNA was extracted with a mini prep kit (Sigma) and sequenced 
(Sanger sequencing, Source Bioscience). Positive bacterial clones were stored as glycerol 
stocks (750 μL of bacteria supplemented with 250 μl of 60 % glycerol) at -80°C. 
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Table 2.4.2 Molecular biology solutions and reagents 
 
2.4.7 Maxi preparation of plasmid DNA 
Plasmid DNA was purified from bacterial cultures with Pure Yield Maxi prep Kit (Promega) 
following the manifacturer’s instructions. 
 
2.5 Viral construction 
 
2.5.1 The Adenoviral Expression System 
Gateway® Vector Technology (Invitrogen) was used to introduce desired construct 
expression in dividing and non-dividing mammalian cultured astrocytes/organotypic slice 
astrocytes using adenoviral vectors. Initially the gene of interest (GOI) was cloned into an 
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entry vector (pENTRTM4A, Invitrogen, #A10465) before being transferred to a pAd/PL-
DESTTM Gateway® viral vector (Invitrogen, #V494-20) using Clonase II induced AttL-AttR 
recombination. This technology takes advantage of the site-specific recombination properties 
of bacteriophage lambda (Landy, 1989). The GOI, promoter and polyadenylation (pAd) tail 
sequence must all be cloned between the Att sites of the entry clone to ensure proper 
expression of the gene within the adenovirus vector (AV).  In this case the AV was a human 
adenovirus type 5. Subsequent amplification of the AV using ViraPower™Adenoviral 
Expression System produces a replication-incompetent AV. This involved digesting the 
destination vector with PacI to expose the viral inverted terminal repeats (ITRs) prior to 
transfecting into a HEK-293A Cell Line to produce a crude adenoviral stock. This was 
subsequently amplified by infecting the 293A cells with the adenoviral stock. Finally, the 
adenoviral stock was titred to establish purity (plaque forming units) before using it to 
transduce cells/tissue of interest. 
 
2.5.2 Adenovirus (AV-5)-mtdsRed2-ires-EGFP 
An AV encoding mtdsred2-ires-EGFP was created using a pENTRTM4A dual vector 
containing (3' to 5'); a CAG promoter, the mitochondrially targeted red fluorescent protein, 
mtdsred2, an internal ribosome entry site (ires/ir) followed by enhanced green fluorescent 
protein (EGFP). The entry clone pENTR-mtdsRed2-ires-EGFP was subsequently cloned into 
the pAd/PL-DEST vector before being amplified by the ViraPower™Adenoviral Expression 
System (Invitrogen). The vector also contained a pAd tail and a Woodchuck hepatitis 
promoter regulatory element (WPRE) to enhance expression. Amplification of the AV-
mtdsred2-ires-EGFP was performed by Nathalie Higgs. 
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2.5.3 Adeno-associated virus (AAV-2)-mtdsRed2-ires-egfp 
A modified adeno-associated virus (AAV) was created to sparsely label neurons with 
transgenes of interest, long-term, with minimal cytotoxicity. The AAV backbone was 
modified from a pAAV vector containing EF1a-double floxed EYFP flanked by inverted 
terminal repeats (ITRs). Expression was driven by a CAG promoter and contained a 
polyadenylation tail (pAd) and a WPRE. In order to allow the insertion of constructs into the 
AAV backbone a sequence from the pAd/PL-DEST vector was inserted between the ITRs of 
the pAAV (replacing the EF1a-double floxed EYFP). This sequence consisted of AttR1-
chloramphenicol resistance (Chlr)-ccdB-AttR2. This insert allows AttL-AttR recombination 
of entry clones into the modified AAV vector as well as negative selection of subsequent 
probes. Following successful recombination (with Clonase II) the AAV-mtdsRed2-ires-egfp 
construct was sent to Penn Vector Core (University of Pennsylvania) for production.  
 
2.5.4 Adenovirus (AV-5)-CRE 
An adenovirus encoding CRE was purchased from Penn Vector and used to induce CRE-loxP 
recombination and consequently, expression of mito-dendra2 in slices from the mouse 
transgenic line floxed-stop-mito-dendra2 (Pham et al., 2012). 
 
2.6 Transfection 
 
Transfection or transduction (viral mediated transfection) is the process by which cells are 
manipulated to express a specific protein of interest. Depending on the preparation, different 
techniques are used to transfect specific cell-types of interest.  
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2.6.1 Viral transduction 
Slices were infected by adding 20 µl of virus diluted in slicing media (1:1000) for 3 days 
prior to imaging or fixing. Virus titres are as follows: AV-Cre, 1x1014 plaque forming units 
(PFU); AV-mtdsRed2-ires-EGFP, 2.6x1016 PFU; AAV-mtdsRed2-ires-EGFP, 2.4x1012 PFU.  
 
2.6.2 Lipofection 
Lipofectamine 2000® (Life Technologies) was used to transfect E18 hippocampal neurons (at 
DIV7-10) (Al Awabdh et al., 2012) with some modifications. For two 13 mm coverslips or 
one 25 mm coverslip, 2 µg DNA was added to 2 µl of Lipofectamine reagent, each in 
unsupplemented neurobasal (NB, Gibco) (100 µl or 200 µl, respectively) and incubated at 
room temperature for 30 minutes. Conditioned media was then added to the DNA-
Lipofetamine mix (300 µl or 500 µl, respectively) before adding to cultures and allowed to 
complex for 2 hours after which the media was replaced with conditioned media. 
Lipofectamine transfection was used to transfect cultured neurons with Sy-GCaMP5, which 
were then co-cultured with primary cortical astrocytes. Lipofectamine transfection was also 
used to overexpress (OE) either Miro1WT-ires-mtdsRed2 or Miro1ΔEF-ires-mtdsRed2 
constructs with GFAP-driven GFP in E18 neuronal cultures (which contained astrocytes). 
 
2.6.3 Nucleofection 
To transfect hippocampal astrocytes (E18), before co-culturing with hippocampal neurons 
(E18), an Amaxa Nucleofector® was used following the manufacturer’s protocol. 1 µg of 
DNA was added to pelleted cells, obtained using trypsinization of confluent 10 cm dish, 
resuspended in 100 µl WT-EM buffer solution (5 mM NaH2PO4, 35 mM Na2HPO4, 5 mM 
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KCl,  10 mM MgCl2, 11 mM glucose, 100 mM NaCl, 20 mM HEPES). Astrocytes were 
transfected using the rat astrocyte program (T-020) before being co-cultured with 
hippocampal neurons. Transfected astrocytes were maintained with neurons for 3-4 days 
before live Optosplit imaging.  
 
 
 
 
 
Table 2.6.1 Transfection solutions 
 
 
2.6.4 Biolistic slice transfection 
Unfortunately, transfecting cells in intact tissue remains a rate-limiting factor in the study of 
many areas of neurobiology, including astrocyte biology. Biolistic transfection is a physical 
method of transfection in which the target tissue is bombarded with DNA-coated gold 
particles (bullets) using a gene-gun. The gene-gun uses pressurised gas to facilitate tissue 
penetration of the gold. Once a cell has been penetrated by the gold particles the DNA is 
likely to be taken up by the cell. In this way, cells of interest can be labelled with fluorescent 
molecules or proteins of interest can be overexpressed or knocked-down. 
 
Organotypic slice cultures (rat P7, 300 µm thick) were biolistically transfected at 7 DIV using 
a Helios gene gun (BioRad) (Woods and Zito, 2008). Slices greater than 300 µm thick display 
lower transfection efficiency (Benediktsson et al., 2005). Biolistic transfection involved 
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coating small (0.6 µm) gold particles (Benediktsson et al., 2005) with up to 40 µg of DNA (a 
maximum of 20 µg for each construct if more than one was used). This allowed sparse 
transfection of astrocytes in organotypic slices. For optimal transfection of astrocytes gene 
gun bullets were prepared with 9–12 mg of gold per 75 cm of tubing, compared to 7–9 mg of 
gold for optimal labelling of neurons. The distance of the gene gun tip to the tissue slice was 
another variable that affects astrocyte transfection efficiency. If the tip was too close (< 1 cm), 
cells located at the edges of the slice were primarily transfected. Another important variable 
was the health of the slice at the time of transfection, affected by the angle at which the tissue 
was initially cut as well as the frequency at which cultures were fed. Slicing off-axis (i.e. at an 
angle) increases neuronal damage and results in low tissue viability (Benediktsson et al., 
2005). Feeding cultures more frequently (i.e. every 2-3 days) promotes tissue viability.  
 
Transfection typically yielded 20–100 labelled cells per slice. Slices were maintained for 2 
days, following shooting, before imaging to improve visibility. Labelled cells were present 
several days after transfection. Post-imaging immunohistochemistry (IHC) staining with 
GFAP and MAP2 was used to confirm cell-type specificity. The triple expression system 
involved coating bullets with Miro1WT/ΔEF-ir-mtdsRed2 and GFAP promoter driven GFP DNA 
or GCaMP6s DNA.    
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Figure 2.6.4 Biolistic slice transfection. Once cultured for at least a week and allowed to recover 
from the insult of slicing, the tissue can be transfected using DNA-coated gold particles and a Helios 
gene-gun (Bio-rad). Helium gas is pressurised to 180 mmHg, which forces the DNA-coated gold 
particle through a filter to lessen the impact and into the tissue below. Expression takes around 1-2 
days following shooting.  
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2.7 Treatment of organotypic hippocampal slice cultures for fixed 
imaging 
Slices were treated 3 days post infection. Slices were placed in a well containing organotypic 
media supplemented with the relevant drugs for 10 minutes at 37°C. The slices were then 
washed with organotypic media before fixing with 4 % PFA (4 % paraformaldehyde, 4 % 
sucrose, 50 % PBS (137 mM NaCl, 2.7 mM KCL, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7). 
Depending on the mechanism of action drugs were added for sufficient time for required 
activation. For experiments using EBSS + Ca2+ the composition was as follows: EBSS (no 
Ca2+, GIBCO) supplemented with 1.8 mM CaCl2, 1 mM MgCl2 and 5.56 mM D-glucose. For 
experiments with 0[Ca2+]e, EBSS (no Ca2+, GIBCO) was supplemented with 1 mM MgCl2, 
5.56 mM D-glucose and 100 µM EGTA. 
 
2.8 Imaging  
 
2.8.1 Live imaging 
 
2.8.1.1 Confocal imaging  
Hippocampal slices (imaging was confined to the CA3 where possible) or cultured astrocytes 
were imaged using an upright Zeiss LSM700 confocal with a 63x 1 NA water objective. 
Upon live imaging, cells/slices were transferred to a recording chamber, perfused at 5 ml/min 
with imaging solution (ACSF) at pH 7.4 (125 mM NaCl, 10 mM D-glucose, 10 mM HEPES, 
5 mM KCl, 2 mM CaCl2, 1 mM MgCl2) and heated to 35-37°C. Perfusion was supplemented 
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with drug combinations as indicated in the text for 5 minutes, slices were then washed for 5 
minutes. Images were acquired at 1 frame every 5 seconds, except for imaging GCaMP6s 
where images were acquired at a frame rate of 2 seconds. Excitation was achieved via diode 
lasers at wavelengths of 488 m and 555 nm.  	
2.8.1.2 Custom optosplit imaging  
An inverted Zeiss Axiovert 200 microscope (63x 1.4 NA oil objective), attached to an Evolve 
(EMCCD) camera (Photometrics), fitted with an image splitter (Optosplit II, Cairn Research), 
allowed simultaneous acquisition of images at two separate emission wavelengths. Images 
were acquired with 30 ms exposure at 1 frame every 2 seconds using Micro-manager software 
(Edelstein et al., 2010). Excitation was achieved through a D470/40X filter (Chroma) and 
emission was split using a 565DCXR dichroic beam-splitter (Chroma), subsequently 
collecting with HQ522/40M and HQ607/75M (Cairn Research) filters for SyGCaMP5 and 
mtdsRed2, respectively. A Grass S9 stimulator and a stimulation bath (Warner Instruments) 
allowed field stimulation (20 Hz for 10 s) of 25 mm coverslip-plated neuron-astrocyte 
enriched cultures.  
 
2.8.2 Immunofluorescence 
Cultures for immunocytochemistry were fixed with PFA for either 5 min for surface staining 
or 10 min for whole cell staining. Coverslips were washed with PBS and subsequently 
incubated with block solution (PBS containing 10 % HRS, 0.5 % BSA (bovine serum 
albumin), 0.2 % Triton-100) at room temperature (RT) for 1 hour. Coverslips were then 
incubated with primary antibody, diluted in block solution, for 2 hours at RT. Following 
washing with PBS the cells were incubated for a further hour at RT with secondary 
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antibodies, diluted in block solution at 1:800 (AlexaFluor, Invitrogen). The coverslips were 
washed several times and then mounted on microscope slides using Pro-Long Gold antifade 
reagent mounting medium (Invitrogen). For organotypic slice immunohistochemisty, slices 
were incubated with block solution with 0.4 % Triton for 4-6 hours before incubating in 
primary antibody overnight at 4°C. The following day the slices were washed (with PBS) and 
blocked for a further 4-6 hours before being incubated with secondary antibodies (diluted in 
block solution, 0.4 % Triton) overnight at 4°C. Slices were then mounted on microscope 
slides with Vectorshield hard set mounting medium (Vector Labs) and then covered with 18 
mm coverslips. Images of fixed cultures or slices were taken on a Zeiss LSM700 confocal 
using a 63x oil objective (1.4 NA).  
 
 
 
 
 
 
 
 
 
 
Table 2.8.1 Immunohisto/cytochemistry and imaging solutions 	
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2.8.3 Image Processing 
 
2.8.3.1 Mitochondrial morphology 
Mitochondrial morphology was analysed by manually calculating mitochondrial length in a 
maximum intensity projection of regions of interest, using ImageJ. This was achieved by 
tracing the longest line along each mitochondrion and establishing the output length in µm.  
 
2.8.3.2 Mitochondrial mobility 
Mitochondrial mobility was assessed by counting the percentage of mitochondria moving 
during an imaging period (5 min). Mitochondria in a field of view were manually classed as 
moving if they moved more than 2 µm. Oscillating mitochondria were identified as moving 
back and forth no more than 2 µm. Immobile mitochondria were manually identified as not 
moving and not oscillating.  
 
2.8.3.3 Kymograph creation 
Kymographs were created as described previously (Macaskill et al., 2009b, Muir et al., 2010, 
Twelvetrees et al., 2010). Curved processes were straightened using the Straighten macro in 
ImageJ and kymographs created using the Multiple Kymograph plugin (ImageJ) (with a line 
width of 1). Resultant kymographs show the process along the x-axis and time projected 
down the y-axis. Height of the kymographs is 15 min, unless otherwise stated, and time 
increases down the page. Immobile mitochondria can be identified as straight lines, diagonal 
lines represent moving mitochondria and oscillating mitochondria can be seen as zigzag lines.  
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2.8.3.4 Mitochondrial velocity analysis 
The average velocities (µm/s) of moving mitochondria were quantified using the ImageJ 
Manual Tracking plugin. Since mobility was usually accompanied by brief pauses, along with 
changes in direction, stops greater than 5 seconds were omitted. Again, mitochondria were 
only included in the analysis if they moved more than 2 µm, with the aim of avoiding the data 
being dominated by mitochondria that did not move throughout the experiment and excluded 
oscillating mitochondria.  
 
2.8.3.5 Synaptic recruitment of astrocyte mitochondria  
For synaptic recruitment experiments, mtdsRed2 labelled mitochondria distributed along 
astrocytic processes were assessed in relation to VGLUT1 labelled pre-synaptic vesicles (used 
to label synapses). Images were manually thresholded and using the ImageJ plugin JACoP 
(Objects based methods of co-localisation) (Bolte and Cordelieres, 2006) the distance from 
the centre of each mitochondrion to the centre of each VGLUT1 puncta in the proximal axon 
was calculated. For each mitochondrion, the distance to its nearest synapse was then extracted 
using Excel (Microsoft). From the JACoP data the number of synapses and mitochondria was 
also calculated per µm of astrocyte process.  
 
2.8.3.6 Mitochondrial fusion rate analysis 
In each experiment, an 80x80 µm region in the distal processes was switched with 405 nm 
confocal laser light (200 iterations ~ 0.6 mW). This switched the green mito-dendra2-labelled 
mitochondria to red in the region exposed to 405 nm light. To calculate the mitochondrial 
fusion rate, an automated approach was used to measure co-localisation (Pearson’s R-value, 
JACoP, ImageJ) of the manually thresholded red and green mito-dendra2 channels. This 
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represents overlap between the switched red mito-dendra2 signal and green mito-dendra2 
signal redistributing into the switched area. Results were normalised to the R-value of the pre-
switched region in each experiment to account for any noise in the system.  
 
2.8.3.7 Particle analysis 
The ImageJ plugin Analyse Particles was used for automated calculations of synapse number 
and size (VLGUT1, homer puncta or GluR2 puncta) following manual thresholding.  
 
2.8.3.8 Sholl analysis 
The ImageJ Sholl analysis plugin (Gensel et al., 2010) was used to calculate the number of 
astrocyte process intersections contained within concentric circles radiating out from the soma 
at 10 µm increments with a cut off at 100 µm. Images were manually thresholded prior to 
Sholl analysis and all if applicable the processes of other cells removed manually. 
 
2.9 Western Blotting 
Nitrocellulose membranes with transferred cells (pure astrocyte cultures) were blocked in 
block solution (4 % Marvel Milk powder, 0.1 % Tween-20 in PBS) for 1 hour prior to 
addition of primary antibody (Miro1 rabbit Atlas antibody (1:1000) and Actin rabbit Sigma 
antibody (1:1000)). Primary antibodies were incubated overnight in a sealed plastic bag at 
4°C. Residual antibody was then removed by washing 3 times for 5 minutes (with block 
solution) before incubating with HRP conjugated secondary antibody (Rockland HRP-
conjugated rabbit antibody in block solution) for 1 hour at room temperature. Membranes 
were washed 4 times for 10 minutes with block solution and rinsed with 1x PBS. Membranes 
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were then allowed to dry on 3 mm blotting paper and incubated for 5 minutes with super 
signal enhanced chemiluminescent Crescendo substrate (Milipore) to allow detection of 
signal with a LAS 4000 imager (GE Healthcare). 
 
 
 
 
 
 
 
 
 
  
 
 
  
  
 
 
 
Table 2.9.1 Biochemistry buffers and reagents 
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2.10 Statistical Analysis 
All data were obtained using cells from at least three different animals/preparations. Results 
are presented as mean ± SEM. Statistical analysis was performed using student's unpaired, 
two-tailed, two-sample t-test (homoscedastic variance) in Excel. One-sample t-tests were 
performed in Mathematica. Statistical significance is indicated by: p < 0.05, *; p < 0.01, **; p 
< 0.001, ***. Significance was corrected for multiple comparisons, where applicable, by 
dividing the p-value required for significance by the number of comparisons made 
(Bonferroni correction) and n’s are indicated in the figure legends. For mitochondrial 
mobility, velocity and length analysis, p-values indicated in the text reflect comparisons made 
to their corresponding pre-treatment values, where possible (in the case of TTX treatment and 
0Ca2+ p-values reflect comparisons made across all pre-treatments excluding TTX and 0Ca2+ 
pre-treatments). 
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Chapter 3 
 
Neuronal activity induces stopping of astrocyte mitochondria close 
to synapses. 
 
3.1 Introduction 
 
The processes of astrocytes that ensheath synapses have been shown to contain a significant 
number of mitochondria (Grosche et al., 1999, Lovatt et al., 2007, Oberheim et al., 2009). 
Here, their positioning could be of particular importance for intracellular Ca2+ regulation, 
which influences Ca2+-dependent gliotransmission. However, whether and how astrocyte 
mitochondria are able to respond to neuronal activity and position themselves accordingly 
remains to be addressed. Reciprocally, how their positioning may regulate aspects of neuronal 
signalling is also an important unanswered question.  
 
A study by Kremneva and colleagues addressed the regulation of mitochondrial mobility in 
cultured astrocytes (Kremneva et al., 2013). Mitochondria were highly motile in regions of 
low intracellular Ca2+. This motility and velocity was significantly reduced in response to low 
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(1 μM) and high (5 μM) doses of ionomycin, which raises intracellular Ca2+. In addition, the 
reduction in motility corresponded to a significant rise in (Fura2 labelled) intracellular Ca2+. 
ATP (100 μm) also induced a significant rise in intracellular astrocyte Ca2+, alongside a 
decrease in mitochondrial motility (Kremneva et al., 2013). Astrocyte mitochondrial mobility 
was concluded to be mainly microtubule dependent when intracellular Ca2+ was low (baseline 
signalling), where they were highly motile. However, during elevations in intracellular Ca2+ 
mitochondrial movement ceased as they become anchored to actin filaments, dependent on 
Ca2+ induced interactions (Kremneva et al., 2013). Human astrocytes also respond to ATP 
(100 μM-5 mM) by increasing their intracellular Ca2+ (Oberheim et al., 2009). Furthermore, 
electrical stimulation of CA3-CA1 projecting Schaffer collateral (SC) axons (50 Hz, 2 s) 
increased intracellular astrocyte Ca2+ in hippocampal slices (Porter and McCarthy, 1996). The 
astrocyte response to electrical stimulation was enhanced by 4-AP (100 μM) (K+ channel 
antagonist that stimulates neuronal activity) and blocked by TTX (1 μM) (Na+ channel 
blocker that decreases neuronal firing) and the mGluR antagonist MCPG (1 mM). Inhibiting 
the response of astrocytes to electrical stimulation and 4-AP required not only MCPG but also 
the iGluR antagonist kynurenic acid. Porter and McCarthy conclude from this that higher 
levels of neuronal activity (in the case of combining electrical stimulation with 4-AP) activate 
astrocyte mGluRs and iGluRs (Porter and McCarthy, 1996). These results indicate that rises 
in astrocyte intracellular Ca2+ reduce mitochondrial mobility and that neuronal activity 
regulates intracellular Ca2+ in astrocytes via mGluR and iGluR activation in the hippocampus. 
This provides a likely link between stimulation of neuronal activity and alterations in 
mitochondrial mobility in astrocytes. However, exactly how this regulation occurs remains to 
be resolved.  
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Jackson and colleagues found that although astrocyte mitochondria were mobile in astrocyte 
processes, they moved significantly slower and covered shorter distances than in dendrites 
(Jackson et al., 2014). Average displacement was around 5 μm for astrocyte mitochondria and 
25 μm for neuronal mitochondria. In neurons, the mean maximal instantaneous velocity was 
0.65 μm/s, in the retrograde direction and 0.55 μm/s, in the anterograde direction. In 
astrocytes, the mean maximal instantaneous velocity was 0.2 μm/s in the retrograde direction 
and 0.15 μm/s in the anterograde direction. However, the length of individual mitochondria in 
astrocytes and neuronal dendrites were similar. This suggests that different mechanisms may 
regulate mitochondrial trafficking in astrocytes. 
 
Under basal conditions, astrocyte mitochondria undergo fission and fusion events, where 50 
% of events were fusion and 50 % where fission events in acute cortical slices (Motori et al., 
2013). Pharmacologically elevating intracellular Ca2+ in astrocytes resulted in remodelling or 
rounding of mitochondria (Tan et al., 2011). Although the functional relevance of altering 
mitochondrial morphology is not clear, it may affect their ability to buffer Ca2+ and release 
ATP. Longer mitochondria, perhaps, might allow a greater area for ATP production and Ca2+ 
buffering, while it may be easier for shorter, more rounded mitochondria to position 
themselves in spatially restricted regions of the cell (i.e. very fine astrocyte processes known 
as perisynaptic astrocytes processes (PAPs)) (Chang et al., 2006). Interestingly, cellular injury 
alters the balance between mitochondrial fission and fusion events in astrocytes (Motori et al., 
2013). 
There is evidence suggesting that astrocytes can spatially regulate mitochondria in order to 
regulate their function. Astrocyte mitochondria have been shown to localise at sites of 
glutamate uptake in astrocytes (Chaudhry et al., 1995, Bezzi et al., 2004). In addition, the Na+ 
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channel blocker TTX (which blocks neuronal activity) decreased the positioning of 
mitochondria at GLT-1. It has not been investigated whether astrocyte mitochondria position 
themselves near synapses with stimulation of neuronal activity. Thus, investigating whether 
mitochondria respond to neuronal activity stimulation, which increases their presence near 
synapses is the main aim of this section.  
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3.2 Results 	
3.2.1 Labelling mitochondria in neurons and astrocytes in organotypic slices. 	
Slices of CNS tissue prepared from rodent brains can be maintained in culture for many 
weeks or even months. Under these conditions, neurons continue to differentiate and develop 
in a similar manner to that which is observed in an intact brain (Gahwiler et al., 1997). The 
interface method allows for maintenance of the intact three-dimensional structures within the 
tissue. Organotypic slice culturing incorporates several advantages over acute slices. For 
example, most debris and dead cells, ensuing from the slicing itself disappear after 2 weeks in 
vitro (Gahwiler, 1981). In addition, organotypic slices have the time to accommodate/recover 
from the alterations in metabolic state resulting from physically the cutting of the tissue. In 
addition, astrocytes maintain much of their three-dimensional morphology in organotypic 
slice cultures, with many thin processes radiating from the cell body and the presence of 
numerous branchlets (Benediktsson et al., 2005). 
 
In conjunction with organotypic slice cultures, adenoviral vectors were used to label 
astrocytes. Serotype 5 human adenoviruses, in particular, preferentially transduce astrocytes, 
due to the high levels of coxsackievirus and adenovirus receptor (CAR) expression in 
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astrocytes, to which the AV binds (Duale et al., 2005). This was confirmed using glial 
fibrillary acidic protein (GFAP), a marker of astrocytes commonly detectable by 
immunohistochemistry in many astrocytes throughout the healthy CNS (Figure 3.2.1A and 
B). However, it is important to note that many mature astrocytes in healthy CNS tissue do not 
express GFAP. Astrocyte GFAP expression exhibits regional variability that is dynamically 
regulated by a large number signalling molecules (inter- and intra-cellular) (Sofroniew, 2009). 
A serotype-5 human adenovirus (AV) was used to transduce astrocytes with mitochondrially-
targeted dsRed2 (mtdsRed2) and EGFP (Figure 3.2.1A and B).  
 
Neurons were transduced with a serotype-2 adeno-associated virus (AAV), also encoding 
mtdsRed2 and EGFP (Figure 3.2.1D and E). Adeno-associated viruses, in particular serotype-
2, preferentially transduce neurons via their selective binding to integrin receptors, more 
highly expressed by neurons (Bartlett et al., 1998). 75 % of AV transduced cells co-localised 
with GFAP (Figure 3.2.1B and C), while 82 % of cells transduced with the AAV co-localised 
with MAP2 (a marker of neuronal dendrites) (Figure 3.2.1E and F). Thus correct viral tropism 
was confirmed in this system and throughout this thesis the AV encoding mtdsRed2 and 
EGFP will be used to selectively transduce astrocyte mitochondria (unless otherwise stated).  	
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Figure 3.2.1 Viral tropism of AV-mtdsRed2-ir-EGFP and AAV-mtdsRed2-ir-EGFP. A. The AV 
consists of a CAG promoter, the mitochondrially-targetd fluorophore mtdsRed2, enhanced green 
fluorescent protein (EGFP) and a Woodchuck Hepatits Virus Post-transcriptional Regulatory Element 
(WPRE) to enhance expression. B. An example of AV labelling, in hippocampal organotypic slices, 
along with immuno-labelled GFAP, a marker of astrocytes. Scale bar, 15 µm. C. Quantification of the 
percentage of AV transduced cells positive for GFAP and MAP2 as well as cells negative for both 
GFAP and MAP2 (other). D. The AAV also consists of a CAG promoter, mtdsRed2, EGFP and a 
WPRE. E. Example AAV labelling, in hippocampal organotypic slices, along with immuno-labelled 
MAP2, a marker of neuronal dendrites. Scale bar, 15 µm. F. Quantification of the percentage of AAV 
transduced cells positive for GFAP and MAP2 as well as cells negative for both GFAP and MAP2 
(other).  
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3.2.2 Mitochondria are present in the finer processes of astrocytes in situ. 
Using the viral approach described above to label astrocytes in hippocampal slices, it was 
possible to visualise the distribution of mitochondria in their processes in situ. With this 
approach it was evident that mitochondria were non-uniformly distributed throughout the 
processes of astrocytes, including the finer processes and end-feet, with an accumulation in 
soma (Figure 3.2.2A-B). It has been reported that astrocyte mitochondria can be found in the 
thinner processes in situ (~ 600 nm in diameter) (Jackson et al., 2014). In this thesis, 
mitochondria were found in processes around 250 nm wide (Figure 3.2.2C).  
A recent study by Derouiche and colleagues revealed that a substantial proportion of astrocyte 
mitochondria are present in PAPs, which ensheath synapses (Derouiche et al., 2015). PAPs 
are the astrocytic compartments implicated in buffering glutamate, where it is subsequently 
converted to non-toxic glutamine and supplying glutamate to axon terminals (Hertz et al., 
2007, Dienel, 2013). On average, mitochondria were smaller in these PAPs than the stem 
(wider) processes. They find that in general, the majority of astrocyte mitochondria are small 
(0.2-0.4 µm), spherical and not elongated. The density of mitochondria in PAPs is much 
lower than in the stem processes. Thus, PAPs are not devoid of mitochondria as previously 
thought, but contain a large amount of mitochondria (Derouiche et al., 2015). These results 
are supported here, as finer processes (which included end-feet had an average width of ~ 600 
nm) contained significantly more spherical, smaller mitochondria (~ 0.5 µm) while wider 
processes (which, on average had a width > 800 nm) contained more elongated mitochondria 
(~ 2.6 µm)  (Figure 3.2.2D). This is likely to be because smaller mitochondria can more easily 
invest into the spatially restricted regions of the finer processes and end-feet. 
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Figure 3.2.2 Mitochondria are present in the thinner processes of astrocytes in hippocampal slices. A. 
Representative live confocal images of astrocyte processes transduced with mtdsRed2 and EGFP (AV 
infected hippocampal slices) with zooms of regions of interest (ROI’s) 1 and 2. Scale bar, 15 µm. Ai. 
ROIs show example astrocyte processes containing and lacking mitochondria in the same cell. Scale 
bar, 5 µm. B. Example end-foot containing mitochondria. Scale bar 2 µm. C. Minimum process width 
of process containing and lacking mitochondria. It is important to note that this analysis overestimated 
the minimum process width due to resolution limitations (resolution of the confocal is around 200-250 
nm). D. Mitochondrial length in wide (< 800 nm) and thin (> 800 nm) processes (wide processes n=15 
processes; thin processes n=16 processes).  
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3.2.3 Basal mitochondrial trafficking dynamics differs in astrocytes compared to 
neurons.  
 
Initially, the nature of mitochondrial trafficking in hippocampal astrocytic processes was 
compared to hippocampal neurons, in situ. Under basal conditions, significantly more 
mitochondria were moving in neuronal dendrites (53.6 ± 1.3 %) compared to the processes of 
astrocytes (31.3 ± 3.2 %) (Figure 3.2.3C, p = 0.0007). In astrocyte processes, a significant 
percentage of mitochondria were also found to exhibit oscillating (back and forth) movements 
(36.8 ± 5.8 %), in contrast to neurons, where this type of movement was almost absent (2.5 ± 
0.4 %) (Figure 3.2.3C, p = 0.002). The function of these oscillating movements is not known. 
Neuronal mitochondria moved significantly faster (0.28 ± 0.02 µm/s) than astrocytic 
mitochondria (0.12 ± 0.01 µm/s) (Figure 3.2.3D, p = 1x10-7). Maximum instantaneous speed 
was significantly greater in dendrites (0.66 ± 0.04 µm/s) compared to astrocyte processes 
(0.38 ± 0.04 µm/s) (Figure 3.2.3E, p = 0.0001). Mitochondrial length was also seen to be 
significantly greater in dendrites (4.7 ± 0.3 µm) than in astrocyte processes (2.4 ± 0.2 µm) 
(Figure 3.2.3F, p = 0.002). It can therefore be concluded that, although mitochondria are 
mobile in the processes of astrocytes, their trafficking dynamics are slower than that observed 
in neurons. This may be due to different adaptors and transport machinery in astrocytes. It 
may also be due to the slower signalling cascades that exist in astrocytes (Wang et al., 2006, 
Shigetomi et al., 2013). Astrocyte mitochondria were nevertheless capable of covering similar 
distances (9.8 ± 1.1 µm) compared to mitochondria in neuronal dendrites (11.9 ± 1.2 µm) 
(Figure 3.2.3G, p = 0.15). Thus, the spatial extension of their neuromodulatory role may not 
be limited.  
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Figure 3.2.3 Basal mitochondrial trafficking dynamics differs in astrocyte processes compared to 
neuronal dendrites in situ. A. Representative confocal image of an organotypic slice hippocampal 
(HPC) astrocyte transduced with an AV expressing mtdsRed2 and EGFP. Scale bar, 15 µm. Inset 
example kymograph of basal mitochondrial trafficking over a 15-minute period. Scale bar, 5 µm. B. 
Example HPC neuron transduced with an AAV expressing mtdsRed2 and EGFP. Scale bar, 15 µm. 
Inset example kymograph of basal mitochondrial trafficking over a 15-minute period. Scale bar, 5µm. 
C. Basal mitochondrial mobility in astrocyte processes and dendrites, defined as moving, oscillating or 
immobile (neurons n = 4 cells, 4 slices; astrocytes n = 7 cells, 7 slices). D. Basal speed of moving 
mitochondria in astrocyte processes and neuronal dendrites (neurons n = 21 mitochondria, 8 cells, 8 
slices; astrocytes n = 20 mitochondria, 9 cells, 9 slices). E. Maximum instantaneous speed of moving 
mitochondria in astrocyte processes and dendrites (neurons n = 21 mitochondria, 8 cells, 8 slices; 
astrocytes n = 20 mitochondria, 9 cells, 9 slices). F. Mitochondrial length in astrocyte processes and 
dendrites (neurons 3 cells, 3 slices; astrocytes 3 cells, 3 slices). G. Bidirectional run length of moving 
mitochondria in astrocyte processes and dendrites (neurons n = 21 mitochondria, 8 cells, 8 slices; 
astrocytes n = 20 mitochondria, 9 cells, 9 slices). 
	 114	
3.2.4 Mitochondrial trafficking in astrocytes is regulated by neuronal activity 
 
An important question that required investigation was whether astrocyte mitochondria are 
spatially regulated by neuronal activity. A study by Jackson and colleagues revealed that 
inhibiting neuronal activity increased mitochondrial mobility (Jackson et al., 2014) and from 
this they infer that neuronal activity regulates mitochondrial trafficking in astrocyte processes. 
To build on this finding it was essential to investigate whether stimulating neuronal activity 
influenced mitochondrial trafficking dynamics in astrocyte processes. This was addressed 
using hippocampal organotypic slices transduced with AV-mtdsRed2-ir-EGFP. 
 
An acute (5 minute) treatment of 4-AP (100 µM), which stimulates neuronal activity, 
significantly (by non-specifically blocking K+ channels) reduced mitochondrial mobility 
(Figure 3.2.4B, p = < 0.0001) and speed (Figure 3.2.4C, p = 0.0003) in the processes of 
astrocytes. The reduction in mitochondrial mobility and speed induced by 4-AP recovered to 
basal levels 30 minutes following treatment showing that these alterations are transient 
(Figure 3.2.4B, p = 0.7 and C, p = 0.7). In addition, omitting extracellular Ca2+ from the 
perfusion media, along with EGTA (100 µM) to chelate any existing Ca2+, blocked the 
reduction in mitochondrial mobility and speed induced by 4-AP (Figure 3.2.4B, p = 0.5 and 
C, p = 0.1), which suggests that neuronal activity induces astrocyte Ca2+ elevations. 
Conversely, blocking neuronal activity with TTX (1 µM) (which blocks Na+ channels) for 30 
minutes significantly increased astrocyte mitochondrial mobility and speed (Figure 3.2.4B, p 
= 0.04 and C p = 0.04). This reveals that mitochondrial trafficking is regulated by neuronal 
activity and confirms that blocking neuronal activity increases mitochondrial mobility in 
astrocytes (Jackson et al., 2014).  
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Figure 3.2.4 Neuronal activity induces mitochondrial stopping in astrocyte processes in situ. A. 
Schematic explanation of the imaging protocol, whereby mitochondria were imaged for 5 minutes 
before being perfused with ASCF containing 4-AP or TTX and subsequently washed during the 
remaining imaging period. B. Mitochondrial moving during the 5 minutes post treatment (except 4-AP 
+ 30 minutes) (control (combined pre) n = 7 cells, 7 slices; 4AP (100 µM) n = 7 cells, 7 slices; 4-AP + 
30 min n = 3 cells, 3 slices; 0[Ca2+]e + 4-AP n = 4 cells, 4 slices; TTX (1 µM) n = 3 cells, 3 slices). C. 
Speed of mitochondria moving post treatment (except 4-AP + 30 minutes) (control (all pre) n = 13 
mitochondria, 4 slices; 4AP n = 11 mitochondria, 4 slices; 4-AP + 30 min n = 18 mitochondria, 4 
slices; 0[Ca2+]e + 4-AP n = 12 mitochondria, 4 slices; TTX n = 16 mitochondria, 3 slices). 
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3.2.5 Neuronal activity induces intracellular Ca2+ signalling in astrocyte 
processes 
Pharmacologically elevating neuronal activity (4-AP, 100 µM) in situ has been shown to 
induce significant Ca2+ transients in astrocytes, detected using Calcium Green-1 AM (an 
ester-bound dye that is lipophilic and can easily be taken up by cells where esterases cleave 
the ester bonds to allow indicator function) (Porter and McCarthy, 1996). However, according 
to Srinivasan and colleagues, many issues exist with dye loading and it is therefore important 
to bare this in mind when analysing astrocyte Ca2+ dynamics (Srinivasan et al., 2015). 
Previous studies using bulk loading of organic Ca2+ indicator dyes have underestimated 
astrocyte Ca2+ signalling and potentially miss the vast majority of fluctuations that occur in 
their processes (Srinivasan et al., 2015). Therefore, hippocampal astrocytes were biolistically 
transfected with the slow variant of the cytosolic genetically encoded calcium indicator 
(GECI) GCaMP6s along with mtdsRed2 (Figure 3.2.5A).  
GECIs are excellent tools for studying Ca2+ signalling in astrocytes and they have shed new 
light on areas such as the processes that have previously been difficult to explore (Srinivasan 
et al., 2014). It is necessary to monitor Ca2+ fluctuations in astrocyte compartments in order to 
understand how astrocytes contribute to brain function, akin to the need to understand 
signalling in dendritic spines and nerve terminals (Srinivasan et al., 2015). It is conceivable 
that cytosolic GECIs might miss Ca2+ signals in fine astrocyte processes (Srinivasan et al., 
2015). However, astrocytes in the CA3 region of the hippocampus reported fewer 
spontaneous Ca2+ signals with membrane-bound (Lck) GCaMP3 than cytosolic GCaMP3 
(Haustein et al., 2014). This suggests that fewer signals are mediated by near-membrane Ca2+ 
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signals in the CA3 of the hippocampus in situ. More recently, more optimised forms of 
GCaMP have been developed, including GCaMP6 fast, slow and medium (GCaMP6f, 
GCaMP6s and GCaMP6m) (Chen et al., 2013b). These improved GCaMPs were produced by 
non-selective mutagenesis and screening to select the brightest and most sensitive variants. 
GCaMP6s allows for increased sensitivity of cytosolic Ca2+ sensing (Chen et al., 2013b) with 
more suitable decay dynamics for monitoring astrocyte signalling (i.e. slower) (Fiacco and 
McCarthy, 2006).  
The method of biolistic transfection of astrocytes used here has been shown previously to 
label more glial cells than neurons (typically 3 glial cells to 1 neuron) (Benediktsson et al., 
2005). Additionally, labelling was confirmed by the fact that the GCaMP6s signal co-
localised with the astrocyte marker GFAP (Figure 3.2.5B). Astrocyte process Ca2+ transients 
were elevated with ATP treatment and when neuronal activity was stimulated with 4-AP 
(Figure 3.2.5C-F). Compared to basal signalling, ATP and 4-AP significantly increased the 
amplitude (Figure 3.2.5D, p = 1.9x10-7 and 9.4x10-7, respectively) and frequency (Figure 
3.2.5E, p = 1.3x10-5 and 0.002, respectively) of process Ca2+ transients. The duration of the 
response to ATP and 4-AP was unchanged (Figure 3.2.5D, p = 0.3). This supports the 
literature showing that pharmacologically elevating neuronal activity activates astrocyte Ca2+ 
signalling in their processes and indicates that neuronal activity elevates astrocyte Ca2+, which 
is responsible for altering their mitochondrial dynamics.  
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Figure 3.2.5 Neuronal activity and ATP stimulates Ca2+ entry in astrocyte processes in hippocampal 
slices. A. Example astrocyte biolistically transfected with GCaMP6s and mtdsRed2. Scale bar, 15 µm. 
B. GCaMP6s co-localises with GFAP confirming transfection specificity for astrocytes. Scale bars, 15 
µm. C. Example normalised GCaMP6s fluorescence under basal conditions (normalised to the first 10 
seconds) and 100 µM ATP for 2 minutes or 200 µM 4-AP for 5 minutes (normalised to the first 20 
seconds). D. Amplitude of the response to ATP and 4-AP compared to basal signalling (GCaMP6s 
normalised fluorescence) (Basal n = 27 ROIs; ATP n = 10 ROIs; 4-AP n = 9 ROIs). E. Frequency of 
the response to ATP and 4-AP compared to basal signalling (Basal n = 27 ROIs; ATP n = 10 ROIs; 4-
AP n = 9 ROIs). F. Duration of the response to ATP and 4-AP (ATP n = 10 ROIs; 4-AP n = 9 ROIs). 
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3.2.6 Ca2+ entry plays a role in regulating mitochondrial trafficking dynamics in 
astrocyte processes. 
Exogenous glutamate (100 µM + 1 µM glycine), used at high levels to activate glutamate 
receptors in organotypic slices, induced mitochondrial stopping in astrocyte processes, as 
indicated by the kymograph, where straight lines represent immobile mitochondria following 
glutamate treatment (Figure 3.2.6A). Glutamate significantly reduced mitochondrial mobility 
(Figure 3.2.6B, p = < 0.0001) and speed (Figure 3.2.6C, p = 0.001) in astrocyte processes. The 
reduction in mobility and speed, induced by glutamate, was transient as recovery was visable 
roughly 15 minutes following treatment (Figure 3.2.6B, p = 0.4 and C, p = 0.3).  
Subsequently, the glutamate receptors that are involved in regulating glutamate receptor 
dependent mitochondrial stopping in astrocytes were investigated. AMPA receptors and 
mGluRs have been shown to play an important role in increasing astrocytic Ca2+ (Araque et 
al., 2001, D'Ascenzo et al., 2007, Srinivasan et al., 2015). Mitochondrial mobility was 
significantly reduced when glutamate was added together with the broad spectrum mGluR 
blocker MCPG (1 mM) (Figure 3.2.6B, p < 0.0001), however, not to the same degree as with 
glutamate alone (Figure 3.2.6B, p = 0.02), suggesting a partial role for mGluRs in mediating 
glutamate-dependent stopping of mitochondria in astrocyte processes. With the addition of 
the AMPA receptor blocker NBQX (50 µM), glutamate treatment still caused a significant 
reduction in mitochondrial mobility (Figure 3.2.6B, p < 0.0001) that was not significantly 
different to the reduction observed upon glutamate treatment alone (Figure 3.2.6B, p > 0.9). 
In contrast, the NMDAR antagonist, D-APV (50 µM) did prevent glutamate-induced 
alterations in mitochondrial mobility (Figure 3.2.6B, p = > 0.9), demonstrating that activation 
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of NMDARs is a major pathway in the glutamate-dependent control of astrocyte 
mitochondrial mobility. Removing extracellular Ca2+ (omitting Ca2+ from the perfusion media, 
in addition to supplementing with the Ca2+ chelator EGTA, 100 µM), in the presence of 
glutamate, blocked the alterations in mobility (Figure 3.2.6B, p = 0.6) and significantly 
increased mitochondrial speed (Figure 3.2.6C, p = 0.04).  
This reveals that the changes in mitochondrial trafficking induced by glutamate are dependent 
on the influx of extracellular Ca2+ and suggests that mGluRs play a partial role in regulating 
mitochondrial trafficking in hippocampal astrocyte processes in situ, supporting other 
investigations (Porter and McCarthy, 1995).  
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Figure 3.2.6 Glutamate reduces mitochondrial trafficking dynamics in astrocyte processes in 
hippocampal slices. A. Example slice astrocyte transduced with AV-mtdsRed2-ir-EGFP (image shows 
just mtdsRed2). Inset kymograph shows the effects of mitochondrial mobility with glutamate treatment 
(100 µM + 1 µM glycine). Scale bar, 15 µm. B. Basal mitochondrial mobility 5 minutes post treatment 
(except glutamate + 15 minutes) (control (combined pre) n = 32 cells, 29 slices; glutamate n = 8 cells, 8 
slices; glutamate + 15 min n = 3 cells, 3 slices; MCPG (1mM) + glutamate n = 12 cells, 7 slices; 
NBQX (50 µM) + glutamate n = 11 cells, 11 slices; D-APV (50 µM) + glutamate n = 5 cells, 3 slices; 
0[Ca2+]e (100 µM EGTA) + glutamate n = 4 cells, 3 slices). C. Speed of moving mitochondria 5 
minutes post treatment (except glutamate + 15 minutes) (control (combined pre) n = 12 mitochondria, 4 
slices; glutamate treatment n = 13 mitochondria, 4 slices; glutamate + 15 min n = 23 mitochondria, 3 
slices; 0[Ca2+]e + glutamate n = 11 mitochondria, 4 slices).  	
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3.2.7 Cessation of mitochondrial trafficking is coupled to alterations in 
morphology in culture and involves astrocyte NMDAR activation. 
In cultured neurons, glutamate arrests mitochondrial trafficking and decreases their length 
(with recovery after 2 hours) (Rintoul et al., 2003). A decrease in mitochondrial length is 
indicative of fission and indeed these spherical mitochondria associate with the pro-fission 
protein Drp-1 (Frank et al., 2001). However, these changes in mitochondrial morphology can 
occur independent of fission-mechanisms. Mitochondria can contract or undergo rounding 
where they change from elongated to spherical mitochondria (Tan et al., 2011), resulting in a 
reduction in mitochondrial length. This process is often referred to as remodelling. The 
morphological state of mitochondria has been linked to their capacity to produce energy, as 
well as cell death mechanisms (Chen et al., 2005, Benard and Rossignol, 2008). Elevating 
astrocyte Ca2+ has been shown to induce mitochondrial swelling (Kristal and Dubinsky, 1997) 
and because glutamate has been shown to induce Ca2+-dependent changes in mitochondrial 
trafficking, the effects of glutamate on astrocyte mitochondrial morphology were examined.  
Isolated pure astrocyte cultures (> 98 %) were AV-transduced to label mitochondria with 
mtdsRed2 (Figure 3.2.7A) and following glutamate (100 µM + 1 µM glycine) mitochondrial 
length was greatly reduced (Figure 3.2.7B and C, p = 0.002). Interestingly, the active 
NMDAR antagonist MK-801 (100 µM) blocked the reduction in mitochondrial length in the 
absence of neurons (Figure 3.2.7C, p = 0.002). Previously, it was clear that NMDARs 
mediated the alterations in mitochondrial trafficking induced by glutamate (Figure 3.2.6), but 
the origin of the receptors was unclear. This result suggests that astrocyte NMDARs are 
involved in mediating the Ca2+-dependent effects of glutamate on mitochondrial trafficking 
and morphology. 
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Figure 3.2.7 Glutamate alters mitochondrial morphology in astrocyte processes in culture. A. Example 
hippocampal astrocyte transduced with AV-mtdsRed2-ir-EGFP and co-immunolabelled with GFAP. 
Inset shows long, elongated mitochondria. Scale bar, 15 µm, inset 5 µm. B. Example astrocyte AV-
transduced post glutamate treatment (100 µM glutamate + 1 µM glycine, 10 minutes). Inset shows 
round, spherical mitochondria. Scale bar 15 µm, inset 5 µm. C. Quantification of mitochondrial length 
post-glutamate treatment and glutamate + MK-801 (100 µM) (control and glutamate treatment n = 7 
cells; glutamate + MK-801 n = 10 cells). 
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3.2.8 Mitochondria become fragmented upon stimulation in situ. 
 
In situ, hippocampal astrocytes were AV-transduced to label mitochondria with mtdsRed2 
and EGFP (Figure 3.2.8A). Following glutamate treatment (100 µM + 1 µM glycine, 10 
minutes), mitochondria change from elongated to round (Figure 3.2.8A and B). This can be 
seen as a dramatic shift in the cumulative distribution of mitochondrial length (Figure 
3.2.8C). To establish whether glutamate treatment induced mitochondrial remodelling or 
fission, the total number of mitochondria along the process was quantified before, during and 
after glutamate treatment, within the same cell. Glutamate treatment did not appear to alter 
the average number of mitochondria suggesting mitochondrial remodelling is occurring and 
not fission (Figure 3.2.8D, p = 1). 
 
Stimulating neuronal activity with 4-AP (100 µM) also dramatically decreased mitochondrial 
length (Figure 3.2.8E p = 3x10-5), while decreasing neuronal activity with TTX (1 µM) did 
not alter mitochondrial length (Figure 3.2.8E p = 0.8). Where glutamate greatly reduced 
mitochondrial length (Figure 3.2.8E, p = 7x10-35), mitochondria were significantly elongated 
after 24 hours without glutamate (Figure 3.2.8E, p = 0.02). This reveals that the changes in 
mitochondrial morphology are not cytotoxic. The effects of glutamate treatment were blocked 
when extracellular Ca2+ chelated with EGTA (100 µM) (Figure 3.2.8E, p = 0.1). MK-801 
(100 µM) also blocked the effects of glutamate (Figure 3.2.8E, p = 0.3). However, NBQX (50 
µM) did not block the effects of glutamate treatment on morphology (Figure 3.2.8E p = 3x10-
11). Taken together it can be concluded that neuronal activity, via glutamate release, regulates 
mitochondrial morphology in astrocytes where glutamate could be acting on NMDARs to 
mediate these alterations.  
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Figure 3.2.8 Stimulation alters mitochondrial morphology in astrocyte processes in hippocampal 
slices. A. Example astrocyte transduced with AV-mtdsRed2-ir-EGFP. Inset shows long elongated 
mitochondria within the processes. Scale bar, 15 µm, inset 5 µm. B. Example astrocyte AV-transduced 
post glutamate treatment (100 µM glutamate + 1 µM glycine, 10 minutes). Inset shows round, spherical 
mitochondria. Slices were treated for 10 minutes after culturing for 7-10 days (3 days following AV 
infection). Scale bar, 15 µm, inset 5 µm. C. Cumulative distribution of mitochondrial morphology in 
control conditions (solid line) and following glutamate treatment, 15 min post (broken line). D. 
Normalised number of mitochondria before, during and after glutamate treatment (pre n = 3 cells; 
glutamate n = 3 cells; post n = 3 cells). E. Quantification of mitochondrial length post-treatment 
(control n = 53 cells, 53 slices; 4AP (100 µM) n = 11 cells, 11 slices; TTX (1 µM) n = 3 cells, 3 slices; 
glutamate n = 58 cells, 58 slices; glutamate + 24 hours n = 10 cells, 10 slices; NBQX (50 µM) + 
glutamate n = 25 cells, 25 slices; MK-801 (100 µM) + glutamate n = 24 cells, 24 slices; 0[Ca2+]e + 
glutamate n = 24 cells, 24 slices). 
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3.2.9 Glutamate reduces mitochondrial fusion in astrocyte processes. 
 
To further investigate mitochondrial dynamics in astrocytes a fusion assay was set up in 
organotypic slices, using time-lapse confocal microscopy and the photo-switchable 
fluorescent protein, Dendra2 (Gurskaya 2006}, targeted to the mitochondrial matrix (mito-
dendra2). Dendra2 fluoresces green and switches to red when photo-activated with 405 nm 
(UV) light. The photo-conversion is irreversible, non-toxic and stable, making mito-dendra2 
ideal for observing fusion of labelled mitochondria when a small subset is photo-converted 
(Magrane et al., 2012, Pham et al., 2012). Fusion events between the red and the green 
mitochondria result in the transfer of fluorescence, which indicates mitochondrial matrix 
exchange (seen as a mixing of red and green- forming orange mitochondria) (Pham et al., 
2012). Expression of mito-dendra2 does not adversely affect mitochondrial morphology 
(Pham et al., 2012; Magrane et al., 2012). 
 
A transgenic mouse line expressing a loxP-flanked termination signal upstream of the mito-
dendra2 (loxP-stop-loxP-mito-dendra2) only allows mito-dendra2 expression when CRE is 
present (Pham et al., 2012). CRE binds to the floxed region and removes the stop cassette, 
subsequently allowing mito-dendra2 expression. The CRE protein is a site-specific DNA 
recombinase, and if the loxP sites are parallel, it forms dimers of the signal between them. 
These are then cut and the sequence between the loxP sites is removed. The downstream 
signal can then be transcribed (Figure 3.2.9A). 
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Specific mito-dendra2 expression in astrocytes was induced with infection of an AV encoding 
CRE (AV-CRE). Expression was specific to astrocytes as the mito-dendra2 signal co-
localised with GFAP and not NeuN (a marker of neuronal cell bodies) (Figure 3.2.9B). Upon 
photo-conversion of a small subset of mito-dendra2 labelled mitochondria, fusion events 
between the red and the green mitochondria result in the transfer of fluorescence, which 
indicates mitochondrial matrix exchange (seen as a mixing of red and green- forming orange 
mitochondria) (Figure 3.2.9C) (Magrane et al., 2012, Pham et al., 2012). In this system, 
mitochondrial fusion remained unchanged with glutamate treatment (100 µM + 1 µM 
glycine) (Figure 3.2.9C, 2-10 min compared to pre-switch, p = 0.5, 0.7, 0.2, 0.1 and 0.6, 
respectively), where the fusion rate significantly increased in untreated controls (Figure 
3.2.9D, 2-10 min compared to pre-switch, p = 0.02, 0.005, 0.02, 0.01 and 0.002, respectively). 
This suggests that glutamate alters mitochondrial morphology in astrocyte processes in situ. A 
reduction in the fusion rate could be a consequence of a reduction in mitochondrial mobility 
induced by glutamate. 
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Figure 3.2.9 Glutamate reduces mitochondrial fusion in astrocyte processes in hippocampal slices. A. 
The mito-dendra2 transgenic mouse line is constructed so that the mito-dendra2 signal is downstream 
of a floxed (loxP flanked) stop cassette, under a ubiquitous CAG promoter. With addition of and 
adenovirus (AV) encoding encoding CRE, the stop cassette is removed and subsequently mito-denra2 
is expressed in astrocytes. B. Mito-dendra2 is expressed in astrocytes in organotypic slices. This 
induced mito-dendra2 signal overlapped with the astrocyte marker GFAP and not NeuN (a marker of 
neuronal cell bodies). Scale bar, 15 µm. C. Mito-dendra2 was then switched with 405 nm laser light in 
a small region of the distal astrocyte process and the rate of fusion was analysed. Upon switching, 
green mitochondria can be seen to change to red and over time new, green mitochondria move into the 
switched region creating orange mitochondria. Scale bars, 5 µm. D. Quantification of the overlap of 
green and red mitochondria over a 10-minute period post switching in untreated controls and with 
glutamate treatment (control n = 5 cells, 5 slices; glutamate n = 4 cells, 4 slices).  
	 129	
 
 
3.2.10 Mitochondrial trafficking in astrocytes is regulated by intracellular Ca2+. 
 
Astrocytes were biolistically transfected with GCaMP6s along with mtdsRed2 in order to 
establish the relationship between mitochondrial trafficking and intracellular Ca2+. GCaMP6s 
expression was previously confirmed to be astrocyte specific by increased co-localisation 
with the astrocyte marker GFAP (Figure 3.2.5). Using kymographs, mitochondria were 
overlaid with the GCaMP6s signal that corresponded to the levels of intracellular Ca2+ within 
the region of interest (ROI) (Figure 3.2.10A).  
Stationary mitochondria corresponded more often with regions of high intracellular Ca2+ 
(pseudo-coloured red-orange GCaMP6s), while more mobile mitochondria were observed in 
regions of low Ca2+ (blue-black) within the same cell (Figure 3.2.10A). In addition, 
mitochondrial speed was elevated (0.42 ± 0.05 µm/s) in these regions of low Ca2+ (defined as 
F/F0 < 5) compared to regions of high Ca2+ (0.01 ± 0.01 µm/s) (defined as F/F0 > 5) (Figure 
3.2.10B, p = 0.01). This suggests that intracellular Ca2+ in astrocytes regulates mitochondrial 
trafficking and that they stop more frequently within regions of elevated intracellular Ca2+. 
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Figure 3.2.10 Mitochondria within regions of elevated intracellular Ca2+ are less mobile than in 
regions of low intracellular. A. Kymogaphs of GCaMP6s (pseudo-coloured) along with 
corresponding mitochondrial trafficking. Overlays show that mitochondria are mobile when GCaMP6s 
signal is relatively low and are immobile at regions of elevated Ca2+ in the same cell. Scale bars, 5 µm. 
B. Quantified mitochondrial speed in regions of the cell where Ca2+ is low and high. Inset shows the 
fluorescence intensity defined as low and high Ca2+, respectively (Low Ca2+ n = 4 cells, 3 slices; High 
Ca2+ n = 5 cells, 3 slices).  
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3.2.11 Field stimulation induces astrocyte mitochondrial stopping 
 
The relationship between electrical field stimulation (a more physiological form of inducing 
neuronal firing) and astrocyte mitochondrial dynamics was subsequently investigated. 
Hippocampal neurons were transfected with synaptically targeted GCaMP5 (Sy-GCaMP5), to 
label active synapses, and co-cultured with hippocampal astrocytes pre-transfected with 
mtdsRed2 (Figure 3.2.11A). This allowed separation of the astrocyte mtdsRed2 signal and the 
neuronal Sy-GCaMP5 signal in order to observe the effects of stimulating neuronal activity 
specifically on astrocyte mitochondrial dynamics.  
Upon field stimulation (20 Hz for 20 s), a four-fold increase was observed in the Sy-GCaMP5 
signal, confirming that field stimulation drives increased neuronal synaptic activity (Figure 
3.2.11B). In addition, field stimulation rapidly decreased (< 30 s delay) the trafficking of 
astrocyte mitochondria (% moving) compared to pre-stimulated controls (Figure 3.2.11C, p = 
0.001 and p = 7x10-12, respectively). This decrease in mitochondrial mobility recovered 5 
minutes following stimulation (Figure 3.2.11C, p = 0.2). Field stimulation also reduced the speed of astrocyte mitochondria compared to pre-stimulated controls (Figure 3.2.11D, p = 
0.001 and 6x10-5, respectively). There was also recovery in the decrease in speed 5 minutes 
after stimulation (Figure 3.2.11D, p = 0.4). 
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Figure 3.2.11 Electrical field stimulation reduces mitochondrial trafficking in astrocyte processes. A. 
Cultured neurons were transfected with synaptically targeted GCaMP5 (Sy-GCaMP5, whereby a 
synaptophysin tag was inserted upstream of GCaMP5) and co-cultured with astrocytes pre-transfected 
with mtdsRed2. Scale bar, 10 µm. B. Upon field stimulation, 20 Hz for 20 s, an increase was seen in 
the Sy-GCaMP5 signal, confirming synaptic activation. C. Mitochondrial mobility (% moving) before, 
during stimulation, 30 s post stimulation and 5 minutes post stimulation compared to pre-stimulated 
controls (-30 s and stim n = 11 cells; 30 s post n = 9 cells; 5 min post n = 6 cells; -30 s and no stim n = 
9 cells; 30 s post no stim n = 7 cells; 5 min post no stim n = 5 cells). D. Speed of moving mitochondria 
before, during stimulation, 30 s post stimulation and 5 minutes post stimulation compared to pre-
stimulated controls (-30 s stim n = 30 mitochondria; stim n = 27 mitochondria; 30 s post stim n = 24 
mitochondria; 5 min post stim n = 21 mitochondria; -30 s no stim n = 24 mitochondria; no stim, 30s 
post no stim and 5 min post no stim n = 18 mitochondria). 
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3.2.12 Astrocyte mitochondria position themselves near synapses in culture, 
with activation of glutamate receptors. 
 
The relationship between mitochondria, within the processes of astrocytes, and synaptic 
regions remains to be clarified. In light of this, the question of whether activity-driven 
mitochondrial immobilisation occurs at regions within astrocyte processes in close proximity 
to synapses was addressed. Initially, hippocampal cultured astrocytes, in the presence of 
hippocampal neurons, were AV-transduced to label astrocyte mitochondria and synapses were 
immuno-labelled with VGLUT1 (a marker of pre-synaptic terminals) (Figure 3.2.12A).  
 
Following glutamate treatment (5 minutes, 100 µM + 1 µM glycine), a significant decrease 
was seen in the distance between the centre of each astrocyte mitochondrion and the centre of 
its nearest VGLUT1 puncta (synapse) compared to untreated controls (Figure 3.2.12B, p = 
0.04). In addition, the distance between each mitochondrion pixel and each synapse pixel was 
established to account for the change in mitochondrial morphology following glutamate 
treatment (Figure 3.2.12C, p = 0.03). Importantly, there was no change synapse number (per 
µm) (Figure 3.2.12D, p = 0.2). There was, however, a significant increase in the number of 
mitochondria (per µm), which suggests that mitochondrial fission might be occurring (i.e. the 
existing mitochondria are breaking/splitting apart) (Figure 3.2.12.E, p = 0.02). This may 
allow them to move into the smaller PAPs that are in close proximity to synapses. Taken 
together, this reveals that glutamate triggers mitochondrial retention near synapses in culture. 
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Figure 3.2.12 Glutamate induces mitochondrial confinement within astrocyte processes in close 
proximity to synapses in culture. A. Astrocyte mitochondria labelled with mtdsRed2 (AV-mtdsRed2-ir-
EGP transduced) and co-immunolabelled with VGLUT1 (a marker of pre-synaptic terminals) under 
control (untreated conditions) and with application of glutamate (5 min, 100 µM + 1 µM glycine). 
Scale bars, 5 µm. B. The distance between each mitochondrion (centre of mass) and its nearest synapse 
(centre of mass) under control conditions and with glutamate treatment. C. The distance of each 
mitochondrion pixel to its nearest synaptic pixel under control conditions and with glutamate treatment. 
D. Number of VGLUT1 positive synapses per µm in untreated controls and following glutamate 
treatment. E. Number of mitochondria per µm in untreated controls and following glutamate treatment. 
Control n = 6 ROIs, 6 cells; glutamate n = 7 ROIs, 7 cells. 
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3.2.13 Field stimulation induces astrocyte mitochondrial confinement near 
active synapses.  
 
Analysing the effects of field stimulation on astrocyte mitochondria revealed that along with a 
rapid decrease in mitochondrial trafficking (Figure 3.2.11), they localise near active Sy-
GCaMP5-labelled synapses (3.2.13A). Mitochondrial retention near synapses is reflected by a 
decrease in the distance between astrocyte mitochondria and their corresponding nearest 
activated synapse, which is seen to occur within the first 30 seconds following stimulation (20 
Hz 20 s) (Figure 3.2.13B, p = 0.003, 0.007, 0.009, 0.005 and 0.008, respectively). 
Mitochondria remain confined within close proximity to their nearest activated synapse for 
around 50 seconds and then begin to move away roughly 80 seconds following stimulation. 
Interestingly, electrical stimulation of neuronal-astrocyte co-cultures resulted in a similar 
recruitment of astrocyte mitochondria near synapses as observed for exogenously applied 
glutamate (Figure 3.2.12). Furthermore, the response was shown to be transient as the 
decrease in distance between astrocyte mitochondria and their nearest activated synapse 
increased around 80 seconds following stimulation. This result also reveals a fairly fast 
timescale in which astrocyte mitochondria become confined near synapses (~ 30 s) (Figure 
3.2.13B). This is comparable to the timescale in neurons (MacAskill et al., 2009a) where 
mitochondria are recruited to synapses in dendrites within 60 s. However, confinement 
seemed to persist for longer in dendrites than in astrocytes (around 120 s vs 50 s, 
respectively).  
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Figure 3.2.13 Electrical field stimulation transiently induces mitochondrial confinement within 
astrocyte processes close to synapses. A. An example of a synapse transfected with Sy-GCaMP5 and 
nearby astrocyte mitochondria transfected with mtdsRed2. Following stimulation the nearby 
mitochondrion moves closer to the marked synapse (within 30 s) where it remains for around 20 
seconds. Around 50 seconds following stimulation the mitochondrion begins to move away. Scale bar, 
1 µm. B. Quantification of mitochondria near synapses (< 15 µm) move even closer to their nearest 
synapse, temporarily, following field stimulation (20 Hz 20 s) (n = 12 mitochondria, 8 ROIs from 8 
cells).  
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3.2.14 Astrocyte mitochondria position themselves near synapses in situ, with 
pharmacological elevation of neuronal activity. 
 
The influence of pharmacologically elevating neuronal activity on astrocyte mitochondrial 
confinement was investigated in an intact, more physiological system (organotypic brain 
slices). AV-mtdsRed2-ir-EGFP was used to label mitochondria and synapses were immuno-
labelled with VGLUT1, in hippocampal slices (Figure 3.2.14A). Similar to astrocytes in 
culture, mitochondria in situ became confined near synapses when neuronal activity was 
stimulated with 4-AP (5 minutes, 100 µM) (Figure 3.2.14B, p = 0.02), without causing a 
significant change in mitochondrial or synapse number (per µm) (Figure 3.2.14C, p = 0.7 and 
p = 0.7, respectively).  
 
These data indicate that, in addition to a decrease in mitochondrial trafficking dynamics, 
stimulating neuronal activity recruits astrocyte mitochondria near synapses. This novel 
finding highlights that neuronal signalling alters mitochondrial dynamics within the processes 
of astrocytes, recruiting them to areas of activity where they can provide metabolic support. 
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Figure 3.2.14 Neuronal activity induces mitochondrial confinement within astrocyte processes near 
synapses, in situ. A. Astrocyte mitochondria labelled with mtdsRed2 (AV-mtdsRed2-ir-EGP 
transduced) along with immuno-labelled VGLUT1 in untreated slices and following application of 4-
AP (5 min, 100 µM). Arrows indicate mitochondria in close association with VGLUT1 labelled 
synapses. Scale bars, 5 µm. B. The distance between mitochondria (centre of mass) and their nearest 
synapse (centre of mass) under control conditions and following treatment with 4-AP. C. Number of 
VGLUT1 positive synapses and mitochondria per µm in untreated controls and following 4-AP 
treatment. Control n = 6 ROIs, 6 cells, 3 slices; 4-AP n = 5, 5 cells, 3 slices.  
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3.3 Discussion 
 
Here, further insights are gained into the regulation of activity-dependent trafficking and 
positioning of mitochondria in astrocytes. The results in this chapter support the well-
established idea that astrocytes can sense neuronal activity by raising their intracellular Ca2+ 
and add that this alters their mitochondrial trafficking dynamics, inducing transient docking of 
mitochondria near synapses.  
 
Firstly, the recent finding by Derouiche and colleagues, showing that PAPs are not devoid of 
mitochondria, is supported here. Mitochondria were smaller in these finer processes (< 800 
nm) supporting the study by Derouiche and colleagues (Derouiche et al., 2015). Interestingly, 
the number of mobile mitochondria was decreased in astrocytes, as well as the speed at which 
they were capable of moving, compared to dendrites, supporting previous observations by 
Jackson and colleagues (Jackson et al., 2014). However, astrocyte mitochondria were still 
capable of covering the same distances as neuronal mitochondria (9.8 ± 1.1 µm vs 11.9 ± 1.2 
µm, respectively). These differences in trafficking dynamics could be due to differences in 
the trafficking machinery utilised by neurons and astrocytes. 
 
Synaptic activity can evoke feedback Ca2+ transients in astrocytes, which may alter their 
ability to release gliotransmitters (Perea and Araque, 2005, Serrano et al., 2006, Di Castro et 
al., 2011, Navarrete et al., 2013). Here, enhancing neuronal activity alters mitochondrial 
trafficking dynamics and morphology in astrocyte processes in a Ca2+-dependent manner. 
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Mitochondria became shorter with a concomitant reduction in mobility and speed when 
synaptic activity was stimulated (with field stimulation, glutamate and 4-AP the reduction in 
mobility and speed persisted for 5 minutes, 15 minutes and 30 minutes, respectively). 
Alterations in mitochondrial morphology can be accompanied by a marked increase in ROS 
and autophagy (Motori et al., 2013). However, in this study, mitochondria were significantly 
more elongated after 24 hours, showing that these changes in morphology are reversible.  
 
The response to glutamate involved NMDARs and partially involved mGluRs but not 
AMPARs. However, it should be noted that it is difficult to separate the inhibition of neuronal 
NMDARs and astrocytic NMDARs, in situ. This was overcome by stimulating pure astrocyte 
cultures in the presence of an NMDAR antagonist, which blocked the glutamate-induced 
reduction in mitochondrial length. There is evidence to suggest that hippocampal astrocytes in 
situ express functional iGluRs of the NMDAR sub-type (Porter and McCarthy, 1995, Latour 
et al., 2001, Verkhratsky and Kirchhoff, 2007). For example, Porter and McCarthy show that 
in 45 % of astrocytes TTX (1 µM) was unable to block NMDA induced astrocyte Ca2+ 
elevations. In addition, some of these astrocyte Ca2+ responses to NMDA in the presence of 
TTX might have been missed due to the use of bulk-loaded Ca2+ dye imaging (Ca2+ Green-1 
AM), which is not sufficient for observing all astrocyte Ca2+ fluctuations (especially within 
their processes) (Srinivasan et al., 2015). NMDAR expression (NR2B) in astrocytes has also 
been observed in the hippocampus following ischaemia (Krebs et al., 2003). Porter and 
McCarthy also show that 80 % of astrocytes responded to the mGluR agonist t-ACPD, where 
a larger percentage of astrocytes responded to t-ACPD than glutamate (Porter and McCarthy, 
1995). 
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Another possible route for Ca2+ entry could be activation of the reverse mode of the Na+/Ca2+ 
exchanger (NCX), which removes Na+ that enters with glutamate uptake via glutamate 
transporters in exchange for Ca2+ (Goldman et al., 1994). Here, the proposed route for 
astrocyte Ca2+ entry, occurring during stimulation of neuronal activity, partially involves 
mGluRs and NMDARs but confirming this absolutely requires further investigation. It could 
be that these two receptor sub-types co-ordinate the uptake of astrocyte Ca2+, providing 
astrocytes a greater arsenal for dealing with extracellular glutamate. Overall, astrocyte 
mitochondrial dynamics are shown here to be tightly coupled to neuronal activity. 
 
Previously, it has been proposed that mitochondria localise within astrocyte processes in close 
proximity to glutamate transporters in an activity-dependent manner (Chaudhry et al., 1995, 
Genda et al., 2011, Jackson et al., 2014). However, until now, it was unknown whether 
stimulating neuronal activity results in the retention of astrocyte mitochondria near synapses. 
Here, it was revealed that with neuronal stimulation, astrocyte mitochondria are temporarily 
recruited near synapses in culture and in situ. The timescale for recruitment was around 30 
seconds, where mitochondria remained confined and immobile for 50 seconds before moving 
away. It would be logical to assume that mitochondria would be required to provide ATP for 
glutamate detoxification and also to buffer the downstream entry of Ca2+ occurring in 
response to glutamate uptake (Goldman et al., 1994). For these reasons, it may be that 
mitochondrial positioning in astrocytes is important for overall astrocyte function. 
Interestingly, the timescale of recruitment was similar to that observed in dendrites (60 
seconds).  
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Chapter 4 
 
 
The Ca2+-sensing EF-hands of the Mitochondrial Rho-GTPase 
protein (Miro1) controls astrocyte mitochondrial trafficking and 
positioning. 
 
4.1 Introduction 
 
The mitochondrial Rho-GTPase 1, Miro1, is an important regulator of neuronal mitochondrial 
trafficking and contains two GTPase domains and two EF-hand Ca2+-sensing domains. Miro1 
binds kinesin and dynein motors to couple mitochondria to the microtubule transport network 
(Macaskill et al., 2009b, Wang and Schwarz, 2009). Upon Ca2+ binding to the EF-hand motifs 
of Miro1, a conformational change induces uncoupling of mitochondria from the transport 
network, enabling docking of mitochondria at sites requiring energy and Ca2+ buffering. 
Localised energy production and Ca2+ buffering is important for maintaining ion homeostasis 
and thus proper signalling in neurons (Attwell and Laughlin, 2001, Macaskill et al., 2009b, 
Vos et al., 2010).  
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Saotome and colleagues first describe how overexpression of the Miro1 mutant lacking the 
ability to bind Ca2+ (EF-hand domain double mutation E208K and E328K, referred to here as 
Miro1ΔEF) prevented Ca2+-induced mitochondrial arrest (Saotome et al., 2008). Neuronal 
activity was shown to induce Miro1-EF-hand-dependent stopping of neuronal mitochondria 
(Macaskill et al., 2009b, Wang and Schwarz, 2009) in close proximity to synapses (Macaskill 
et al., 2009b). Functionally, Wang and Schwarz showed that overexpression of Miro1ΔEF 
drastically reduces neuronal survival with application of acute NMDA (5 min, 3 µM, 10 µM 
and 30 µM) compared to overexpression of WT Miro1 and in experiments where Miro1 is not 
overexpressed. They conclude from this that disrupting Miro1-EF-hand-dependent 
mitochondrial trafficking in neurons diminishes neuronal resistance to excitotoxicity (Wang 
and Schwarz, 2009).  
 
Although Miro has two isoforms in mammals (Miro1 and Miro2), most studies have focused 
on the function of Miro1. The two proteins have been suggested to have similar functions 
(Fransson et al., 2006), however some differences have emerged. The work of Misko and 
colleagues, found that knock down of Miro2, but not Miro1, in cultured neurons alters axonal 
mitochondrial transport (mainly anterograde transport) (Misko et al., 2010). Knock down of 
Miro1 only altered the somatic distribution of mitochondria (Misko et al., 2010) but this is not 
an expected finding. This study, therefore, suggests that Miro2 plays a more important role in 
regulating mitochondrial trafficking, at least in axons, but it could also indicate that Miro2 
can compensate for the loss of Miro1. 
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The trafficking of mitochondria within astrocyte processes has been shown to be dependent 
on both the microtubule and actin cytoskeletons (Kremneva et al., 2013, Jackson et al., 2014) 
but the motor proteins and adaptors involved are yet to be identified. Astrocytes express 
kinesin motors at the mRNA level (KIF11 and KIF22) (Cahoy et al., 2008), however, their 
potential involvement in regulating astrocyte mitochondrial trafficking is unknown. While 
Miro1 is well established as an important regulator of mitochondrial trafficking and 
positioning in neurons, whether Miro proteins are present and important for the spatial 
regulation of mitochondria within astrocytes is not yet known. Therefore, the main aim of this 
chapter will be to address whether Miro, in particular the EF-hand Ca2+-sensing abilities of 
Miro1, is conserved in astrocytes. In addition, whether Miro1 is important for regulating 
astrocyte function as well as the downstream impact of on neuronal function will be 
investigated. 
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4.2 Results 
 
4.2.1 Astrocytes express Miro1 and Miro2, which localise to mitochondria along 
their processes. 
An RNA-sequence transcriptome database indicates that astrocytes (mouse P7) express the 
gene for Miro1 (Rhot1) at higher levels than neurons (Zhang et al., 2014). However, the 
expression of Miro1 at the protein level has not been investigated to date. Thus, astrocytes 
were isolated from rat and mouse brains and probed for Miro proteins (Figure 4.2.1A). 
Indeed, both isoforms of Miro (Miro1 and Miro2) were present in isolated astrocyte cultures 
at similar levels to those seen in neurons (Macaskill et al., 2009b). Interestingly, Miro2 was 
present at higher levels than Miro1 in mouse cultures (E16) but no difference was seen in the 
expression levels in rat cultures (P1). It may be that Miro1 expression is developmentally 
delayed and upregulated postnatally.  
Subsequently, the localisation of Miro1 was investigated in organotypic slices (Figure 
4.2.1B). Labelling endogenous Miro (Miro1 and Miro2) alongside astrocyte mitochondria 
(AV-mtdsRed2-ir-EGFP transduced) revealed most mitochondria co-localise with Miro 
proteins. This novel finding reveals that Miro localises to astrocyte mitochondria in situ, 
suggesting that it may play a role in regulating their trafficking in astrocytes. 
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Figure 4.2.1 Astrocytes express Miro proteins (Miro1 and Miro2), which localise to mitochondria in 
slices. A. Western blot analysis of endogenous Miro expression in cultured hippocampal mouse (E16) 
and rat (P1) cortical astrocytes. B. Immuno-labelling of Miro1 and Miro2, in situ, which localises to 
mitochondria. Images show an example organotypic HPC slice infected with AVmtdsRed2-ir-EGFP 
and immuno-stained for Miro (atlas rabbit αMiro). Scale bar, 15 µm. 
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4.2.2 The EF Ca2+-sensing domains of Miro1 are important for mitochondrial 
trafficking and morphology regulation in astrocyte processes, in culture. 
 
To observe the role of Miro1’s EF-hands in regulating mitochondrial trafficking dynamics 
and morphology in astrocytes, astrocyte-neuron co-cultures were transfected with either wild-
type Miro1 (Miro1WT) or EF-hand mutant Miro1 (Miro1ΔEF), which can no longer bind Ca2+ 
(Figure 4.2.2A). These bicistronic vectors overexpress either Miro1WT or Miro1ΔEF along with 
mtdsRed2 to identify mitochondria. Cultures were co-transfected with GFAP promoter driven 
GFP (GFAP-GFP), to identify astrocytes (Figure 4.2.2B and C). As a further control, 
astrocytes were transfected with mtdsRed2 alone (not overexpressing Miro1) and GFAP 
driven-GFP. Potentially, the Miro1ΔEF could be a dominant-negative mutant as, in previous 
studies, Miro1ΔEF OE prevented Ca2+-induced mitochondrial stopping within dendrites 
(Saotome et al., 2008) near synapses (Macaskill et al., 2009b). In addition, Miro1ΔEF OE in 
neurons also diminished their resistance to excitotoxicity (Wang and Schwarz, 2009). 
 
Interestingly, both Miro1WT and Miro1ΔEF overexpression (OE), in culture, increased basal 
mitochondrial mobility (Figure 4.2.2D, p = 0.02 and p = 0.01, respectively) and speed (Figure 
4.2.2E, p = 0.001 and p = 0.01, respectively). This suggests that Miro1 regulates 
mitochondrial trafficking under basal conditions in astrocytes and that the EF-hands of Miro1 
are not necessary for mitochondria to bind their transport network.  
 
Following glutamate treatment (100 µM + 1 µM glycine, 5 min), mitochondrial mobility and speed were reduced to a similar degree with control mtdsRed2 transfection and Miro1WT OE 
(Figure 4.2.2D, p = 0.4 and 4.2.2E, p = 0.9). Interestingly, post-glutamate treatment, 
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compared to Miro1ΔEF OE, mitochondrial mobility (Figure 4.2.2D, p = 0.001 and p = 0.0003, 
respectively) and speed (Figure 4.2.2E, p = 0.0008 and p = 0.02, respectively) were 
significantly reduced in control conditions and with Miro1WT OE i.e. Miro1ΔEF OE impairs 
glutamate-induced halting of astrocyte mitochondria, where mobility and speed were similar 
to pre-treatment conditions. This reveals a previously unappreciated role for Miro1 in 
astrocytes, whereby its EF-hand-Ca2+-sensing abilities are important for regulating basal 
mitochondrial trafficking and inducing mitochondrial stopping in response to glutamate 
treatment.  
 
Furthermore, the role of the EF-hands of Miro1 in regulating astrocyte mitochondrial 
morphology was also investigated. Interestingly, with Miro1ΔEF OE mitochondria were more 
elongated compared to Miro1WT OE but not significantly different from control (mtsdRed2) 
conditions (figure 4.2.2F, p = 0.01). Following glutamate treatment, mitochondrial length was 
significantly reduced in control conditions and with Miro1WT OE compared to pre-treatment 
conditions and compared to Miro1ΔEF OE (Figure 4.2.2F, p = 0.0007 and p = 0.01). This 
suggests that the EF-hands of Miro1 are also important for regulating mitochondrial 
morphology in astrocytes. It could be that through mutating the EF-hands their interactions 
with pro-fission proteins, such as Drp1, are impaired (Saotome et al., 2008). 
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Figure 4.2.2 Miro1’s EF hands regulate mitochondrial trafficking and morphology in cultured 
hippocampal astrocytes. A. Primary structure of Miro1 showing the point mutations that exist in the 
mutant form of Miro1∆EE-KK (Miro1∆EF), which can’t bind Ca2+. B. Astrocyte transfected with Miro1WT-
ires-mtdsRed2 (WT) and GFAP-driven-GFP. Scale bar, 15 µm. Inset kymograph of mitochondrial 
trafficking with glutamate treatment (100 µM + 1 µM glycine, 5 minutes). Scale bar, 5 µm. C. 
Astrocyte transfected with Miro1∆EF-ires-mtdsRed2 (ΔEF) and GFAP-GFP. Scale bar, 15µm. Inset 
kymograph with glutamate treatment. Scale bar, 5 µm. D. Mitochondria moving pre (left) and post-
glutamate treatment (right). Controls were transfected with mtdsRed2 and GFAP-GFP (control and 
Miro1WT (pre and post) n = 3 cells; Miro1∆EF (pre and post) n = 4 cells). E. Mitochondrial speed pre 
and post glutamate (control pre and Miro1WT post n = 10 mitochondria, 3 cells; Miro1WT pre n = 12 
mitochondria, 3 cells; Miro1∆EF pre n = 11 mitochondria, 4 cells; control post n = 9 mitochondria, 3 
cells; Miro1∆EF post n = 13 mitochondria, 3 cells). F. Mitochondrial length pre and post glutamate 
(Miro1WT and Miro1∆EF n = 3 cells). 
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4.2.3 The EF-hands of Miro1 are important for regulating mitochondrial 
trafficking in astrocytes in response to neuronal activity in situ. 
 
To further investigate the role of Miro1 in astrocytes in an intact system, organotypic slices 
were biolistically transfected with either Miro1WT or Miro1ΔEF, both bicistronically expressing 
mtdsRed2, along with co-transfection of GFAP driven-GFP (Figure 4.2.3A). This allowed the 
role of Miro1 in astrocytes to be examined where network connectivity is preserved.  
 
Stimulating neuronal activity with 4-AP, resulted in a significant reduction in mitochondrial 
mobility (Figure 4.2.3B, p = 0.03), speed  (Figure 4.2.3C, p = 9x10-6) and length (Figure 
4.2.3D, p = 0.0003) in astrocytes, with Miro1WT OE, which was not observed with Miro1ΔEF 
OE (Figure 4.2.3C, p = 0.8, p = 0.9 and p = 0.6, respectively). These results support the 
results in culture and indicate that Miro1 may regulate activity-driven mitochondrial 
trafficking and morphology in vivo. 
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Figure 4.2.3 The EF-hands of Miro1 are essential for regulating mitochondrial trafficking in astrocytes 
in hippocampal slices. A. Example images of Miro1WT-ir-mtdsRed2 (WT) and Miro1EF-ir-mtdsRed2 
(ΔEF) co-transfected with GFAP-driven GFP in situ imaged 2-3 days post shooting (slices were shot at 
7 DIV). Scale bars, 15 µm. B. Mitochondrial mobility before (control) and after 4-AP treatment (100 
µM, 5 minutes) with Miro1WT and Miro1ΔEF OE (Miro1WT (control and 4-AP) n = 3 cells, 3 slices; 
Miro1ΔEF (control and 4-AP) n = 3 cells, 3 slices). C. Speed of moving mitochondria before and after 4-
AP treatment with Miro1WT or Miro1ΔEF OE (Miro1WT control n = 11 mitochondria, 3 slices; Miro1WT + 
4-AP n = 10 mitochondria, 3 slices; Miro1ΔEF (control and 4-AP) n = 10 mitochondria, 3 slices). D. 
Mitochondrial length before and after 4-AP treatment with Miro1WT or Miro1ΔEF OE (Miro1WT n = 3 
cells, 3 slices; Miro1ΔEF n = 3 cells, 3 slices). 
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4.2.4 Activity-dependent positioning of astrocyte mitochondria near synapses 
requires the EF-hands of Miro1, in situ. 
 
To investigate the role of the EF-hands of Miro1 in regulating mitochondrial positioning 
within astrocyte processes, in hippocampal slices, Miro1WT or Miro1ΔEF vectors bicistronically 
expressing mtdsRed2 were used to label mitochondria with biolistic transfection and synapses 
were immuno-labelled with VGLUT1 (Figure 4.2.4A). With Miro1WT the distance between 
mitochondria and their nearest synapse significantly decreased following 4-AP treatment (5 
minutes, 100 µM), compared to untreated controls (Figure 4.2.4B, p = 0.02). This decrease 
was not observed, however, in slices with mutant Miro1ΔEF OE, where following treatment, 
the distribution was similar to untreated control conditions (Figure 4.2.4B, p = 0.8). 
Importantly, no significant change was seen in synapse or mitochondrial number (per µm) 
(Figure 4.2.4C, p = 0.5 and p = 0.8, p = 0.1 and p = 0.8, respectively). Therefore, it appears 
that the EF-hands of Miro1 are important for regulating activity-driven mitochondrial 
stopping and their concomitant retention in astrocyte processes in close proximity to synapses 
in situ. Ultimately, the spatial confinement of mitochondria within perisynaptic astrocyte 
processes in response to increased levels of neuronal activity is expected to not only have 
important consequences for astrocyte function but also neuronal synaptic transmission. 
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Figure 4.2.4 Astrocyte mitochondrial recruitment near synapses is dependent on the EF-hand Ca2+ 
sensing domains of Miro1, in situ. A. Representative images of mitochondrial distribution in relation to 
VGLUT1 labelled synapses with Miro1WT-ir-mtdsRed2 (WT) and Miro1ΔEF-ir-mtdsRed2 (ΔEF) OE 
prior to and following 4-AP treatment (5 minutes, 100 µM). Scale bars, 5 µm. B. Distance between 
mitochondria and their nearest VGLUT1 labelled synapse (centre of mass) under basal conditions and 
with 4-AP treatment. C. Number of mitochondria and VGLUT1 puncta in analysed ROIs (per µm) 
with Miro1WT or Miro1ΔEF OE. Miro1WT control n = 7 ROIs, 7 cells, 3 slices; Miro1WT + 4-AP n = 6 
ROIs, 6 cells, 3 slices; Miro1ΔEF control n = 7 ROIs, 7 cells, 3 slices; Miro1ΔEF + 4-AP n=7 ROIs, 7 
cells, 3 slices. 
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4.2.5 The ability of mitochondria to sense elevated intracellular Ca2+ is disrupted 
when Miro1 is mutated. 
 
The ability of mitochondria to localise to regions of high intracellular Ca2+ could be important 
for Ca2+ buffering and the downstream release of neuro-active substances from astrocytes. 
Thus, the ability of Miro1’s EF-Ca2+ hands to regulate this function was investigated. Slices 
were biolistically co-transfected with GCaMP6s to image intracellular Ca2+ levels and either 
Miro1WT or Miro1ΔEF bicistronically expressing mtdsRed2 to label mitochondria. 
Subsequently, mitochondrial trafficking was analysed in regions of the same cell exhibiting 
relatively high or low levels of intracellular Ca2+, reflected by GCaMP6s fluorescence 
intensity. Interestingly, the halting of mitochondria at Ca2+ hot spots seen in control 
conditions (Miro1WT OE) was disrupted with mutant Miro1ΔEF OE (Figure 4.2.5A, p = 0.002). 
Relative levels of intracellular Ca2+ were quantified following measurement of mitochondrial speed (Figure 4.2.5Ai).  
This result further supports a role for the EF-hand Ca2+-sensing motifs of Miro1 in regulating 
mitochondrial trafficking in the processes of astrocytes in situ. The spatial regulation of 
astrocyte mitochondria by Miro1 could be important for their positioning near synapses 
during activity, where they are required to provide energy to maintain ion flux and channel 
activity as well as buffering Ca2+ influx, which can occur in a spatially restricted manner 
within their processes (Srinivasan et al., 2015). The spatial regulation of astrocyte 
mitochondria could, therefore, impact of their release of gliotransmitters. 
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Figure 4.2.5 Mutant Miro1 (Miro1ΔEF) overexpression alters the ability of mitochondria to localise at 
regions of elevated Ca2+. A. Mitochondrial speed in regions of low and high intracellular Ca2+ with 
overexpression of Miro1WT-ires-mtdsRed2 and mutant Miro1ΔEF-ires-mtdsRed2 (Miro1WT low n = 6 
mitochondria, 3 slices; Miro1WT high n = 5 mitochondria, 3 slices; Miro1ΔEF low n = 5 mitochondria, 3 
slices; Miro1ΔEF high n = 5 mitochondria, 3 slices).  Ai. Relative levels of intracellular Ca2+ (maximum 
GCaMP6s fluorescence normalised to the first 5 frames (10 s)) where high intracellular Ca2+ levels 
were relative to regions of the same cell where Ca2+ was low.  
 
	 156	
 
 
4.2.6 Mutating the EF-hands of Miro1 alters basal astrocyte Ca2+ signalling in 
situ. 
 
To investigate the impact of disrupting mitochondrial trafficking and positioning in 
astrocytes, organotypic slices were biolistically co-transfected with GCaMP6s and either 
Miro1WT or Miro1ΔEF vectors bicistronically expressing mtdsRed2 to indicate Miro1 
overexpression (OE) (Figure 4.2.6A). Specific transfection of astrocytes was confirmed by 
significant co-localisation of the GCaMP6s signal with GFAP (as shown previously in Figure 
3.2.6).  
Interestingly, the frequency of basal Ca2+ transients was increased with Miro1ΔEF OE in the 
processes of astrocytes compared to Miro1WT OE (Figure 4.2.6B and Bi p = 4x10-5). In 
addition, Miro1ΔEF OE significantly increased the amplitude of Ca2+ transients in astrocyte 
processes compared to Miro1WT OE (Figure 4.2.6B and Bi p = 2x10-5). These results reveal 
that the spatial regulation of mitochondria by the EF-hands of Miro1 is important for 
intracellular Ca2+ signalling in astrocytes, which could have important consequences for their 
function, particularly in relation to gliotransmission.   
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Figure 4.2.6 Mutant Miro1 (Miro1EF) overexpression alters basal astrocytic Ca2+ signalling in 
hippocampal slices. A. Example astrocyte biolistically transfected with GCaMP6s and Miro1WT-ir-
mtdsRed2 (WT) or Miro1ΔEF-ir-mtdsRed2 (ΔEF). B. Example basal process Ca2+ signalling with 
Miro1WT or Miro1ΔEF OE, F/F0 normalised to the first 5 frames (10 s). Bi. Amplitude (F/F0, normalised 
to the first 5 frames (10 s)) and frequency (process events/min) of basal Ca2+ transients with Miro1WT or 
Miro1ΔEF OE (Miro1WT n = 14 ROIs, 7 slices; Miro1ΔEF n = 27 ROIs, 7 slices).    
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4.2.7 Mutating the EF-hands of Miro1 increases activity-driven astrocyte Ca2+ 
signalling, in situ. 
 
Subsequently, the question of whether astrocytes could respond to stimulation with 
overexpression (OE) of the mutant form of Miro1 was addressed. Astrocytes in hippocampal 
slices were again biolistically co-transfected with GCaMP6s and either Miro1WT or Miro1ΔEF 
vectors bicistronically expressing mtdsRed2 to indicate Miro1 overexpression (OE). With this 
approach, a significant increase in the dynamics of astrocyte Ca2+ signalling was observed 
following stimulation, in the processes. The response to 4-AP treatment (5 minutes, 200 µM), 
to stimulate neuronal activity, in astrocytes with Miro1ΔEF OE was greater in amplitude 
compared to Miro1WT OE astrocytes (Figure 4.2.7A and Ai p = 0.001). In addition, the 
response frequency and duration was significantly elevated with Miro1ΔEF compared to 
Miro1WT (Figure 4.2.7Ai p = 0.002 and p = 1x10-5, respectively). 
With ATP treatment (2 minutes, 100 µM), to stimulate a rise in intracellular Ca2+, the rise in 
Ca2+ was even higher with Miro1ΔEF OE compared to Miro1WT OE.  Miro1ΔEF increased the 
ATP response amplitude (Figure 4.2.7Ai p = 0.02), frequency (Figure 4.2.7Ai p = 0.01) and 
duration (Figure 4.2.7Ai p = 0.02).  
These results reveal that the spatial regulation of mitochondria by Miro1 is important for 
intracellular Ca2+ signalling in astrocytes, which could have important consequences for the 
pathogenesis of disease in the CNS. 
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Figure 4.2.7 Mutant Miro1 (Miro1EF) overexpression alters activity-driven astrocyte Ca2+ signalling, in 
situ. A. Example activity-stimulated process Ca2+ signalling with Miro1WT-ir-mtdsRed2 (WT) or 
Miro1ΔEF-ir-mtdsRed2 (ΔEF) OE. Slices were perfused with 200 µM 4-AP for 5 minutes or 100 µM 
ATP for 2 minutes. Ai. Response amplitude (F/F0, normalised to the first 10 frames (20 s)), frequency 
(process events/min) and duration with 4AP and ATP treatment (Miro1WT + 4-AP n = 11 ROIs, 5 
slices; Miro1ΔEF + 4-AP n = 10 ROIs, 4 slices; Miro1WT + ATP n = 8 ROIs, 4 slices; Miro1ΔEF + ATP n 
= 9 ROIs, 7 slices). 
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4.2.8 Mutating the EF-hands of Miro1 in astrocytes alters the number of 
excitatory synapses, in culture.  
 
It appears that mutating the EF-hands of Miro1 not only impact on the function of astrocytes 
but also that it alters the number of excitatory synapses. Cultured hippocampal astrocytes 
were pre-transfected with either Miro1WT-ir-mtdsRed2 (WT) or Miro1ΔEF-ir-mtdsRed2 (ΔEF) 
before being co-cultured with hippocampal neurons (at 3 DIV) for 7-10 days. Excitatory pre- 
and post- synaptic terminals were immuno-labelled with a VGLUT1 antibody and a homer 
antibody, respectively. 
Neurons in close proximity to astrocytes overexpressing (OE) the mutant form of Miro1 
(Miro1ΔEF) exhibit a reduced number of VGLUT and homer puncta (per µm) compared to 
neurons that are not in close proximity to mutant Miro1 OE astrocytes (Figure 4.2.8B, p = 
0.02 and p = 0.003, respectively). The size of VGLUT puncta were also significantly 
decreased but not the size of the homer puncta (Figure 4.2.8C, p = 0.001 and p = 0.6, 
respectively). OE of the mutant form of Miro1 (Miro1ΔEF) also decreased the density of 
synapses i.e. the proportion of homer with VGLUT contacts sites and, reciprocally, the 
proportion of VGLUT with homer contacts (Figure 4.2.8D, p = 0.01 and p = 0.04, 
respectively). Importantly, there was no significant change in the number or area of homer 
and VGLUT1 puncta or the proportion of VGLU1 with homer and the proportion of homer 
with VGLUT1 in close proximity to Miro1WT OE astrocytes compared to neurons not in close 
proximity to Miro1WT or Miro1ΔEF OE astrocytes (Figure 4.2.8B-D). 
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This implies that improper intracellular Ca2+ handling in astrocytes impacts on the number of 
excitatory synapses. Aastrocyte Ca2+ elevations can induce the release of gliotransmitters, 
prolonged release of which, disrupts neuronal signalling and causes excitotoxic cell death 
(Araque et al., 1998, Di Castro et al., 2011). A decrease in synaptic density may indicate cell 
death or a compensatory response in order to down-regulate synaptic activity to counteract the 
increased presence of gliotransimitters release by nearby astrocytes. More broadly it shows 
that the consequence of disrupted intracellular Ca2+ regulating, through altered Miro1-EF-
hand-dependent mitochondrial spatial regulation, does indeed have an impact on the 
surrounding neuronal architecture.  
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Figure 4.2.8 Mutant Miro1 (Miro1EF) OE alters the number of excitatory synapses. A. Representative 
images of hippocampal neurons co-cultured with hippocampal astrocytes pre-transfected with either 
Miro1WT-ir-mtdsRed2 (WT) or Miro1ΔEF-ir-mtdsRed2 (ΔEF). Neuronal dendrites were immuno-
labelled with MAP2 and pre- and post-synaptic terminals were labelled with VGLUT1 and homer, 
respectively. These images also show synaptic labelling in close proximity to OE astrocytes (near) and 
not in close proximity to OE astrocytes (far).  Scale bars, 5 µm. B. Number of VGLUT and homer 
puncta per µm near and far from WT/EF OE astrocytes. C. The size of VGLUT and homer puncta 
(µm2) near and far from WT/EF OE astrocytes. D. The proportion of VGLUT1 with homer was 
quantified by calculating the number of VGLUT1 puncta that came into contact with homer puncta 
divided by the total number of VGLUT1 puncta (near and far from WT/EF OE astrocytes). 
Reciprocally, the proportion of homer with VGLUT1 was quantified by calculating the number of 
homer puncta that came into contact with VGLUT1 puncta divided by the total number of homer 
puncta (near and far from WT/EF OE astrocytes). Near Miro1WT n = 10 ROIs, 10 cells; Mito1WT far n = 
4 ROIs, 4 cells; near Miro1ΔEF n = 5 ROIs, 5 cells; Miro1ΔEF far n = 6 ROIs, 6 cells). 
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4.2.9 Mutating the EF-hands of Miro1 in astrocytes alters the presence of 
GluR2-containing neuronal AMPA receptors. 
 
Additionally, mutating the EF-hands of Miro1 not only impacts on the number of synapses 
but also the formation of functional excitatory GluR2-containting synapses. Cultured 
hippocampal astrocytes were pre-transfected with either Miro1WT-ir-mtdsRed2 (WT) or 
Miro1ΔEF-ir-mtdsRed2 (ΔEF) before being co-cultured with hippocampal neurons (at 3 DIV) 
for 7-10 days. Functional synapses were immuno-labelled with a GluR2 antibody, a marker 
for AMPARs. These receptors, in particular GluR2-containing AMPARs, are widely accepted 
as critical for synaptic transmission (Liu and Zukin, 2007). 
With overexpression (OE) of the mutant form of Miro1 (Miro1ΔEF) the number of total 
GluR2-positive synapses per µm was significantly decreased (Figure 4.2.9B, p = 0.04). The 
average area of GluR2-positive synapses was also significantly reduced (Figure 4.2.9C, p = 
0.009). This implies that improper intracellular Ca2+ handling in astrocytes impacts on the 
number and size of GluR2-positive synapses. This may be because disrupted intracellular 
Ca2+ regulating through altered Miro1-EF-hand-dependent mitochondrial spatial regulation 
impacts on the activity of the surrounding neuronal architecture.  
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Figure 4.2.9 Mutant Miro1 (Miro1EF) OE alters the formation of GluR2-containing AMPARs. A. 
Representative images of hippocampal neurons co-cultured with hippocampal astrocytes pre-
transfected with either Miro1WT-ir-mtdsRed2 (WT) or Miro1ΔEF-ir-mtdsRed2 (ΔEF). Neuronal 
dendrites were again immuno-labelled with MAP2 and a GluR2 antibody was used to label total 
process AMPARs (permeabilised staining). GFAP was also used to label nearby astrocytes OE Miro1. 
Scale bars, 5 µm. B. Number (per µm) of GluR2 puncta near Miro1WT or Miro1ΔEF OE astrocytes. C. 
Area (µm2) of GluR2 puncta near Miro1WT or Miro1ΔEF OE astrocytes. Miro1WT n = 5 ROIs, 5 cells; 
Miro1ΔEF n = 5 ROIs, 5 cells. 
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4.3 Discussion 
 
Here, a mechanism is proposed whereby mitochondrial trafficking, morphology and 
positioning in astrocyte processes is regulated by the Ca2+-sensing abilities of Miro1. The 
spatial regulation of astrocyte mitochondria by the EF-Ca2+-sensing hands of Miro1 is 
essential for astrocyte intracellular Ca2+ buffering, which is important downstream for the 
formation of excitatory synapses and post-synaptic GluR2-containing AMPARs. 
Mechanistically, elevations in intracellular astrocyte Ca2+ likely result in gliotransmitter 
release and a loss in the number of synapses potentially due to excitotoxic neuronal cell death. 
 
Several novel features exist in the control of astrocyte mitochondrial trafficking and 
positioning involving Miro1. First, Miro1 is expressed in rodent astrocytes at the protein level 
and it localises to mitochondria. Second, the Ca2+-binding EF-hand domains of Miro1 are not 
required for basal mitochondrial trafficking or for mitochondria binding to the microtubule or 
actin transport network, but here it is suggested that Miro1 regulates basal mitochondrial 
trafficking in astrocytes. It could be that increasing Miro1 (Miro1WT or Miro1ΔEF) increases 
the binding of mitochondria to microtubules or actin in astrocyte processes, allowing them to 
move more with increased speed. Third, the EF-hands of Miro1 are essential for inducing 
mitochondrial cessation in response to elevations in intracellular Ca2+. Fourth, the EF-hands 
also appear to be important for regulating astrocyte mitochondrial morphology, where 
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mutating the EF-hands prevents mitochondrial remodelling/fission following stimulation of 
neuronal activity. This reveals that the EF-hands of Miro1 are important for regulating 
activity-driven mitochondrial stopping and morphology in astrocytes.   
Another interesting observation made by this study is that the EF-hands of Miro1 appear to be 
important for the activity-driven retention of mitochondria at synapses. This suggests that 
Ca2+ binding the EF-hands of Miro1 is important for inducing mitochondrial stopping at 
predicted Ca2+ hot spots. Finally, overexpressing the mutant form of Miro1 (Miro1ΔEF) alters 
the ability of astrocytes to regulate their intracellular Ca2+ levels, in situ. Miro1∆EF OE 
increased the frequency and amplitude of basal Ca2+ transients and increased the response to 
neuronal activity and ATP. Here, astrocytes may be more vulnerable to Ca2+ overload when 
the Ca2+-sensing abilities of Miro1 are disrupted. It would be interesting to test whether Miro1 
OE alters mitochondrial membrane potential and consequently their ability to buffer Ca2+. 
Disrupted intracellular Ca2+ regulation in astrocytes could have important consequences for 
their unique propagation of Ca2+ waves and suggests that the spatial regulation of 
mitochondria by Miro1 plays an important role in regulating astrocyte signalling.  
Since the regulation of intracellular Ca2+ also has the potential to impact on gliotransmission, 
this thesis reveals another potential route for bi-directional communication between astrocytes 
and neurons. This could be linked to instances of pathology, as disrupted astrocyte Ca2+ 
dynamics due to altered mitochondrial function has devastating consequences for neuronal 
function (Katayama et al., 1995, Danbolt, 2001, Shin et al., 2005, Voloboueva et al., 2007, Li 
et al., 2008, Bradford et al., 2009, Oliveira and Goncalves, 2009). Interestingly, basal Ca2+ 
transients are elevated in astrocytes in mice expressing mutant human Aβ precursor protein 
(Kuchibhotla et al., 2009). Similarly, expression of proteins containing PD-related gene 
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mutations (for example, human protein deglycase DJ-1 mutations) in cultured astrocytes 
impairs mitochondrial dynamics. This compromises their neuroprotective ability and thus 
renders neurons more sensitive to toxic insults (Larsen et al., 2011, Schmidt et al., 2011, Lev 
et al., 2013). 
Here, improper intracellular Ca2+ handling in astrocytes impacts on the formation of 
excitatory synapses. This may be because astrocyte Ca2+ elevations can induce the release of 
gliotransmitters, which may disrupt neuronal signalling transmission and cause exocytotic cell 
death (Araque et al., 1998, Di Castro et al., 2011). A reduction in synapses may indicate cell 
death or a compensatory response to down regulate synaptic activity in order to counteract the 
increased presence of gliotransimitters release by nearby astrocytes. This highlights that 
Miro1-dependent mitochondrial trafficking in astrocytes is functionally not only important for 
astrocyte signalling but also affects neuronal function. It means that understanding the tightly 
coupled mechanisms of feedback signalling between neurons and astrocytes are important and 
the results shown here implicate astrocyte mitochondrial regulation in this feedback 
signalling. 
In summary, the EF-hands of Miro1 have been shown here to regulate trafficking and 
morphology of mitochondria in the processes of astrocytes, as well as retention of 
mitochondria in close proximity to excitatory synapses. The spatial regulation of astrocyte 
mitochondria by the EF-hands of Miro1 was essential for astrocyte intracellular Ca2+ 
regulation, which could have important consequences for Ca2+ wave propagation and 
gliotransmission. Here, disrupting EF-hand-dependent intracellular astrocyte Ca2+ regulation 
altered the formation of excitatory synapses. Further work is required to confirm exactly how 
altering Miro1-mediated astrocyte mitochondrial positioning affects glitotransmission.  
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Chapter 5 
 
 
Miro1KO astrocytes have disrupted mitochondrial trafficking 
dynamics and this is critical for proper synapse regulation. 
 
5.1 Introduction 
 
Recently, Nguyen and colleagues investigated the role of Miro1 in regulating aspects of 
mitochondrial localisation in motor neurons. They find that the consequence of a total loss of 
Miro1 is lethal (death occurs prior to birth- prenatally) (Nguyen et al., 2014). Neuron-specific 
loss of Miro1 causes depletion of mitochondria from corticospinal tract axons. Additionally, 
they find progressive neurological deficits, indicative of motor neuron disease (MND), in 
neuron-specific Miro1 KO mice. Defects were observed in retrograde axonal mitochondrial 
transport, although mitochondrial respiratory function is preserved. Moreover, they deduce 
that Miro1 is not essential for Ca2+-mediated inhibition of mitochondrial mobility or 
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mitochondrial Ca2+ buffering. It could be that Miro2 compensates for a loss of Miro1 to 
regulate mitochondrial mobility and mitochondrial Ca2+ buffering. This, however, has not 
been conclusively demonstrated to date. It could be that normal astrocyte Miro1 function can 
somehow compensate for a neuronal loss of Miro1. Nguyen and colleagues do conclude that 
neuronal mitochondrial mobility defects and impaired mitochondrial distribution are 
sufficient to cause neurological disease (Nguyen et al., 2014). In conclusion, this study 
indicates that Miro1 is important for regulating mitochondrial density and proper neuronal 
function and suggests a need to investigate the role of Miro1 in astrocytes.  
The consequence of a total loss of astrocyte Miro1, however, has not been determined. Due to 
the importance of the EF-hand domains of Miro1 in regulating intracellular astrocyte Ca2+ and 
ultimately synapse formation (shown in chapter 4), this indicates that astrocyte mitochondrial 
positioning is important for astrocyte signalling, which has important consequences for the 
surrounding neuronal environment. Thus, a total loss of Miro1 in astrocytes may have even 
more important consequences for astrocyte function and neuronal synapse formation. Where 
Miro-independent trafficking regulation has been proposed in neurons (Cai et al., 2005, 
Nguyen et al., 2014), this may not be the case in astrocytes and thus a total loss of Miro1 in 
astrocytes was investigated. Astrocytes do express genes for other proteins that could 
potentially recruit kinesin-1 motors to mitochondria. These include syntabulin (SYBU) and 
Trak (Trak1 and Trak2) genes (Cahoy et al., 2008). However, whether these proteins are 
expressed and if they are capable of mediating astrocyte mitochondrial transport in the 
absence of Miro is not known. As mentioned previously, astrocytes were shown to express 
Miro2, which may be able to compensate for the total loss of astrocyte Miro1.  
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It may be that through the loss of all of Miro1’s regulatory domains that mitochondrial 
morphology is affected in astrocytes as well as potential trafficking defects. This is because 
the GTPase domains of Miro1 have been proposed to regulate mitochondrial morphology 
(Fransson et al., 2006) as well as trafficking (MacAskill et al., 2009a). For example, the 
recruitment of Trak2 to neuronal mitochondria is dependent on the activity of the first 
GTPase domain of Miro1, where GDP-bound Miro1 recruits Trak2, allowing mitochondrial 
coupling to the microtubule network (MacAskill et al., 2009a). In addition, removing the EF-
hand domains of Miro1 completely, as apposed to overexpressing the EF-hand mutant, that 
only has a single point mutation in each EF-hand domain, might disrupt Miro1’s potential 
interactions with mitofusins (Misko et al., 2010) (astrocytes express the genes for Mfn1 and 
Mfn2 (Cahoy et al., 2008)). Additionally, Miro1 interactions with the adaptor proteins Trak 
and KIF are thought to occur via the EF-hands (Macaskill et al., 2009b). Thus, completely 
removing astrocyte Miro1 might affect these interactions more so than mutating the EF-hand 
domains. 
Investigating the total loss of Miro1 in astrocytes was also investigated to overcome the 
caveats of overexpressing the EF-hand mutant, where endogenous Miro1 is present. By 
utilising the Miro1KO mouse it was possible to obtain isolated astrocytes that lack the ability to 
synthesise Miro1. Thus any impact of the isolated astrocytes on aspect of astrocyte 
mitochondrial dynamics or neuronal defects would be due, specifically, to astrocyte loss of 
Miro1. Thus, an improved system was established for examining the role of Miro1, not only 
in astrocytes, but also to examine the consequences of disrupted astrocyte Miro1 on neuronal 
synapse formation. 
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5.2 Results 
 
5.2.1 A total loss of Miro1 is perinatally lethal. 
In order to remove Miro1 from astrocytes a transgenic line was used that globally lacks Miro1 
(i.e. the Rhot1 gene, which encodes for Miro1) from all cells. From this line astrocytes could 
then be isolated to investigate the effects of removing Miro1 from astrocytes in culture.  
The Rhot1 transgenic line was obtained from the Wellcome Trust Sanger Institute (Skarnes et 
al., 2011). The transgenic line was generated following the Knockout-First strategy to disrupt 
Rhot1 transcription. The targeted knockout-first allele (tm1a) has a lacZ/neo cassette inserted 
between exons 1 and 2, resulting in a null allele through splicing to the lacZ-trapping element 
(Figure 5.2.1A). Genotyping was carried out using DNA gel electrophoresis, confirming that 
the lacZ cassette was only present in the Rhot1-/- embryos (Figure 5.2.1B). Miro1 KO 
offspring were born alive at the expected Mendelian ratios and were similar in size and shape 
to their WT littermates (Figure 5.2.1C). However, they died 15-30 minutes following birth 
(perinatally) (Figure 5.2.1D). Western blot analysis of the protein levels in Miro1 WT and KO 
astrocyte cultures confirmed that indeed Miro1 was absent in the KO astrocytes (Figure 
5.2.1E). Miro2 was present in the Miro1 KO cultures at comparable levels to the WT (Figure 
5.2.1E). 
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Figure 5.2.1 The Rhot1 transgenic mouse line. A. Diagram of the wildtype (WT, +/+) and Rhot1 
knock-out (KO, -/-) alleles. The lacZ/neo cassette is inserted after the first exon and is flanked (3’ and 
5’) by FRT sites. Exon 2 has a 3’ and 5’ loxP sites. B. Example DNA gel used for genotyping the 
transgenic mouse cultures. The higher band at 546 base pairs (bp) represents expression of the full-
length protein (primers aF and aR shown in panel A), while the lower band represents expression of the 
disrupted mutant allele (aF and a’R primers). LacZ is expressed in Rhot1-/- embryos, but not in WT 
embryos (zF and zR primers). C. WT (Rhot1+/+) and KO (Rhot1-/-) embryos taken at E16 (pictures were 
taken by Dr Guillermo Lopez-Domenech). D. Percentage of pups born alive (quantified by Dr Lopez-
Domenech). E. Western blot expression analysis of Miro1 protein levels in WT and KO pure 
hippocampal-cortical astrocyte cultures showing a complete loss of Miro1 in KO astrocytes compared 
to WT littermates.  
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5.2.2 Co-culture system - culturing Miro1KO astrocytes with WT neurons.  
 
Utilising the Rhot1 KO transgenic line, as described above, it was possible to obtain pure 
astrocyte cultures lacking Miro1, prior to perinatal death (E18). Isolated astrocytes lacking 
Miro1 were subsequently added to WT neurons of the same species, stage of development 
and density (mouse E18, 800-1 million cells/coverslip). With this approach, any defects in 
astrocyte mitochondrial dynamics can be attributed to astrocyte specific loss of Miro1. It may 
be that through the loss of all of Miro1’s regulatory domains that mitochondrial morphology 
is affected in astrocytes as well as potential trafficking defects. This is because the GTPase 
domains of Miro1 have been proposed to regulate mitochondrial trafficking (MacAskill et al., 
2009a) and morphology (Fransson et al., 2006). In addition, removing the EF-hand domains 
of Miro1 completely might disrupt Miro1’s potential interactions with mitofusins (Misko et 
al., 2010) and the adaptor proteins Trak and KIF. Thus, completely removing astrocyte Miro1 
might affect these interactions more so than mutating the EF-hand domains. 
Interestingly, neuronal specific Miro1 loss shows preserved mitochondrial respiratory 
function (Nguyen et al., 2014). This could indicate that normal astrocyte Miro1 function can 
somehow compensate for a neuronal loss of Miro1 and thus it is particularly important to 
establish the role of Miro1 in astrocytes.  
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Figure 5.2.2 Rhot1 KO astrocyte co-culture system with WT neurons. A. Diagram of the co-culture 
system, which involved culturing isolated cortical astrocytes from the Rhot1 KO transgenic line (E18) 
for around 5-10 days. When the cultures were ~ 60 % confluent they were infected with AV-
mtdsRed2-ir-EGFP to enable visualisation of the KO astrocytes after plating them onto WT E18 mouse 
neurons. B. An example astrocyte AV-tansduced to label the cell with EGFP and mitochondria with 
mtdsRed2 before being added to mouse neurons. Neuronal dendrites were labelled with MAP2.  Scale 
bar, 15 µm. 
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5.2.3 Miro1 KO astrocytes display profoundly disrupted mitochondrial 
dynamics in co-culture with WT neurons. 
 
Using the co-culture technique described above, it was possible to monitor mitochondrial 
trafficking dynamics in astrocytes that were co-cultured with WT mouse neurons. With this 
approach the astrocyte mitochondria exhibited dramatically altered dynamics compared to 
Miro1WT astrocytes co-cultured in the same way.  
Where Miro1WT astrocyte mitochondria were mobile, almost all Miro1KO astrocyte 
mitochondria were immobile (Figure 5.2.3A). Around 40 % of mitochondria were moving in 
Miro1WT astrocytes, while only around 10 % of mitochondria were moving in Miro1KO 
astrocytes (Figure 5.2.3B, p = 0.04). The speed of mobile mitochondria was significantly 
reduced in Miro1KO astrocytes (0.05 µm/s ± 0.009) compared to Miro1WT astrocytes (0.16 ± 
0.02 µm/s) (Figure 5.2.3C, p = 0.0007). Mitochondria were also significantly more round and 
less elongated in Miro1KO astrocytes (0.6 µm ± 0.06) compared to Miro1WT astrocytes (1.4 µm 
± 0.2) (Figure 5.2.3D, p = 0.02). 
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Figure 5.2.3 Miro1KO astrocytes in co-culture with WT neurons exhibit altered mitochondrial 
dynamics. A. Example kymographs of mitochondrial trafficking in transgenic astrocytes transduced 
with AV-mtdsRed2-ir-EGFP. Scale bars, 5 µm. B. Mitochondria moving in Miro1WT and Miro1KO 
astrocytes. Miro1WT n=4 cells; Miro1KO n=4 cells. C. Speed of moving mitochondria in Miro1WT and 
Miro1KO astrocytes. Miro1WT n = 20 mitochondria, 4 cells; Miro1KO n = 10 mitochondria, 3 cells. D. 
Mitochondrial length in Miro1WT and Miro1KO astrocytes. Miro1WT n = 3 cells; Miro1KO n = 3 cells. 
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5.2.4 A total lack of astrocyte Miro1 disrupts the ability of astrocyte 
mitochondria to position themselves near synapses 
 
Previously, the EF-hands of Miro1 were shown here to be important for regulating activity-
driven mitochondrial stopping and their concomitant retention in astrocyte processes in close 
proximity to synapses. Therefore, it was investigated whether a total loss of astrocyte Miro1 
supports this data.   
Cultured cortical mouse Miro1WT or Miro1KO astrocytes were pre-infected with AV-
mtdsRed2-ir-EGFP before co-culturing with WT hippocampal mouse neurons (isolated from 
the Rhot1 transgenic line) (Figure 5.2.4A). With this approach, the distance between Miro1WT 
astrocyte mitochondria and their nearest synapse significantly decreased following glutamate 
treatment (5 minutes, 100 µM + 1 µM glycine), compared to untreated controls (Figure 
5.2.4B, p = 0.04). This decrease was not observed in Miro1KO astrocytes, where following 
treatment, the distribution was similar to untreated control conditions (Figure 5.2.4B, p = 0.9). 
In addition, no significant change was seen in synapse or mitochondrial number (per µm) 
(Figure 5.2.4C, p > 0.2). Ultimately, the spatial confinement of mitochondria within peri-
synaptic astrocyte processes in response to increased levels glutamate could not only have 
important consequences for astrocyte function but also neuronal function. 
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Figure 5.2.4 Miro1KO astrocytes in co-culture with WT neurons exhibit altered mitochondrial 
positioning near synapses with glutamate treatment. A. Example images of Miro1KO astrocytes 
transduced with AV-mtdsRed2-ir-EGFP and synapses immuno-labelled with VGLUT1 under basal 
conditions and with glutamate treatment (100 µM + 1 µM glycine, 5 min). Arrows show points of close 
proximity between astrocyte mitochondria and VGLUT1 labelled pre-synaptic terminals. Scale bars, 5 
µm. B. The distance between Miro1WT and Miro1KO astrocyte mitochondria (co-cultured with WT 
neurons) in relation to their nearest synapse (centre of mass)  before and after glutamate treatment. C. 
Mitochondria and VGLUT1 labelled synapses normalised to GFAP processes length (per µm). 
Miro1WT control n = 6 ROIs, 6 cells, Miro1WT + glutamate n = 7 ROIs, 7 cells; Miro1KO control n = 7 
ROIs, 7 cells, Miro1KO + glutamate n = 6 ROIs, 6 cells. 
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5.2.5 Morphology is altered in Miro1KO astrocytes 
 
Axonal mitochondrial pre-synaptic capture is required for proper axonal development, where 
it appears that immobile mitochondria have the unique ability to stimulate axonal branching, 
through promoting axon branch formation and/or branch stabilization and this ability is not 
shared by mobile mitochondria (Courchet et al., 2013). As mitochondrial positioning was 
shown to be particularly important for other aspects of astrocyte function, such as Ca2+ 
signalling, there was a need to investigate whether disrupted mitochondrial positioning would 
have consequences for astrocyte process extension. Interestingly, astrocytes isolated from 
aging brains (26-29 months) exhibited slower growth rates, along with elevated ATP-induced 
Ca2+ responses and mitochondrial disruptions (Lin et al., 2007).  
Firstly, Miro1WT and Miro1KO astrocytes were isolated and co-cultured with WT neurons. 
Prior to co-culturing, the transgenic astrocytes were transduced with AV-mtdsRed2-ir-EGFP, 
where EGFP was used to label astrocyte processes (Figure 5.2.5A). An automated Sholl 
analysis was then performed on sparsely labelled individual astrocytes (Gensel et al., 2010). 
With this approach, Miro1KO astrocytes displayed reduced process complexity compared to 
Miro1WT astrocytes (Figure 5.2.5B, p = 0.001, 0.002, 0.0009, 0.002 and 0.001, respectively). 
This provides evidence that Miro1-dependent astrocyte mitochondrial positioning is important 
for the arborisation of astrocyte processes, whereby localised energy production is likely 
required to induce process outgrowth/stabilisation. This could have important consequences 
for the modulatory role of astrocytes processes at the tri-partite synapse. 
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Figure 5.2.5 Miro1KO astrocytes in co-culture with WT neurons exhibit altered cell morphology. A. 
Example Miro1WT and Miro1KO astrocytes AV-transduced to label cells with EGFP (images are 
manually thresholded).  Scale bars 20 µm. B. Automated blind Sholl analysis of astrocyte process 
intersections at 10 µm increments radiating out from the central soma. Miro1WT astrocytes n = 6 cells. 
Miro1KO astrocytes n = 9 cells. 
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5.2.6 Neurons co-cultured with Miro1KO astrocytes display altered synapses 
density.  
Previously, the EF-hands of Miro1 were shown to impact on the number of excitatory 
synapses and so it was investigated if a total loss of astrocyte Miro1 had similar, or possibly, 
more profound effects on synapse formation. 
Using WT hippocampal mouse neurons (5-6 DIV) co-cultured with cortical mouse Miro1WT 
or Miro1KO (for 5 days) alongside immuno-labelled pre- and post-synaptic terminals (using 
VGLUT1 and homer antibodies, respectively) it was possible to analyse the influence of 
Miro1KO astrocytes on aspects of excitatory synapse formation (Figure 5.2.6A). With Miro1KO 
astrocytes, WT neurons exhibited a reduction in the number of VGLUT and homer puncta 
(per µm) compared to neurons co-cultured with Miro1WT astrocytes (Figure 5.2.6B, p = 
0.0004 and p = 0.01, respectively). The average area (µm2) of VGLUT puncta were also 
significantly decreased but not the size of the homer puncta (Figure 5.2.6C, p = 0.01 and p = 
0.4, respectively). Additionally, Miro1KO astrocytes also decreased the density of synapses i.e. 
the proportion of homer with VGLUT contacts and reciprocally, the proportion of VGLUT 
with homer contacts (Figure 5.2.6D, p = 0.0003 and p = 0.02, respectively).  
This supports previous data showing that the EF-hands of Miro1 are important for regulating 
the number of excitatory synapses in cultured neurons but in a non-overexpression system. It 
is proposed that a total loss of astrocyte Miro1 induces a more profound loss of synapses than 
OE mutant Miro1. Although it is important to note that there may be some endogenous WT 
astrocytes present in this system, it did not appear to impact on the effects observed by co-
culturing these neuro-glia cultures with Miro1KO astrocytes. 
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Figure 5.2.6 WT neurons in the presence of Miro1KO astrocytes exhibit altered synapse formation. A. 
Representative images of WT neurons (DIV 10-12) in the presence of Miro1WT or Miro1KO astrocytes 
(DIV 5). Pre-and post-synaptic terminals were immuno-labelled with VGLUT1 and homer, 
respectively. Neuronal dendrites were immuno-labelled with MAP2. Scale bars, 5 µm. B. VGLUT1 
and homer puncta normalised to MAP2 process length (per µm) with Miro1WT or Miro1KO astrocytes. 
C. VGLUT1 and homer area (µm2) with Miro1WT or Miro1KO astrocytes. D. Synapse density with 
Miro1WT or Miro1KO astrocytes. This was calculated by quantifying the proportion of homer puncta in 
contact with VGLUT1 puncta (normalised to the total number of homer puncta) and the proportion of 
VGLUT1 puncta in contact with homer puncta (normalised to the total number of VGLUT1 puncta). 
Miro1WT n = 18 ROIs, 14 cells; Miro1KO n = 17 ROIs, 16 cells. 
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5.2.7 Miro1KO astrocytes alter the presence of post-synaptic GluR2-containing 
AMPARs.  
 
Furthermore, co-culturing WT neurons with Miro1KO astrocytes altered the presence of 
excitatory GluR2-containting AMPARs. Miro1KO astrocytes were co-cultured with WT mouse 
neurons (at 5-6 DIV) for 9-10 days. GluR2-containting AMPARs were then immuno-labelled 
with a GluR2 antibody (Figure 5.2.7A). 
In the presence of Miro1KO astrocytes, WT neurons displayed a reduction in the number (per 
µm) and size (average area, µm2) of GluR2-positive synapses (Figure 5.2.7B, p = 0.003 and p 
= 0.03, respectively). This implies that a total loss of Miro1 also impacts on the formation of 
functional synapses. It would be important to investigate the spiking activity of these neurons 
as this data suggests that a total loss of astrocyte Miro1 might impact on synaptic transmission 
in this culture system.  
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Figure 5.2.7 WT neurons in the presence of Miro1KO astrocytes exhibit reduced GuR2-containing 
AMPARs. A. Representative images of WT neurons (DIV 13-16) in the presence of Miro1WT or 
Miro1KO astrocytes (DIV 9-10). GuR2-containing AMPARs were immuno-labelled with a mouse 
GluR2 antibody. Neuronal dendrites were immuno-labelled with MAP2. Scale bars, 5 µm. B. Number 
(per µm) and area (µm2) of GluR2 puncta with Miro1WT or Miro1KO astrocytes. Miro1WT n = 7 ROIs, 7 
cells; Miro1KO n = 7 ROIs, 7 cells. 
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5.3 Discussion 
The results in this section support the data showing that the EF-hands of Miro1 are crucial for 
regulating aspects of astrocyte mitochondrial trafficking and positioning, which has important 
consequences for astrocyte signalling. More specifically, these results indicate that the total 
loss of astrocyte Miro1 induces more profound effects than mutating the EF-hands of Miro1 
in an overexpression system. The main advantage of the KO system is that there is no Miro1 
present in astrocytes and thus it overcomes the caveats of overexpressing the EF-hand mutant, 
where endogenous Miro1 is present.  
Astrocytes isolated from the Miro1KO transgenic line displayed severely disrupted 
mitochondrial morphology and trafficking dynamics, where the majority of the mitochondria 
were round and immobile compared to Miro1WT astrocytes in the presence of WT neurons. 
This may be due to the loss of all of Miro1’s regulatory domains and where Miro-independent 
trafficking regulation has been proposed in neurons (Cai et al., 2005, Nguyen et al., 2014), 
this may not be the case in astrocytes. It may be that the GTPase domains of Miro1 play an 
important role in mediating mitochondrial morphology in astrocytes. Given that the EF-hand 
mutant only has two point mutations, it may be that the EF-hand domains are still capable of 
maintaining elongated mitochondrial morphology potentially via interactions with mitofusins 
(Misko et al., 2010) (astrocytes express the genes for Mfn1 and Mfn2 (Cahoy et al., 2008), 
where the Miro1KO astrocytes loose this ability. In addition, Miro1KO astrocytes may loose the 
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ability to interact with adaptors and motors proteins that mediate astrocyte mitochondrial 
trafficking. Miro1 has been proposed to interact with the adaptor proteins Trak and KIF via 
the EF-hands (Macaskill et al., 2009b). Thus, completely removing astrocyte Miro1 might 
affect these interactions more so than mutating the EF-hand domains. Further investigation is 
required to decipher exactly which domains of Miro1 regulate mitochondrial morphology and 
trafficking in astrocytes.  
As well as having severely disrupted mitochondrial trafficking dynamics, it appears that the 
total loss of astrocyte Miro1 prevents the docking of astrocyte mitochondria in close 
proximity to synapses. This supports the previous data showing that this ability is lost when 
the EF-hand mutant from of Miro1 is overexpressed in astrocytes. Functionally, altering 
astrocyte mitochondrial trafficking and positioning appears to have important consequences 
for the outgrowth of astrocyte processes, which would undoubtedly impact on the ability of 
astrocytes to modulate signalling at the tri-partite synapse. Specifically, Miro1KO astrocytes 
appear to have severely reduced process complexity compared to Miro1WT astrocytes. Thus, it 
can be concluded that Miro1-dependent regulation of astrocyte mitochondrial positioning is 
important for the arborisation/stabilisation of astrocyte processes. 
In addition, removing Miro1 from astrocytes impairs the formation of excitatory synapses. 
Importantly, the number of homer-VGLUT1 contact was greatly reduced when WT neurons 
were co-cultured with Miro1KO astrocytes. This supports the data in the previous chapter 
showing that the EF-hand mutant form of Miro1 overexpressed in astrocytes reduces the 
formation of excitatory synapses and the presence of GluR2-containing post-synaptic 
AMPARs. Removing astrocyte Miro1 also reduced the number and area of GluR2-containing 
post-synaptic AMPARs, critical for functional synaptic transmission. Interestingly, there was 
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a greater reduction in synapse density with the total loss of Miro1 than with overexpression of 
the EF-hand mutant form of Miro1. This links with the idea that peri-synaptic astrocyte 
processes alter the formation and functionality of synapses and here this was shown to be 
dependent on the spatial regulation of astrocyte mitochondria by Miro1.  This potentially 
implicates astrocyte Miro1 in the pathogenesis of neurological diseases/disorders. 
 
Interestingly, WT neurons grown with astrocytes from patients with Down’s syndrome have 
abnormal spine development, reduced synaptic density and activity (Garcia et al., 2010). 
Astrocytes from Fmr1 deficient mice (Fmr1 loss induces Fragile X Syndrome) also contribute 
to abnormal dendrite and synapse development (Jacobs et al., 2010). Methyl-CpG-binding 
protein 2 (MeCP2) deficient astrocytes (Rett Syndrome) have also been shown to impair 
neuronal outgrowth and dendrite development (Ballas et al., 2009). Additionally, DJ-1 KO 
astrocytes (a Parkinson’s Disease-associated mutation) render neurons more sensitive to toxic 
insults (Lev et al., 2013). Taken together, these results suggest that it would be interesting to 
investigate whether other aspects of neuronal functionality and development are altered when 
Miro1 is removed specifically from astrocytes, such as spine development and dendritic 
arborisation. Especially since totally removing Miro1 is lethal and neuron-specific loss of 
Miro1 causes a MND-like phenotype (Nguyen et al., 2014). 
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Chapter 6 
 
Final discussion  
 
6.1 Summary 
 
The trafficking of mitochondria within astrocyte processes has been shown to be dependent 
on both the microtubule and actin cytoskeletons (Kremneva et al., 2013, Jackson et al., 2014) 
but the motor proteins and adaptors involved were, until now, unknown. This thesis provides 
a clearer understanding of the mechanisms that underlie the control of mitochondrial 
trafficking in astrocyte processes, involving the EF-hand Ca2+-sensing motifs of the 
mitochondrial Rho-GTPase protein, Miro1. This thesis reveals novel evidence that disrupting 
the spatial regulation of astrocyte mitochondrial, dependent on Miro1, has consequences not 
only for intracellular astrocyte Ca2+ signalling and astrocyte process outgrowth, but also for 
excitatory synapse formation, including the presence of post-synaptic GluR2-contaning 
AMPARs. This, crucially, implicates astrocyte Miro1 in modulating the formation of 
synapses, where disrupted astrocyte Miro1 may induce elevated gliotransmission affecting 
signalling of the surrounding neurons.  
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6.2 Basal mitochondrial trafficking in astrocytes 
 
Initially, mitochondria were shown to be present in the processes of astrocytes where the 
thinner processes contained smaller, more round mitochondria. When compared to neuronal 
mitochondria in situ, the number of mobile mitochondria was decreased in astrocytes 
processes, as well as the speed at which they were capable of moving, supporting previous 
investigations (Jackson et al., 2014). However, astrocyte mitochondria were still capable of 
covering the same distances as neuronal mitochondria. These differences in trafficking 
dynamics could be due to different trafficking machinery utilised by neurons and astrocytes. 
Mitochondrial mobility in astrocyte processes was directly related to intracellular Ca2+, where 
they were mobile in regions of low intracellular Ca2+ and relatively immobile in regions of 
high intracellular Ca2+. These results, taken together, reveal that mitochondrial trafficking in 
astrocyte processes is dependent on the levels of intracellular Ca2+. 
 
6.3 Activity-dependent mitochondrial trafficking regulation in astrocytes 
 
Enhancing neuronal activity alters astrocytic mitochondrial morphology and trafficking 
dynamics in culture and in situ. Mitochondria became shorter with a concomitant reduction in 
movement in astrocyte processes, when synaptic activity was stimulated with 4-AP and when 
glutamatergic signalling was stimulated with glutamate. This reduction in mobility was 
transient, where recovery was seen 30 minutes and 15 minutes following treatment with 4-AP 
and glutamate, respectively. Conversely, blocking neuronal activity with TTX increased 
mitochondrial trafficking in astrocyte processes. Stimulating neuronal activity with electrical 
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field stimulation, in culture, also rapidly reduced astrocyte mitochondrial trafficking. This 
reduction was also transient, where astrocyte mitochondrial mobility and speed recovered to 
basal levels (pre-stimulation) within 5 minutes. Thus, it can be concluded that mitochondrial 
trafficking in astrocytes is tightly coupled to neuronal activity. The response to activity is 
shown here to dependent on activation of glutamate receptors and involves elevations in 
intracellular Ca2+, possibly occurring via mGluRs and/or astrocyte NMDARs (Figure 6.1).  
 
In addition to arresting mitochondria and inducing remodelling/fission in astrocyte processes, 
stimulating neuronal activity resulted in astrocyte mitochondrial becoming confined near 
synapses. Astrocyte mitochondria position themselves near VGLUT1 labelled pre-synaptic 
terminals, following glutamate treatment in culture and 4-AP in situ. This retention was also 
transient, where mitochondria remained confined and immobile near Sy-GCAMP5 labelled 
pre-synaptic terminals for ~ 100 seconds, before moving away ~ 160 seconds following field 
stimulation. The timescale for astrocyte mitochondrial confinement near pre-synaptic 
terminals (~ 60s) was comparable to neuronal dendrite post-synaptic mitochondrial retention 
(~ 60s). However, neuronal mitochondrial retention persisted for longer than in astrocytes 
(120 s vs 100 s). This may have important consequences for the modulatory role of astrocytes 
at the synapse. Taken together, these results reveal that neuronal activity regulates 
mitochondrial trafficking in astrocytes and when synaptic transmission is elevated, astrocyte 
mitochondria become transiently confined in close proximity to synapses to provide localised 
energetic and metabolic support. The spatial regulation of astrocyte mitochondria could have 
important consequences for Ca2+ wave propagation and gliotransmission. This means that 
astrocytes regulate mitochondrial positioning along their processes to meet the demands, not 
only of astrocyte signalling but that of the surrounding neurons.  
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6.4 Miro1 EF-hand-dependent regulation of astrocyte mitochondrial 
trafficking dynamics   
The first attempts to examine the role of Miro1 in astrocytes were made in this thesis. Miro1 
was shown, for the first time, to be expressed in rodent astrocytes, where it is present on the 
mitochondria. Subsequently, as mitochondrial mobility in astrocyte processes was inversely 
correlated to intracellular Ca2+, it was investigated if this ability was dependent on the EF-
hand Ca2+-sensing domains of Miro1. Overexpression (OE) of the EF-hand Miro1 mutant 
(Miro1∆EF) disrupted the ability of astrocyte mitochondria to immobilise within regions of 
high intracellular Ca2+, indicating that these domains are important for regulating Ca2+-
dependent stopping under basal conditions. The EF-hands of Miro1 are not, however, 
required for basal mitochondrial trafficking. The EF-hand Ca2+-sensing motifs of Miro1 
where, however, shown to be necessary for activity-dependent stopping of astrocyte 
mitochondria, both in culture and in situ. OE of the Miro1 mutant (Miro1∆EF) abolished the 
ability of astrocyte mitochondria to respond to neuronal activity (preventing their activity-
dependent stopping and remodelling). Both mobility and speed of astrocyte mitochondria 
were similar to basal conditions (prior to treatment) with Miro1∆EF OE. Mutating the EF-hands 
is, therefore, proposed to disrupt Miro1’s interactions with pro-fission proteins, such as Drp1. 
In conclusion, the EF-hands of Miro1 are important for regulating activity-driven 
mitochondrial stopping and remodelling in astrocyte processes (Figure 6.1). 
 
The EF-hands of Miro1 also appear to be important for the activity-driven retention of 
mitochondria in close proximity to synapses. This further suggests that Ca2+ binding the EF-
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hands of Miro1 are important for inducing mitochondrial stopping at predicted Ca2+ hot spots, 
such as synapses. Finally, Miro1∆EF OE, in situ, alters the ability of astrocytes to regulate their 
intracellular Ca2+ levels. Miro1∆EF OE increased the frequency and amplitude of basal Ca2+ 
transients and increased the intracellular Ca2+ response to 4-AP and ATP. Here, astrocytes 
may be more vulnerable to Ca2+ overload when the Ca2+-sensing abilities of Miro1 are 
disrupted. Disrupted intracellular Ca2+ regulation in astrocytes could have important 
consequences for their unique propagation of Ca2+ waves and suggests that the spatial 
regulation of mitochondria by Miro1 plays an important role in regulating astrocyte 
signalling. Since the regulation of intracellular Ca2+ also has the potential to impact on 
gliotransmission, this reveals another potential route for bi-directional communication 
between astrocytes and neurons. This could be linked to instances of pathology, as disrupted 
astrocyte Ca2+ dynamics due to altered mitochondrial function has devastating consequences 
for neuronal function (Katayama et al., 1995, Danbolt, 2001, Shin et al., 2005, Voloboueva et 
al., 2007, Li et al., 2008, Bradford et al., 2009, Oliveira and Goncalves, 2009).  
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Figure 6.1 Proposed Miro1 EF-hand-dependent mitochondrial trafficking regulation in astrocyte 
processes. A. Schematic representation of an astrocyte containing a mitochondrion that buffers the 
uptake of Ca2+ expected to ensue from increased neuronal activity. This is proposed to involve 
ionotropic glutamate mediated astrocyte Ca2+ entry. Ai. During low levels of activity astrocyte Ca2+ is 
low and mitochondria are mobile and elongated. Upon Ca2+ elevations, which occur as a result of 
increased neuronal activity astrocyte mitochondria become round and their trafficking ceases. 
Subsequently, they dock near synapses. Downstream, this regulation has important consequences for 
the surrounding neuronal architecture. 
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Interestingly, basal Ca2+ transients are elevated in astrocytes in mice expressing mutant 
human Aβ precursor protein (Kuchibhotla et al., 2009). This was observed to induce 
mitochondrial depolarisation through activation of the DNA repairing enzyme poly ADP-
ribose polymerase-1 (PARP-1) and opening mitochondrial permeability transition pore 
(mPTP) (Angelova and Abramov 2014). With beta-amyloid peptide treatment astrocyte 
specific mitochondrial disruptions precedes any neuronal phenotype associated with AD. In 
the study conducted by Angelova and Abramov 2014, amyloid-β peptide (Aβ) induced 
elevated Ca2+ signalling in astrocytes but not in neurons. This was due to the high levels of 
membrane cholesterol expression in astrocytes. Aβ significantly reduced the levels of 
glutathione (GSH) in neurons and astrocytes, an effect that was dependent on Ca2+ entry from 
external sources. Altering membrane cholesterol regulation modified the astrocyte response to 
Aβ (elevated Ca2+ signalling, ROS production and mitochondrial depolarisation), which lead 
to improved neuroprotection (Angelova and Abramov, 2014, Narayan et al., 2014). This 
indicates that astrocyte intracellular Ca2+ regulates mitochondrial function and that both are 
disrupted in disease. 
Astrocyte mitochondrial positioning could be important for regulating the release of neuro-
active substances from astrocytes. This could include synaptogenic molecules or substances 
that promote synapse elimination. The mechanisms controlling release of these astrocyte-
derived factors are relatively unclear. Although there are caveats to using an overexpression 
system, where endogenous astrocyte Miro1 is present it does highlight the functional 
importance of mitochondrial positioning in astrocyte processes. 
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Importantly, in addition to regulating astrocyte signalling, the EF-hands of Miro1 also appear 
to have important functional consequences for the surrounding neuronal architecture. OE of 
the mutant form of Miro1 alters the formation of excitatory synapses as well as the number 
and size of GluR2-containing post-synaptic AMPARs. Mutating the Ca2+ sensing domains of 
Miro1 may mean that there is an increased likelihood of gliotransmitter release, since the rise 
in intracellular Ca2+ directly correlates to the release probability of transmitters such as 
glutamate from astrocytes (Parpura and Zorec, 2010). Subsequently, prolonged 
gliotransmitter release may disrupt neuronal signalling and cause excitotoxic cell death. A 
decrease in synaptic density may indicate cell death or a compensatory response in order to 
down-regulate synaptic activity to counteract the increased presence of gliotransimitters 
released by nearby astrocytes. More broadly it shows that the consequence of disrupted 
intracellular astrocyte Ca2+ signalling, through altered Miro1-EF-hand-dependent 
mitochondrial positioning, does indeed have an impact on the surrounding neuronal 
environment.   
 
6.5 Consequences of the total loss of astrocyte Miro1  
A total loss of astrocyte Miro1, in culture, supports the data showing that the EF-hands of 
Miro1 are important for regulating aspects of astrocyte mitochondrial trafficking and 
positioning, which has important consequences for astrocyte signalling. More specifically, 
Miro1KO in astrocytes induces more profound effects than mutating the EF-hands of Miro1 in 
an overexpression system. 
Miro1KO astrocytes displayed severely disrupted mitochondrial morphology and trafficking 
dynamics, where the majority of the mitochondria were round and immobile compared to 
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Miro1WT astrocytes (in the presence of WT neurons). This may be due to the loss of all of 
Miro1’s regulatory domains and where other mitochondrial adaptors/regulators have been 
proposed in neurons (Cai et al., 2005, Nguyen et al., 2014), this may not be the case in 
astrocytes. Given that the EF-hand mutant only has two point mutations, it may be that the 
EF-hand domains are still capable of maintaining elongated mitochondrial morphology 
potentially via interactions with mitofusins (Misko et al., 2010), where the Miro1KO astrocytes 
loose this ability. This warrants experimentations to decipher exactly which domains of Miro1 
regulate mitochondrial morphology and trafficking. 
As well as having severely disrupted basal mitochondrial trafficking dynamics, it appears that 
the total loss of astrocyte Miro1 prevents activity-dependent docking of astrocyte 
mitochondria in close proximity to synapses. This supports the previous data showing that 
this ability is lost when the EF-hand mutant from of Miro1 is overexpressed in astrocytes. 
Similarly, removing Miro1 from astrocytes impairs the formation of excitatory synapses. 
Importantly, the number of homer-VGLUT1 contact was greatly reduced. Additionally, 
removing astrocyte Miro1 also reduced the number and area of GluR2-containing AMPARs, 
critical for functional synapse formation. Interestingly, there was a greater reduction in 
synapse density with the total loss of Miro1 than with OE of the EF-hand mutant form of 
Miro1. Even though there are still native WT astrocytes in the WT neuronal cultures used in 
co-culture with Miro1KO astrocytes, the effects were still observed. However, it would be 
interesting to titre down the number of Miro1KO introduced to the WT cultures to see if fewer 
astrocytes may induce these effects on synapse formation.  
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Disrupted astrocyte mitochondrial positioning might affect the formation of excitatory 
synapses through increased release of astrocyte factors that promote synapse elimination, a 
decrease in astrocyte-released synaptogenic molecules or through direct activation of 
astrocytic phagocytic pathways. A candidate astrocyte factor SPARC negatively regulates 
synaptogenesis, which is important for preventing over-excitation in the CNS (Jones and 
Bouvier, 2014). Astrocyte-released SPARC reduces the levels of post-synaptic AMPARs. 
Neurons grown with SPARC KO astrocytes had significantly more surface containing GluR1 
and GluR2 synapses than neurons co-cultured with SPARC WT astrocytes. Jones and 
colleagues also found enhanced synaptic signalling and impaired LTP in hippocampal slices 
from SPARC KO mice (Jones et al., 2011). They show that SPARC regulates surface 
AMPARs through β3-integrin receptors, which have been shown to stabilise GluR2 subunits 
at synapses (Clingolani et al., 2008). SPARC-like-1 or Hevin increases synapses in RGCs in 
vitro and in vivo and is required for their maturation (Kucukdereli et al., 2011). 
Thrombospondins (TSPs) decrease synaptic AMPARs, so decreasing neuronal excitability 
(Sloan and Barres, 2014). Lack of TSPs leads to defects in injury-induced structural plasticity 
of the developing barrel cortex (Eroglu et al., 2009) and hampers synaptic recovery after 
stroke, showing an important role for astrocyte-derived TSPs in regulating the formation of 
new synapses. In addition, reducing the levels of Gpc4 and Gpc6 reduced clustering of 
surface GluR1-containing AMPARs and reduced synaptic activity (Allen et al., 2012). It may 
be that through disrupted astrocyte mitochondrial dynamics the release of synaptogengic 
molecules such as SPARC-like-1 (Hevin), TSPs or Gpc4/6 are reduced. 
 
Astrocytes increase postsynaptic activity by inducing AMPA receptor localization to the 
postsynaptic density, and enhance presynaptic function by increasing release probabilities 
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(Chung et al., 2015). Interestingly, reactive astrocytes have been shown to release GABA in a 
mouse model of Alzheimer’s disease (AD), reducing the spiking activity of granule cells in 
the dentate gyrus (Jo et al., 2014). A reduction in excitatory synapse formation might be 
explained by an increase in inhibitory signalling either through homeostatic plasticity or 
through the release of inhibitory transmitters from disrupted astrocytes. In terms of pathology, 
disrupted glutamatergic signalling contributes to the pathogenesis of schizophrenia 
(Moghaddam and Javitt, 2012). Importantly, Motori and colleagues highlight that a failure to 
maintain the functional architecture of mitochondria affects astrocyte survival (Motori et al. 
2013). In addition, specific disruption of astrocyte mitochondrial function has dramatic 
consequences for aspects of neuronal function and in some cases survival. Treatment with 
flurocitrate (FC) induced specific disruptions in astrocyte mitochondrial function and resulted 
in focal, followed by global epileptiform activity (epilepsy) with some animals exhibiting 
convulsive seizures (Voloboueva et al., 2007). This resulted in neuronal damage and eventual 
death. In addition to this, abnormal synapse development, function and elimination were 
observed along with an imbalance in the E/I balance. mHtt (a mutation associated with HD) 
compromised the ability of astrocytes to buffer glutamate at the synapse, decreasing the 
threshold for excitotoxic neurodegeneration (Oliveria and Goncalves, 2009). In Fragile X 
Syndrome, astrocytes contribute to abnormal dendrite and synapse development in Fmr1 (loss 
of which induces Fragile X) deficient mice (Jacobs et al., 2010).  
 
6.6 Future directions 
 
Future studies will seek to determine the precise role of astrocytes in altering synapse 
formation, which may help to develop new therapies for synaptopathies, for example. A 
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question that should be addressed is under what circumstances are astrocyte-derived factors 
released? Alternatively, blocking gliotransmission in the early stages of pathology may 
improve disease outcome. Additionally, human iPSC-derived astrocytes from affected 
patients could help to confirm observations made in rodent models and lead to potential 
therapeutic strategies.  
 
Further work is required to confirm the exact interactions that mediate mitochondrial binding 
to the astrocytic transport network, which could be actin or microtubule dependent (Jackson 
et al., 2014). Whether direct astrocyte Ca2+ entry occurs through activation of the reverse 
mode of the Na+/Ca2+ exchanger (NCX) also remains to be investigated. The results showing 
that the EF-hands of Miro1 play an important role in regulating mitochondrial trafficking 
dynamics in slices reveals that there may be an equally important role for Miro1 in vivo. It 
would be interesting to test whether Miro1 OE alters mitochondrial membrane potential and 
consequently their ability to buffer Ca2+. 
 
Miro1 OE has been shown to improve disease outcome. Specifically, it has been shown to 
rescue epithelial damage by enhancing mitochondrial transfer from mesenchymal stem cells 
to epithelial cells (Ahmad et al., 2014). However, it remains to be investigated if Miro1 OE 
can improve the outcome of neurodegenerative diseases, such as AD, where mitochondrial 
dysfunction has been implicated specifically in astrocytes. More specifically, a potential 
therapeutic intervention exists in the form of astrocyte specific antioxidants along with 
increasing astrocyte mitochondrial biogenesis.  
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While ablating astrocyte Miro1 was shown in this thesis to disrupt the number of excitatory 
synapses, it would be useful to investigate whether astrocyte Ca2+ signalling was also 
disrupted in Miro1KO astrocytes in the same way as OE the EF-hand mutant in astrocytes. 
Further, it would be interesting to analyse the dynamics of spontaneous synaptic events of 
WT neurons in the presence of Miro1KO astrocytes. Spiking activity of WT neurons could be 
analysed using electrophysiological techniques or by transfection with a GECI such as 
GCaMP6f in the presence of Miro1KO astrocytes. Additionally, a total loss of astrocyte Miro1 
might affect other aspects of neuronal development such as dendrite arborisation and/or spine 
maturation. 
 
Analysis of neuronal transmission in specific astrocyte Miro1KO slices using GFAP-cre/lox 
induced KO requires investigation. This astrocyte specific Miro1KO system could also be used 
for in vivo analysis of astrocyte mitochondrial trafficking and positioning and the 
consequences for the neuronal development and function. Another approach could be to use 
an adenovirus or biolistic Rnai knockdown of Miro1 in astrocytes in slices, allowing analysis 
of a total loss of astrocyte Miro1 in an intact system.  
 
In this thesis Miro2 was also expressed by astrocytes and in the case of mouse hippocampal 
astrocytes to a higher degree than Miro1. Therefore bearing this in mind, it would be 
interesting to investigate the consequences of a total loss of Miro2 on astrocyte signalling. 
More importantly the loss of both astrocyte Miro1 and Miro2 requires investigation, as this 
may have more profound consequences for astrocyte and neuronal signalling. 
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Miro has also recently been shown to be involved in the cascade that regulates neuronal 
mitophagy (Wang et al., 2011, Birsa et al., 2014, Tsai et al., 2014) and consequently, the 
exact regulation of mitophagy in astrocytes is an important mechanism that remains to be 
addressed (Stephen et al., 2014). It may be that mitophagy is regulated on a different 
timescale to neuronal mitophagy and if this is the case it could explain why astrocyte 
dysfunction precedes signs of pathology in neurons (Abramov et al., 2004). Miro itself has 
also been implicated in disease (Iijima-Ando et al., 2012, Liu et al., 2012). Therefore, along 
with the data shown in this thesis, this alludes to the possibility that astrocyte mitochondrial 
regulation by Miro is important, not only for astrocyte function, but also for neuronal 
signalling, especially in the context of pathology.  
 
6.7 Concluding remarks 
 
In conclusion, this thesis answers a few crucial questions regarding astrocyte energetic and 
metabolic support of neurons. Miro1 was shown to be important for regulating mitochondrial 
positioning in astrocyte processes. This spatial regulation of astrocyte mitochondrial is shown 
here to be important for maintaining astrocyte process outgrowth and Ca2+ signalling, 
potentially impacting on the release of gliotransmitters, which affects the number of 
excitatory synapses and the presence of GluR2-containing post-synaptic AMPARs. 
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